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Abstract 
 
Neuroimaging has enabled important progress in understanding the neurobiology of social 
anxiety disorder (SAD). Functional neuroimaging experiments in SAD have mostly focused 
on regional neural activity in response to anxiety provocation or processing of emotional 
faces, and have found hyper-activations in limbic and paralimbic circuitry. Relatively little 
however, is known about resting-state conditions in SAD and how these are affected by 
pharmacotherapy. What is known is almost entirely based on functional magnetic resonance 
imaging (fMRI) techniques which, while powerful, have some important limitations. 
Similarly, there has been only limited work investigating the resting neural correlates of 
social cognitive biases in SAD; how reward processing is disrupted in the condition; and how 
these respective features are affected by therapy. 
 
This thesis presents the first work on SAD investigating resting functional connectivity 
(RFC) based on nuclear neuroimaging methods. In an experiment that analysed RFC based 
on single photon emission computed tomography with technetium-99m hexamethyl 
propylene amine oxime, it was found that RFC differences in SAD were largely consistent 
with a contemporary network model based on fMRI, as well as implicating disrupted 
connectivity of the cerebellum. Another novel finding was how pharmacotherapy in SAD 
increased RFC of the anterior cingulate cortex. 
 
Using graph theory and resting-state fMRI, the first evidence of reduced global efficiency and 
increased clustering coefficients within the theory-of-mind network in SAD as well as 
independent evidence of social attribution bias in the same sample were reported. 
 
In an experiment that investigated regional resting metabolism in the disorder, there was 
evidence of abnormality in SAD compared to controls, as well as evidence of 
pharmacotherapy effects, in several biologically relevant regions. These results merit further 
investigation. 
 
Finally, in an fMRI-based experiment on reward processing in SAD, initial results identified 
no evidence of disrupted processing on a monetary reward task. 
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The findings here support a neurobiological model of SAD in which alterations in resting 
regional metabolism may underlie disruptions in resting brain networks that have been 
implicated as being important in social cognitive processing. The results also suggest that 
pharmacotherapy may affect resting-state conditions through compensatory effects. Finally, 
the provisional findings are consistent with the theory that reward deficits in SAD may be 
limited to the processing of social reward, and may not extend to the processing of other 
reward types. Future SAD research should focus on collaborative work, using pooled 
datasets, and place greater emphasis on molecular disruptions in neurotransmitter systems 
involved in the disorder. 
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Opsomming 
 
Breinbeelding het belangrike vooruitgang in ons begrip van die neurobiologiese onderbou 
van sosiale angssteuring (SAS) moontlik gemaak. Funksionele breinbeeldingseksperimente in 
SAS het tot dusver meestal gefokus op aktiwiteit in spesifieke areas in reaksie op die 
ontlokking van angs of tydens die verwerking van emosionele gesigsuitdrukkings, en 
resultate het op hiperaktiwiteit in limbiese en paralimbiese kringe gedui. Relatief min is egter 
bekend oor rustende breintoestande in SAS en hoe dit deur farmakoterapie geraak word. Wat 
wel bekend is, berus grootliks op tegnieke van funksionele magnetiese resonansie beelding 
(fMRB). Hierdie tegnieke, hoewel kragtig, het enkele belangrike beperkings. Daar is ook min 
bekend oor die veranderlikes in die brein wat verband hou met die disfunksionele kognitiewe 
sosiale vooroordele tipies van SAS, oor die verwerking van beloning in SAS, en hoe hierdie 
eienskappe deur terapie geaffekteer kan word. 
 
Hierdie proefskrif sluit die eerste SAS-data oor rustende funksionele konnektiwiteit (RFK) in 
die brein – wat gebaseer is op kerngeneeskundige breinbeeldingsmetodes – in. Hierdie 
bevindinge oor RFK (wat gebaseer is op enkelfoton-emissie-rekenaartomografie wat 
technesium-99m heksametielpropileenamienoksiem gebruik), stem grootliks ooreen met 'n 
kontemporêre netwerkmodel wat op fMRB gebaseer is, en dat die RFK van die serebellum in 
SAS ontwrig is. Nog ŉ nuwe bevinding is dat farmakoterapie in SAS RFK van die anterior 
singulaat korteks verhoog. 
 
Deur gebruik te maak van grafiese teorie en fMRB in die rustende toestand, word die eerste 
bewyse van verminderde globale doeltreffendheid en verhoogde trosvormingskoëffisiënte 
binne die “theory-of-mind” breinnetwerk in SAS, sowel as onafhanklike bewyse van sosiale 
attribusie vooroordele (“social attribution bias”) in die steuring gelewer. 
 
Na aanleiding van ŉ ondersoek oor rustende metabolisme in sekere brein-areas in SAS, word 
abnormaliteite in SAS in vergelyking met gesonde kontrolepersone gerapporteer, sowel as 
bewyse van die effek van farmakoterapie op verskeie biologies-relevante areas gelewer. 
Hierdie resultate regverdig verdere navorsing. 
 
Stellenbosch University  https://scholar.sun.ac.za
 vi 
 
Ten slotte, in 'n fMRB-gebaseerde eksperiment oor die verwerking van beloning in SAS was 
daar geen bewyse van ontwrigte verwerking in monetêre beloning nie. 
 
Hierdie bevindinge ondersteun 'n neurobiologiese model van SAS waarin veranderinge in 
rustende metabolisme in sekere brein-areas onderliggend is aan die ontwrigting van rustende 
brein-netwerke wat belangrik is tydens sosiale kognitiewe prosessering. Die bevindinge dui 
ook daarop dat farmakoterapie RFK in SAS beïnvloed, moontlik via die aktivering van 
kompenseringsmeganismes. Ten slotte, die voorlopige resultate stem ooreen met die teorie 
dat tekorte ten opsigte van die verwerking van beloning in SAS moontlik beperk is tot die 
prosessering van sosiale beloning, en dat dit nie veralgemeen kan word na die verwerking 
van ander beloningstipes nie. Toekomstige SAS-navorsing behoort op samewerking met 
ander navorsingsgroepe te fokus, sodat gesamentlike groter datastelle gebruik kan word. 
Bykomend hiertoe behoort daar groter klem te wees op ondersoeke na die ontwrigting op 
molekulêre vlak in die neuro-oordragstelsels van individue met SAS. 
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Introduction 
 
Background Information 
 
People with social anxiety disorder (SAD) experience excessive anxiety during, or while 
anticipating, social interactions. Sufferers exhibit excessive fear that they will be embarrassed 
or humiliated by their actions or words, and dread that evidence of their distress (such as 
sweating, tremor, blushing, stammering) will be noticed by others. As a result, social 
situations are either avoided, or endured with intense discomfort (American Psychiatric 
Association and DSM-5 Task Force 2013). When one considers that humans are an 
inherently social species, that we have a need to feel accepted and liked by others, and that 
we derive much of our joy from the reward of interpersonal relationships, it becomes clear 
that a condition that impairs one’s ability to experience and enjoy social interaction is 
particularly cruel. SAD sufferers have been shown to experience a lower quality of life, and 
have higher rates of unemployment and absenteeism, greater risk of suicide, and higher risk 
of comorbid substance abuse and depression (Wittchen and Beloch 1996; Lecrubier et al. 
2000).  
 
SAD typically starts in childhood or adolescence (between 10 and 16.6 years of age), is more 
common in women than men (3:2), and has a higher lifetime prevalence in developed (6-
12%) than in developing (2.1%) countries (Wittchen and Fehm 2003; Kessler RC et al. 2005; 
Stein et al. 2010, 2017). While there are several treatment options for SAD, including 
cognitive behaviour therapy and pharmacotherapy (e.g. with selective serotonin reuptake 
inhibitors or monoamine oxidase inhibitors), a significant proportion of patients do not 
respond to interventions (National Collaborating Centre for Mental Health (UK) 2013). 
Despite its prevalence and its morbidity, SAD has remained relatively understudied 
(Liebowitz et al. 1985; Nagata et al. 2015).  
 
Early research in SAD was mostly limited to investigating the behavioural features of the 
condition. These studies were predominantly focused on developing instruments to assist in 
diagnostic evaluation of anxiety patients, but some also explored the cognitive processing 
that characterized the disorder, and to a more limited extent, its underlying biology 
(Liebowitz et al. 1985). Such work for example, suggested differences in how patients with 
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SAD processed social information such as when attributing causes to socially-relevant 
outcomes (Heimberg et al. 1989), and confirmed physiological arousal (on monitoring of 
heart rate, breathing and skin conductance) in performance contexts (Johansson and Öst 
1982). This work was important, but could only progress knowledge of the disorder so far. 
The real breakthrough that would fundamentally change neuropsychiatric research came in 
the mid-1980s. This period marked the adoption and rapid growth in availability of scanners 
capable of imaging brain anatomy and function in three dimensions. Since then, functional 
neuroimaging techniques such as single photon emission tomography (SPECT), positron 
emission tomography (PET), and functional magnetic resonance imaging (fMRI) have been 
used to great effect in furthering our understanding of psychiatric conditions, including SAD. 
 
The great value of neuroimaging in psychiatric research is that it provides a non-invasive 
means to study the structure and function of the living brain (Fallgatter 2009; Linden 2012). 
The technical sophistication of neuroimaging techniques has grown dramatically over the 
past three decades. It is now possible to image the brain with high anatomical resolution, to 
image regional neural activity both at rest and while performing tasks, to study the brain’s 
chemical composition, as well as image neurotransmitter systems with great accuracy. In 
parallel with these developments, has been the evolution of techniques to quantify and 
analyse neuroimaging data, in combination with the use of ever more-powerful computing 
resources. In this thesis, work using several of these state of the art techniques applied to the 
study of SAD is presented. 
 
Purpose of Study, Research Objectives  
 
In defining research objectives, it is useful to consider the broader objectives of neuroimaging 
research in psychiatric conditions in general. Firstly, we want to understand the 
pathophysiology (“neurobiology”) of the disorder: in terms of features that predispose to the 
condition, in terms of features that are present (and may eventually be diagnostic) once the 
disorder is manifest, and the change in these features during the disease’s natural progression. 
Secondly, we want to understand the influence of genetics (including epigenetics) and 
environmental factors on the brain (its neurochemistry, neural systems, and anatomy), and 
how these effects result in witnessed behaviours (phenotype). This levels-based approach to 
brain research has been termed the endophenotype concept (Gottesman and Gould 2003). 
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Finally, neuroimaging research may be extremely valuable to study therapy: in terms of 
identifying therapeutic targets, in terms of investigating the mechanisms of action of various 
interventions, and perhaps in the future, identifying features that predict response to treatment 
options (Linden 2006, 2012; Fallgatter 2009). 
 
Placed in this context, very little is actually known about SAD. Researchers have however, 
taken several crucial steps in investigating some of the important basic neural features of the 
disorder and have gone some way to identify several candidate endophenotypes (Bas-
Hoogendam et al. 2016). Fundamentally, functional neuroimaging studies in SAD (including 
both magnetic resonance and nuclear imaging experiments) have contributed in two ways. 
Firstly, they have compared neural activity in the disorder with that of healthy controls, both 
in terms of regional differences, and in terms of how functional relationships between 
different regions (functional connectivity) are altered. Such studies have found SAD-related 
differences within multiple regions (and in interregional relationships), including within (and 
between) limbic and paralimbic structures, various frontal cortical regions, insula, fusiform 
gyrus, precuneus and striatum (Etkin and Wager 2007; Freitas-Ferrari et al. 2010; Brühl et al. 
2014a). The second principal contribution of functional neuroimaging techniques has been to 
elucidate, to a limited degree, disruptions in brain chemistry and neurotransmitter function in 
SAD. These studies have for example, found evidence for differences in regional glutamate 
and N-acetyl-aspartate concentration (Howells et al. 2015) as well as evidence that implicates 
the serotonergic and dopaminergic neurotransmitter systems in the condition (Doruyter et al. 
2017a). Limited evidence suggests that therapy (principally pharmacotherapy) affects some 
of these neural features of SAD in various ways (Brühl et al. 2014a; Doruyter et al. 2017a). 
 
There is still much work to be done before a comprehensive neurobiological model of SAD is 
established and therapy effects are properly understood. In this thesis, several key knowledge 
gaps that merited further research were identified. On reviewing the academic literature in 
SAD, one observation is the paucity of nuclear neuroimaging studies performed in recent 
years. This is mostly due to a shift from nuclear techniques to magnetic resonance imaging 
(MRI) techniques. There are several advantages to MRI that explain this technique’s appeal 
but several important limitations too, that make nuclear methods either more appropriate or 
complementary for the provision of some information (Doruyter et al. 2017a). Findings on 
nuclear imaging studies that support results of MRI-based experiments strengthen the 
existing evidence. However where results differ, questions must be raised regarding the 
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relationship between each measurement and the normally more fundamental biological 
process for which they serve as a surrogate, as well as the reliability of each measurement.  
 
Prior to work presented herein, no resting functional connectivity experiments had been 
performed with nuclear imaging techniques in SAD, and only a single study had investigated 
resting regional metabolism in the disorder.  
Two studies using fMRI are presented. With the exception of one study linking resting 
functional connectivity to the processing of facial emotion, no previous fMRI experiments 
had attempted to correlate resting functional connectivity measures in SAD with a social 
cognition measure. In addition, this work includes one of the few SAD experiments utilizing 
graph theory (functional connectivity at the network level) and is the first to correlate resting 
graph metrics with a measure of social attributional style. This sort of work is valuable in that 
it seeks to identify the behavioural significance of neuroimaging findings in the condition. 
The other fMRI study adds to the limited body of work on reward processing in SAD by 
performing task-based fMRI with a modified version of the monetary incentive delay task. 
Further research in this direction is important, given indirect evidence that reward processing 
may be affected in the condition. Finally, an additional feature common to all the experiments 
in this thesis, was the inclusion of a therapy component in which the effect of a course of 
pharmacotherapy on neuroimaging measures in SAD participants was tested. Neuroimaging 
research on the effects of treatment in SAD is sparse, and yet vitally important given the 
unpredictability of treatment response and incomplete knowledge of how medications exert 
their effects. 
 
The studies presented in this thesis thus had several objectives: 
 To identify, using nuclear imaging techniques, differences in resting functional 
connectivity and resting regional neural activity between SAD participants and healthy 
controls (HCs). 
 To test whether graph metrics based on resting-state fMRI were different between SAD 
and HC groups and whether these could be correlated with a neurocognitive measure of 
social cognition.  
 To detect whether there were any differences in reward processing, measured on task-
based fMRI, between SAD and HC groups. 
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 To investigate whether a course of an approved medication for the treatment of SAD, had 
any effect on the above measures. 
 
Thesis, delineation, research questions  
 
This thesis has been compiled in one of the accepted alternative formats, namely a number of 
published and unpublished articles. One of these articles describes a retrospective 
experiment, three describe prospective experiments, and one represents a narrative review. 
The study population for all experiments was comprised of SAD participants in the Cape 
Town region (South Africa). All studies were conducted with the approval of the 
Stellenbosch University Health Research Ethics Committee. 
 
Experiments were designed around the following research questions: 
 Is there evidence, using nuclear imaging methods, of disrupted resting functional 
connectivity in SAD? How does resting regional neural activity change in SAD after a 
course of moclobemide or citalopram? 
 Is there evidence, using nuclear imaging methods, of disrupted resting regional neural 
activity in SAD? How does resting regional neural activity change in SAD after a 
course of pharmacotherapy? 
 Are there differences in graph metrics, based on resting-state fMRI, within the theory 
of mind network in SAD? Are there deficits in social attributional style in SAD? Can 
these graph metrics be correlated with social attributional style measures? How does a 
course of moclobemide in SAD affect these measures? 
 Are there any differences in how participants with SAD process monetary reward 
during a monetary incentive delay task on fMRI? How does a course of moclobemide 
affect monetary reward processing in SAD? 
 
Assumptions and limitations  
 
The principal assumption in all experiments was that there are intrinsic and generally 
consistent differences in neurobiology and/or neurocircuitry between people with SAD and 
people without psychiatric morbidity which can be detected using currently available 
neuroimaging and analysis techniques. It was also assumed that the samples would be 
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sufficiently representative of the SAD population, that findings would be generalizable to the 
condition, and that any group differences or effects of therapy would be sufficiently large to 
detect using the methods available.  
  
Brief Paper overviews 
 
Paper 1 (pg. 1) represents an overview of nuclear neuroimaging and how it compares to MRI 
techniques, reviews the contribution of nuclear neuroimaging in SAD research to date, and 
discusses possible future directions for SAD research in general. This manuscript has not yet 
been submitted for publication. 
 
Paper 2 (pg. 34) presents a retrospective experiment using perfusion SPECT data in which 
resting functional connectivity between SAD and HC groups was compared, and the effect of 
pharmacotherapy with either moclobemide or citalopram investigated in the SAD group. This 
work has been published in Psychiatric Research: Neuroimaging (Doruyter et al. 2016). 
 
Paper 3 (pg. 61) is written in the format of a short communication. It builds the argument for 
performing resting-state fMRI in social cognition research and presents a summary of 
literature in which resting-state fMRI measures were correlated with social cognition 
measures. This work has been published in Human Psychopharmacology: Clinical and 
Experimental (Doruyter et al. 2017d). 
 
Paper 4 (pg. 76) presents a prospective experiment in which resting graph metrics (based on 
resting-state fMRI) within the theory of mind network in SAD and HC participants were 
compared, group differences in social attributional style were tested for, and correlations 
between graph metrics and a social cognition measure investigated. The effects of 
moclobemide therapy on these measures in the SAD group were also investigated. This work 
is being prepared for journal submission. 
 
Paper 5 (pg. 104) presents another prospective experiment in which resting regional neural 
activity on PET between SAD and HC groups was compared, and the effect of moclobemide 
in the SAD group investigated. This work was awaiting decision by the journal at the time of 
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dissertation submission and has subsequently been published in Metabolic Brain Disease 
(Doruyter et al. 2017b). 
 
Paper 6 (pg. 128) presents a prospective experiment in which the processing of monetary 
reward between SAD and HC groups was compared (using fMRI) and the effects of 
moclobemide on reward processing in the SAD group investigated. Data collection on this 
experiment has been extended and there is a plan to submit this work for publication when 
the group sizes are larger. 
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Abstract 
 
In psychiatric research, nuclear imaging methods are complementary to those of magnetic 
resonance imaging (MRI). Nuclear methods can be used to study regional neural activity, and 
offer quantitative means of studying neurochemistry in-vivo. While recent neuroimaging 
reviews in social anxiety disorder (SAD) have predominantly focused on studies using MRI, 
the purpose of this paper was to review the contribution of nuclear imaging methods in SAD 
research to date. We discuss developments in, and future directions of nuclear imaging 
research in this field. 
 
Keywords: social anxiety disorder, positron emission tomography, single photon emission 
computed tomography; functional neuroimaging; molecular imaging 
 
Introduction 
 
Social anxiety disorder (SAD) is characterized by excessive anxiety in social or performance 
situations, a marked fear of negative evaluation, embarrassment and humiliation, leading to 
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clinically significant distress and functional impairment (American Psychiatric Association 
and DSM-5 Task Force 2013). Epidemiological data demonstrate that the condition is common, 
with a 6–12 % lifetime prevalence in developed countries (Kessler RC et al. 2005; Stein et al. 
2010, 2017). Why developing countries seem to have lower prevalence rates of SAD (e.g. 2.8% 
in South Africa) (Stein et al. 2008) is uncertain, but may relate to both genetic and 
environmental factors, as well as underreporting to lay interviewers. Functional impairment 
and morbidity due to SAD is frequently severe. Sufferers experience lower quality of life, 
higher rates of unemployment and longer absences from work, together with greater risk of 
suicide and increased comorbidity of depression and substance abuse (Wittchen and Beloch 
1996; Lecrubier et al. 2000; Katzelnick et al. 2001). There is evidence that both genetic and 
environmental factors play a role in the pathogenesis of SAD (Mathew et al. 2001; Miskovic 
and Schmidt 2012; Fox and Kalin 2014) but research into how the disorder develops, which 
neurobiological processes are involved, and why only some patients respond favourably to 
therapy is still a long way from complete.  
 
Current clinical guidelines on the management of SAD advocate cognitive behavioural therapy 
or pharmacotherapy as first line options. While many patients experience improvements in 
symptoms from these therapies, the proportion of patients that fully remit is uncertain (National 
Collaborating Centre for Mental Health (UK) 2013). Certainly, a significant proportion of 
patients experience minimal or no relief from therapy while responders frequently experience 
a recurrence of the disorder (Bruce et al. 2005). Greater understanding of how various 
treatments exert their effects in SAD and whether neuroimaging biomarkers can predict therapy 
response may represent a key focus of future research efforts. 
 
Neuroimaging modalities represent valuable tools to investigate brain function in psychiatric 
disorders, including in SAD. Several excellent reviews and meta-analyses of functional 
neuroimaging in SAD have consistently highlighted hyperactivity in limbic and paralimbic 
structures (Etkin and Wager 2007; Freitas-Ferrari et al. 2010) and have led to a network model 
of the disorder (Brühl et al. 2014a). Of these reviews, only those by Freitas-Ferrari et al. and 
Etkin and Wager included nuclear neuroimaging studies, while Brühl et al. focused exclusively 
on magnetic resonance imaging (MRI-) based work. Several additional nuclear imaging 
experiments have been conducted since the publication of these reviews. The aim of this 
narrative review is to summarize the contribution of nuclear neuroimaging to the SAD literature 
to date, and thereby complement recent reviews that have omitted molecular imaging 
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experiments. In the next section of this paper we will provide a brief introduction to nuclear 
imaging techniques and compare them to more familiar magnetic resonance methods. 
 
Methods 
 
Relevant literature was identified using the search terms (“social phobia” OR “social anxiety”) 
AND (“SPECT” OR “SPET” OR “single photon” OR “positron” OR “PET”) in PubMed 
(https://www.ncbi.nlm.nih.gov/pubmed).  
 
Nuclear imaging techniques 
 
Nuclear emission imaging (nuclear imaging) techniques rely on the principle that certain 
radionuclides emit gamma photons as a consequence of nuclear decay. These gamma photons 
pass through human tissue and can be detected and localized in three-dimensional space with 
specialized scanners. After injecting molecules of interest, labelled with such radionuclides 
(radiotracers), it is possible to image the brain at a specific time (static imaging) or, with certain 
radiotracers, over extended periods (dynamic imaging). Depending on the properties of the 
radiotracer and the limitations of the imaging system, various study designs allow researchers 
to investigate a variety of neurophysiological processes at rest, as well as during or after 
intervention.  
 
Imaging of radioactive emissions can be broadly separated into two main technologies, defined 
by the characteristics of the radioactive decay they image. Radionuclides that emit a single 
gamma photon per radioactive decay event are imaged using single photon emission computed 
tomography (SPECT). SPECT cameras are typically designed with one or more rectangular 
detectors that rotate around a patient. These detectors rely on collimation to register only 
photons travelling perpendicular to the detector plane, thereby limiting the emission location 
to somewhere in line with the relevant collimator hole. In this way, SPECT systems are able to 
record a series of two-dimensional projections from different angles and reconstruct these into 
a single three-dimensional volume, in which the regional distribution of radiotracer is relatively 
accurately represented.  
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Some radionuclides decay by emission of a positron (the antiparticle of an electron). The 
positron and a nearby electron will annihilate which results in the simultaneous emission of 
two photons travelling in opposite directions, per decay event. These photons are imaged using 
positron emission tomography (PET). Unlike SPECT cameras, modern PET cameras typically 
have hundreds of detector elements arranged in multiple ring arrays. These ring arrays 
completely encircle the subject and are stationary. Due to the fact that the photons of positron 
decay are emitted simultaneously and in opposite directions (180°), these systems are able to 
localize the location of a decay event (and thus the position of a radiotracer molecule) as 
somewhere between two detectors that have registered a simultaneous detection (coincidence) 
event. Coincidence logic results in more precise “lines of response” than those obtained with 
collimation in SPECT, with resultant improvements in spatial resolution and quantitative 
accuracy. With advancements in electronics, it has become possible to measure tiny 
discrepancies in the arrival time (at the detector) of each photon pair produced by positron 
decay, which allows systems to estimate a likely origin zone along individual lines of response, 
thereby improving spatial resolution still further. Our group has demonstrated previously how 
such time of flight (TOF) techniques are of benefit in brain imaging (Moalosi 2016). The 
simultaneous coverage of most projection angles as well as the superior localization capability 
of PET systems, make it better suited than SPECT to perform quantitative imaging and to 
image dynamic processes in vivo. The superior temporal and spatial resolution of PET is 
especially valuable in tracer kinetic modelling (Nelissen et al. 2012). Both PET and SPECT 
systems make corrections for the amount of attenuation photons undergo while traveling 
through tissues, typically by using serially-acquired low-dose x-ray computed tomography 
(CT). The principles of SPECT and PET imaging are illustrated in Fig 1.1, while examples of 
SPECT and PET images of the brain are illustrated in Fig 1.2. Examples of the (patho-) 
physiological processes that can be imaged with nuclear techniques, and the relevant 
radiotracers are summarized in Table 1.1. Much of the growth in the development of these 
tracers is driven by the fact that with carbon-11, a positron emitter, it is theoretically possible 
to manufacture the radiotracer equivalent of any molecule of interest, provided it contains 
carbon. In practice, the utility of such tracers is constrained by laboratory capability in 
producing the radiolabelled molecules of interest as well as the physical half-life of the relevant 
radionuclides which inherently limits the duration they can be imaged. It should also be pointed 
out that imaging of C-11 based tracers necessitates an on-site cyclotron, due to this isotope’s 
short half-life (20 min). There has however also been quite some work on tracers labelled with 
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fluorine-18 which due to its longer half-life (110 min) hold greater promise for commercial 
applications. 
 
Comparison with magnetic resonance imaging 
 
Like nuclear methods, MRI can be considered a functional neuroimaging modality. MRI relies 
on the application of a powerful magnetic field to modify the orientation of the spin of 
endogenous hydrogen atoms. The radiofrequency excitation induced in the brain by this 
magnetic field, can be detected using specialized coils.  
 
The targets of functional neuroimaging (both nuclear and MR-based) can be divided into two 
main categories: neuronal activity, and neurochemistry. 
 
While neuronal activity cannot be imaged directly, the tight coupling between neuronal firing 
and blood flow (neurovascular coupling), as well as neuronal firing and metabolism 
(neurometabolic coupling) offers several indirect means of imaging neural activity in vivo 
(Bélanger et al. 2011). In the case of functional magnetic resonance imaging (fMRI) this is 
performed by blood oxygen level dependent (BOLD) or arterial spin labelling (ASL) imaging 
which rely on the magnetic properties of either deoxyhaemoglobin or intra-arterial water 
respectively, to perform rapid, sequential imaging. In the case of nuclear imaging, measures of 
regional neuronal activity are obtained through dynamic imaging of regional cerebral blood 
flow with O-15 water PET, or by using static techniques such as F-18 fluorodeoxyglucose 
(FDG) PET and Tc-99m hexamethyl propylene amine oxime (HMPAO) SPECT which 
typically image integrated activity over a standardized uptake period. Nuclear and magnetic 
resonance techniques offer complementary information in this regard. Major advantages of 
fMRI techniques relate to their good temporal resolution and lack of ionizing radiation. Major 
advantages of nuclear methods relate to their relative resistance to artefact; homogeneity of 
signal-to-noise ratio; and the close correlation between the signal detected and target 
physiological processes. With both fMRI and nuclear methods, it is possible to analyse 
interregional correlations in neuronal activity (functional brain networks). Depending on the 
neuroimaging method, such brain networks can either be analysed using interregional temporal 
correlations or interregional cross-subject correlations, or both. A summary comparison of 
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fMRI and common nuclear techniques for the measurement of regional neural activation is 
presented in Table 1.2. 
 
The other main research area in functional neuroimaging is brain chemistry. The ability to 
perform in-vivo imaging of biologically active compounds in the brain has the potential to 
provide great insight into neurobiology and broaden our understanding of therapy effects. 
Again, both magnetic resonance and nuclear techniques play complementary roles in this 
regard. Magnetic resonance spectroscopy (MRS) is a technique that records a spectrum of 
atomic nuclear (typically proton – 1H) resonances across a range of magnetic gradients for 
different regions of brain tissue, typically on a voxel level (McRobbie 2006). On the basis that 
different brain metabolites exhibit different frequencies of resonance, it is theoretically possible 
to measure in vivo concentrations of these molecules by isolating individual peaks in the 
imaged spectra (Fig 1.3). It is also possible to perform dynamic MRS (fMRS) to study real-
time changes in brain chemistry (Apšvalka et al. 2015). There are currently two main factors 
that limit the application of MRS in imaging of brain function however. The first relates to the 
technical difficulties in separating peaks in the MR spectra. Peaks (of different chemicals) 
overlap, making accurate determination of individual chemical concentrations challenging, 
especially at the low (and frequently heterogeneous) signal to noise ratios experienced in 3-
tesla (3T) scanners (McKay and Tkáč 2016). The second limitation of MRS relates to the range 
of molecules that can currently be imaged. While with proton (1H) imaging, it is theoretically 
possible to quantify regional concentrations of about 20 chemicals (Fig. 1.3), and by imaging 
other nuclei (e.g. 13C, 19F) it is possible to image administered tracers labelled with these 
isotopes (including organic molecules such as glucose) (McRobbie 2006), the accurate 
quantification of these chemicals typically requires very high magnetic field strengths (7T) and 
techniques to make quantification reliable are still in development. Currently with 3T MRI 
cameras it is possible to quantify regional concentrations of only four molecules, namely 
lactate, creatine, choline and N-acetylaspartate (McKay and Tkáč 2016). On the other hand, 
techniques for investigating neurochemistry with PET and SPECT are highly sensitive and less 
constrained by technical challenges; are already well-validated and are more widely available. 
A large number of radiotracers that can be used to accurately and quantitatively probe 
neurochemical processes already exists and continues to grow (for examples see Table 1.1).  
 
In the next section of this review we will focus on the contribution nuclear neuroimaging 
methods have made to SAD research. 
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Nuclear imaging in SAD: blood flow 
 
Rest 
 
Research into regional cerebral blood flow (rCBF) during resting conditions in SAD is limited 
to two studies that used HMPAO SPECT. Confining their analysis to 9 a priori regions of 
interest (ROIs), Stein and Leslie reported no differences in rCBF between their SAD and 
healthy control (HC) groups (Stein and Leslie 1996). In contrast, Warwick et al. performed a 
whole brain, voxel-based analysis and reported increased rCBF in several frontal regions and 
in cerebellum, as well as rCBF reductions in pons, cerebellum and precuneus (Warwick et al. 
2008). Disease severity in that study correlated positively with a frontal cluster and negatively 
with clusters in the fusiform and lingual gyri. Data from the same study were later used to 
perform a whole-brain analysis of resting functional connectivity (RFC) of 14 a priori seed 
regions, with interregional correlations performed on a cross-subject basis (Doruyter et al. 
2016). That study found that in the SAD group there was reduced connectivity between 
amygdala and a frontal cluster; as well as between a posterior cingulate cortex/precuneus seed 
and a cerebellar cluster; and increased connectivity between thalamus and a frontal cluster.  
 
Several studies have investigated the effect of therapy on resting rCBF in SAD. A single dose 
of cannabidiol has been shown to reduce resting rCBF measured with Tc-99m ECD SPECT in 
parahippocampal gyrus, hippocampus, and inferior temporal gyrus and increase rCBF in 
posterior cingulate (Crippa et al. 2011). Van der Linden et al. reported that after a course of a 
selective serotonin reuptake inhibitor (SSRI; citalopram), SAD participants exhibited 
reductions in resting rCBF measured with Tc-99m HMPAO SPECT in anterior and lateral 
temporal cortex, multiple mid-frontal cortical regions and the left cingulum, and that baseline 
rCBF in several temporal and frontal regions was higher in responders than in non-responders 
(van der Linden et al. 2000). Combining this dataset with a similar group of SAD participants 
treated with moclobemide (a MAO-A inhibitor), Warwick et al. performed a whole-brain 
analysis and reported reductions (in the combined groups) in bilateral insula post-therapy 
(Warwick et al. 2006). They also found that when comparing subgroups, participants treated 
with citalopram demonstrated a greater reduction in superior cingulate rCBF than those treated 
with moclobemide. A later analysis of this data by the same group reported that 
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pharmacotherapy resulted in increased RFC of dorsal anterior cingulate cortex (ACC) with 
precuneus and middle occipital gyrus (Doruyter et al. 2016). In a combined group consisting 
of participants with SAD; OCD; or PTSD, Carey et al. reported reductions in resting rCBF (on 
HMPAO SPECT) to superior cingulate, right thalamus, ACC, and left hippocampus after a 
course of citalopram (Carey et al. 2004).  
 
Provocation 
 
Most nuclear rCBF studies in SAD have been performed using provocation paradigms (all 
using O-15 water PET). These studies typically imaged participants during the performance of 
a task designed to elicit disorder-specific anxiety (e.g. a public speech), sometimes combined 
with the use of a control condition (e.g. a private speech). This work has added to knowledge 
on the neurological correlates of social anxiety in SAD. For example, in studies performed on 
SAD samples only, such stressors induced reductions in rCBF in temporal pole and cerebellum 
(Tillfors et al. 2002) and lingual gyrus and medial frontal gyrus (van Ameringen et al. 2004); 
and increases in rCBF in dorsolateral prefrontal cortex, inferior temporal cortex and the 
amygdalo-hippocampal region (Tillfors et al. 2002). Several of these studies also found 
correlations between anxiety levels during such provocation experiments and rCBF to 
distributed brain regions (Tillfors et al. 2001; Laukka et al. 2011). Only two provocation studies 
have compared SAD and HC groups: Tillfors et al. reported provocation-induced rCBF 
reductions in SAD and increases in HC in orbitofrontal, insular, and temporal pole regions  and 
also reported a less marked increase in rCBF to parietal and secondary visual cortices and 
absent responses in rCBF to perirhinal and retrosplenial cortices in the SAD group (Tillfors et 
al. 2001). Kilts et al. reported provocation-induced rCBF differences between HC and SAD 
groups in fusiform, lingual, and middle temporal gyri; lateral orbitofrontal cortex; temporal 
pole; and hippocampus (Kilts et al. 2006). Although not demonstrably specific to the disorder, 
several studies have also found some interesting physiological correlates to rCBF changes on 
provocation in SAD samples. Correlations between rCBF and stress-induced cortisol levels 
(Åhs et al. 2006), high-frequency heart rate variability (Åhs et al. 2009), and functional 
polymorphisms in the human serotonin transporter gene (Furmark et al. 2004) have been 
reported in SAD.  
 
In line with the National Institute of Mental Health Research Domain Criteria (RDoC) initiative 
(Cuthbert and Insel 2013), the neural mechanisms of conditioned fear extinction in SAD have 
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been studied by Åhs et al. who reported reductions in amygdalar (but not in ventromedial 
prefrontal cortex or hypothalamic) rCBF upon repeat provocation (Åhs et al. 2017). 
Provocation work by Fredrikson and Furmark found evidence to suggest functional 
lateralization of the amygdalae. Work from their laboratory suggests that rCBF in the right but 
not left amygdala during provocation is positively correlated with anxiety provocation in SAD, 
specific phobia, post-traumatic stress disorder, and fear conditioning in healthy volunteers 
(Fredrikson and Furmark 2003).  
 
Studies investigating how therapy affected rCBF changes during provocation of social anxiety 
using O-15 water PET have reported some interesting results. Furmark et al. found that 
placebo-induced reductions in amygdalar rCBF during provocation were demonstrable only in 
patients with certain serotonergic polymorphisms (Furmark et al. 2008), providing important 
information on the possible mechanisms of the placebo effect. Compared to placebo, there is 
evidence that SSRIs, cognitive behavioural therapy and the experimental NK-1 antagonist 
vofopitant (GR205171) all result in reductions in rCBF to rhinal cortex, amygdala, 
hippocampal and parahippocampal regions, and that these reductions are greater in responders 
than non-responders (Furmark et al. 2002, 2005). Similar results were reported by Faria et al. 
who found that responders to SSRI therapy (citalopram or paroxetine) and placebo 
demonstrated greater reductions in amygdalar rCBF during provocation (Faria et al. 2012) and 
that the changes in provocation-related functional connectivity of the amygdala were different 
between responders and non-responders (Faria et al. 2014). Interestingly however, that group 
reported no difference in rCBF changes between patients that responded to SSRI and those that 
responded to placebo (Faria et al. 2012). Frick et al. reported that citalopram (SSRI), vofopitant 
(NK-1 receptor antagonist GR205171) and placebo all resulted in reductions in provocation-
induced amygdalar rCBF and that this was paralleled by reductions in amygdalar serotonin 
synthesis rates measured on C-11 5-hydroxtryptophan PET (Frick et al. 2016). Work by Kilts 
et al. found that a course of nefazodone (a phenylpiperazine serotonin reuptake inhibitor and 
5-HT2 receptor antagonist) led to reductions in rCBF during provocation in precentral gyrus, 
insula, midbrain/hypothalamus, and middle frontal and dorsal anterior cingulate cortices; and 
increases in middle occipital and bilateral lingual gyri, postcentral gyrus, gyrus rectus and 
hippocampus (Kilts et al. 2006).   
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Emotional processing 
 
A single study has investigated affective processing in the disorder. Using O-15 water PET that 
study reported that in both SAD and HC groups, there were increases in amygdalar rCBF 
during the processing of angry faces. While no difference in this amygdalar response was 
detected between the two groups, the researchers did report a correlation between amygdalar 
reactivity and serotonergic polymorphisms (Furmark et al. 2009).    
 
Nuclear imaging in SAD: metabolism 
 
Only one study investigating regional glucose metabolism has to date been published in SAD 
(Evans et al. 2009). In that study, researchers used F-18 FDG PET to scan a group of SAD 
participants as well HCs at rest before and after a course of therapy with tiagibine, a γ-
aminobutyric acid (GABA) reuptake inhibitor. Compared to controls, the SAD group 
demonstrated reduced metabolism in anterior cingulate cortex and ventromedial prefrontal 
cortex (vmPFC). After therapy, SAD participants exhibited increased metabolism in the 
vmPFC, the degree of response also being inversely correlated with baseline metabolism in 
this region – results which suggest a possible mechanism of treatment effect with this drug. 
 
An illustration summarizing neural activity findings in SAD reported in nuclear imaging 
experiments is found in Fig 1.4. 
 
Nuclear imaging in SAD: receptor-based research 
 
Serotonin 
 
Genetic modification of serotonergic targets in mice has implicated the serotonergic system in 
anxiety and depression phenotypes (Albert et al. 2014). The importance of the serotonergic 
system in SAD is further underscored by the relative efficacy of SSRIs in treating the disorder 
(Ipser et al. 2008). In-vivo, nuclear imaging of the serotonin system, targeting both presynaptic 
and post-synaptic neurons, has made important contributions to knowledge of serotonin’s role 
in SAD. The rate of influx of C-11 5-hydroxytryptophan (C-11 5-HTP), a serotonin precursor, 
can be used to measure the rate of serotonin synthesis in presynaptic neurons. Studies using 
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this tracer suggest that in SAD there are higher rates of serotonin synthesis in hippocampus, 
basal ganglia, amygdala and anterior cingulate (Frick et al. 2015a; Furmark et al. 2016) and 
that serotonin synthesis decreases in amygdala after therapy, paralleled by reductions in 
amygdalar rCBF on O-15 water PET (Frick et al. 2016). Furmark et al. have linked high 
serotonin synthesis rates in amygdala and anterior cingulate with a specific genetic 
polymorphism (tryptophan-2 G-703T) in SAD (Furmark et al. 2016). Another means of 
probing presynaptic serotonergic function is by imaging the serotonin transporter (SERT). This 
was first performed in SAD by Kent et al, who performed PET with C-11 McN5652, which 
binds to SERT. In SAD participants at baseline and several months into a course of paroxetine 
they demonstrated increased occupancy of SERT during therapy (Kent et al. 2002). Using 
another PET ligand (C-11 DASB), Frick et al. have demonstrated that SAD participants have 
increased SERT binding potential (reflecting higher SERT availability) than HCs in the raphe 
nuclei region, caudate nucleus, putamen, thalamus, and insular cortex (Frick et al. 2015a). Only 
one study investigating post-synaptic serotonergic function has been performed in SAD. In that 
study, Lanzenberger et al. performed C-11 WAY-100635 PET to measure binding of the 
serotonin 1A (5-HT1A) receptor in SAD and HC participants. That group reported significantly 
lower binding potentials in several limbic and paralimbic regions, including amygdala, anterior 
cingulate, insula and dorsal raphe nucleus in the patient group. Binding potential in the 
hippocampus was not affected (Lanzenberger et al. 2007). In a later analysis of the same data, 
the researchers also reported a negative correlation between serum cortisol levels and 5-HT1A 
binding in amygdala, hippocampus and retrosplenial cortex across all subjects with stronger 
correlations in the amygdala and hippocampus in the SAD group (Lanzenberger et al. 2010). 
Given the discrete functional roles of different serotonergic targets in rodent models of anxiety 
(Albert et al. 2014), and the limited in-vivo imaging studies in humans with SAD, more 
research using these tracers is warranted. 
 
Dopamine 
 
The dopaminergic system has an established role in reward processing (Wise and Rompré 
1989). Social interaction activates the reward system in similar ways to non-social rewards 
such a money, food or addictive substances (Richey et al. 2017). The rewards achieved through 
personal interactions are thought to drive social affiliation. Consequently, the observation that 
SAD sufferers typically shun social interaction has led some researchers to propose that the 
biology of SAD may have a dopaminergic component. Further evidence of dopamine’s 
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possible role is that patients with idiopathic Parkinson’s disease, a condition characterized by 
dopaminergic degeneration, have much higher rates of SAD that the general population or 
those with chronic medical conditions (Richard 2005). Several studies have investigated the 
dopaminergic system in SAD, both in striatum and in frontal and extrastriatal limbic regions. 
Similar to serotonergic targets, dopaminergic nuclear imaging can investigate both presynaptic 
neurons (using radiolabelled dopamine precursors, or tracers that target the dopamine 
transporter – DAT) and postsynaptic neurons (with ligands that bind to D1 and D2 receptors). 
All studies on presynaptic dopaminergic function in SAD have used SPECT tracers that target 
DAT, such as I-123 ioflupane, I-123 β-CIT, and Tc-99m TRODAT-1. Evidence from those 
studies has to date been inconclusive of abnormality in striatal DAT binding in SAD 
participants compared to healthy controls, with work suggesting decreases (Tiihonen et al. 
1997), no difference (Schneier et al. 2009), or increases (van der Wee et al. 2008a) in the 
disorder. Postsynaptic dopaminergic research in SAD has focused on D2 receptors and has 
been similarly inconclusive of abnormality in the disorder. The earliest study by Schneier et al. 
used I-123 IBMZ to image D2 receptor binding and reported reduced striatal D2 binding 
potential in SAD compared to controls but found no significant correlation with disease 
severity (Schneier et al. 2000). Later studies by the same group (Schneier et al. 2009) found no 
difference in striatal D2 binding between SAD and HC groups using C-11 raclopride PET (an 
arguably more reliable technique). Plavén-Sigray et al. performed PET with another D2 
receptor ligand, C-11 FLB457 and confined their analysis to extrastriatal regions. They 
reported increased D2 binding in SAD in orbitofrontal cortex and dorsolateral prefrontal cortex 
(Plavén-Sigray et al. 2017).  
 
The effects of therapy on nuclear dopaminergic measures has also been investigated in SAD. 
The effect of escitalopram therapy on DAT binding was studied by Warwick et al. who reported 
a therapy-related increase in striatal DAT binding measured on I-123 ioflupane SPECT though 
no correlation between symptom improvement and binding was found (Warwick et al. 2012). 
Post-therapy increases in caudate DAT binding in that study was also seen in a subgroup of 
patients that were homozygous for A10 DAT genotype. Cervenka et al. investigated the effect 
of cognitive behavioural therapy (CBT) on the interaction between disease severity and 
extrastriatal D2 binding in SAD by performing C-11 FLB 457 PET(Cervenka et al. 2012). They 
reported a relationship between symptom reduction after CBT and D2 binding in dorsolateral 
prefrontal cortex, medial prefrontal cortex and hippocampus. This study was also noteworthy 
in that it reinforced the understanding of psychotherapy as a biological intervention, in many 
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respects comparable to pharmacotherapy (Linden 2006). Studies that used nuclear techniques 
to investigate dopaminergic function in SAD patients with comorbid Parkinson’s disease 
(Moriyama et al. 2011) and obsessive-compulsive disorder (Schneier et al. 2008)  have also 
been conducted. 
 
Conflicting results from these few available nuclear imaging studies suggest that further 
research is necessary to establish the role (if any) of dopamine in the disorder. Continued 
interest in dopamine is supported by several recent fMRI studies of the reward system in SAD, 
which reported differences in how SAD participants process both monetary and social reward 
(Manning 2015; Cremers et al. 2015; Richey et al. 2017), and research in healthy volunteers 
linking D1 binding in fusiform gyrus with performance on a facial recognition task (Rypma et 
al. 2015). 
 
Substance P 
 
High concentrations of the neurokinin-1 receptor (NK-1) are expressed in several limbic 
structures (Ribeiro-da-Silva and Hökfelt 2000) and it has been suggested that substance P, 
which binds to this receptor, may play an important role in anxiety disorders (Ebner et al. 2008). 
A single study that used the PET radiotracer C-11 GR205171 to image NK-1 binding in SAD 
demonstrated that compared to HCs, NK-1 binding in the amygdala was higher in the disorder 
(Frick et al. 2015b). 
 
An illustration summarizing the findings of nuclear imaging experiments that targeted 
neurotransmitter systems in SAD is found in Fig 1.5. 
 
Discussion and future directions 
 
Much is already known about the neuroanatomy relevant in social anxiety (Miskovic and 
Schmidt 2012). Neuroimaging research using both fMRI and nuclear techniques further 
support functional models of SAD with increased neuronal activity in limbic and paralimbic 
regions during anxiety provocation in which reductions in anxiety lead to attenuation of this 
hyper-reactivity. Research using nuclear techniques has been complementary to fMRI research 
in this regard. Although resting-state fMRI has provided data on brain networks in the disorder, 
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PET and SPECT work has extended this work by focusing on regional resting neuronal activity 
and suggesting disrupted resting activity in key regions including medial frontal cortex, insula 
and fusiform gyrus as well as in regions that have to date received little consideration in SAD, 
such as cerebellum.  
 
This knowledge, of regional neuronal activity in baseline conditions is important for two 
reasons. Firstly, it allows for the accurate interpretation of disruptions in resting-state 
functional connectivity, typically studied using resting-state fMRI. For example, a reduction in 
resting functional connectivity between two regions may be driven by increases or decreases 
in neuronal activity in either region or unequal increases or decreases in both. While it is 
relatively simple to identify interregional correlations at rest, teasing out the regional changes 
in neuronal activity that drive these correlations is more complex and is difficult to investigate 
with commonly used fMRI methods. Secondly, knowledge of both resting regional activity and 
resting functional connectivity is important in contextualizing the results of task-based 
experiments, since it shifts the focus from context-dependent changes (reactivity or functional 
connectivity on task) to intrinsic variations in the underlying functional network architecture 
(Tavor et al. 2016). Taken together then, nuclear techniques are useful in delineating the 
complex relationships between resting regional activity, resting connectivity and task-based 
reactivity.   
 
Within regions involved in SAD, it is key to understand the relevant neurochemistry. A handful 
of nuclear imaging studies suggest roles for several neurotransmission systems, including 
serotonergic, dopaminergic and substance P, for which there is already evidence of disruption 
from other sources. Given their small number, additional studies of these neurotransmitter 
systems are justified. It is also worth noting that nuclear imaging of neurotransmitter targets in 
SAD has to date entirely focused on resting-state. Research using receptor-based PET imaging 
during task performance is also possible (Christian et al. 2006; Ceccarini et al. 2012) and will 
hopefully be conducted in SAD. Such research might prove key in our understanding of the 
behavioural correlates of functional neuroimaging findings. Beyond the systems presented in 
this review, the examples listed in Table 1.1 show that there are multiple other molecular 
tracers (e.g. GABAergic, cholinergic, etc.) that present interesting research targets in SAD. In 
addition, progress is being made on the development of a PET tracer that is selective for the 
oxytocin receptor in the brain (Wenzel et al. 2016). This would raise the prospect of in-vivo 
imaging of central oxytocin action in SAD, which is of considerable interest given the putative 
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role of this peptide hormone in social anxiety and social cognition (Kirsch 2015). Research 
using new ligands has the potential to identify novel molecular targets for future drug 
development. 
 
Nuclear studies of rCBF and metabolism have provided new insights into how anxiolytics 
change regional neuronal activity both at rest and during symptom provocation in SAD. More 
than this, imaging techniques that target specific brain receptors have identified differences in 
neurochemistry in the disorder. Such findings are relevant to our understanding of the 
neurobiology of SAD; and the mechanisms by which drugs exert their anxiolytic properties. 
This is relevant for drug discovery. While some early work suggests that certain nuclear 
imaging features can predict individual patients’ response to a specific treatment, there is to 
date insufficient evidence that these predictors can be applied clinically. The prospect of 
personalized medicine based on molecular imaging results is tantalizing, and more research 
and the sharing of data will hopefully lead to progress in this regard.  
 
Two further key developments have the potential to impact the role of nuclear imaging methods 
in SAD research in the near future. The first, and arguably most important of these, is the recent 
advent of hybrid PET/MR systems. The ability to simultaneously image BOLD or ASL signal 
and dynamically image a wide range of molecular targets, both during rest and during task, 
promises to transform functional neuroimaging research. The benefit of this synchronous 
measurement is that it allows for the direct temporal correlation between processes imaged by 
fMRI (such as neural activity) and those imaged by PET (such as neurotransmitter kinetics) – 
something impossible to do (due to the impossibility of perfectly matching scan conditions) 
with sequential imaging (Judenhofer et al. 2008; Wehrl et al. 2013). The second development 
relates to the establishment of shared data repositories, which provide open access to 
researchers. Initiatives such as the Human Connectome Project and UK Biobank (which 
currently include only MRI-based neuroimaging data) have enabled mega-analyses that vastly 
increase statistical power, and also allow researchers to use normative modelling as an 
alternative to the typical clustering used in case-control studies (Marquand et al. 2016). Similar 
benefits are seen from the trend towards large-scale, international collaborations such as the 
ENIGMA consortium (Thompson et al. 2017). The future inclusion of nuclear imaging data in 
such repositories and collaborations would potentially add great value to new research 
initiatives, especially when studied in combination with phenotyping and genotyping data. 
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Conclusion 
 
Nuclear neuroimaging techniques represent powerful tools to investigate brain function in SAD 
and the neurobiological effects of therapy that are complementary to MRI-based techniques, 
and have extended upon results of studies utilizing MRI. While basic models of the fear 
response are now well-characterized, research into both regional activity and interregional 
relationships of diverse brain regions outside of the limbic and paralimbic circuits must still be 
conducted. Limited nuclear imaging evidence of disrupted neurochemistry in the disorder 
requires further study to draw definitive conclusions and to provide a foundation for potentially 
targeting treatments based on individuals’ molecular signatures. The development of novel 
brain tracers, the advent of hybrid PET/MRI systems, and the growth of open access data 
repositories which will hopefully include nuclear imaging contributions, all lend promise to 
high quality future research in this condition. 
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Tables and Figures 
 
Table 1.1 Selected (patho-) physiological processes relevant to neuroscience that can be studied with nuclear imaging (Fumita and Innis 2002; 
Ross and Seibyl 2004; Heiss and Herholz 2006; Paterson et al. 2013; Venneti et al. 2013; Hommet et al. 2014; Fowler et al. 2015; Kassenbrock 
et al. 2016; Tronel et al. 2017). 
 
(Patho-) physiological process Molecular target Example radiotracer(s) Imaging modality SAD 
 
Proxies of regional neuronal activity 
 
    
Blood flow N/A O-15 water PET * 
Regional perfusion (no temporal 
component) 
Lipid cell 
membrane 
Tc-99m HMPAO 
Tc-99m ECD 
SPECT 
SPECT 
* 
* 
Glucose metabolism Hexokinase F-18 FDG PET * 
 
 
Neurotransmitter systems 
 
    
Monoaminergic  VMAT2 C-11 DTBZ PET  
 MAOA C-11 clorgyline PET  
 MAOB C-11 L-deprenyl-D2 PET  
Dopaminergic AADC F-18 FDOPA PET  
 DAT 
 
I-123 ioflupane 
I-123 β-CIT 
Tc-99m TRODAT 
C-11 cocaine 
SPECT 
SPECT 
SPECT 
PET 
* 
* 
* 
 D1 C-11 SCH-23390 PET  
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 D2-like I-123 IBZM 
C-11 raclopride 
C-11 FLB457 
F-18 fallypride 
SPECT 
PET 
PET 
PET 
* 
* 
* 
Serotonergic TPH2 C-11 HTP PET * 
 5-HT1A C-11 WAY-100635 PET * 
 5-HT1B C-11 AZ10419369 PET  
 5-HT2A F-18 Altanserin PET  
 5-HT4 C-11 SB207145 PET  
 5-HT6 C-11 GSK215083 PET  
 SERT C-11 DASB 
C-11 McN5652 
PET 
PET 
* 
* 
Noradrenergic NET F-18 FMeNER-D2 PET  
GABAergic GABAA C-11 FMZ 
I-123 IOM 
PET 
SPECT 
 
Endocannabinoid CB1 F-18 FMPEP-D2 PET  
Adenosine A1 C-11 MPDX PET  
 A2A C-11 TMSX PET  
Histaminic H1 C-11 pyrilamine PET  
Cholinergic AChE C-11 donepezil PET  
 mAChR C-11 NMPB PET  
 nAChR I-123 5-I-A-85380 SPECT  
Opioid MOR C-11 carfentanyl PET  
 MOR/KOR/DOR C-11 DPN 
F-18 Cyclofoxy 
PET 
PET 
 
Neuropeptide substance P NK1 C-11 GR205171 PET * 
 
Other 
 
    
Microglial/macrophage activity TSPO C-11 PK11195 PET  
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Blood-brain barrier integrity N/A Tc-99m DTPA 
Ga-68 DTPA 
SPECT 
PET 
 
Protein deposition β-amyloid C-11 PIB 
F-18 florbetaben 
F-18 florbetapir 
PET 
PET 
PET 
 
 
 Tau F-18 THK-5351  
F-18 AV1451 
PET 
PET 
 
 
Abbreviations: 5-HTP:5-hydroxytryptophan; 5-HT1A/1B/2A/4/6: serotonin receptor type 1A/1B/2A/4/6; 5-I-A-85380: 5-iodo-3-[2 (S)-2-
azetidinylmethoxy] pyridine; A1/2A: adenosine receptor type 1/2A; AADC: aromatic L-amino acid decarboxylase; AChE: acetylcholine esterase; 
AV1451: 7-(6-fluoropyridin-3-yl)-5H-pyrido[4,3-b]indole; AZ10419369: 5-methyl-8-(4-methylpiperazin-1-yl)-N-(4-morpholin-4-ylphenyl)-4-
oxochromene-2-carboxamide; C-11: carbon-11; CB1: cannabinoid receptor type 1; D1/2: dopamine receptor type 1/2; DASB:3-amino-4-(2-
dimethylaminomethylphenylsulfanyl)-benzonitrile; DAT: dopamine transporter; DPN: diprenorphine ; DTBZ: dihydrotetrabenazine ; DTPA: 
diethylenetriaminepentaacetic acid; ECD: ethyl cysteinate dimer; F-18: fluorine-18; FDG: fluorodeoxyglucose; FDOPA: 
fluorodeoxyphenylalanine; FMeNER-D2: (S,S)-2-(a-(2-fluoro[2H2]methoxyphenoxy)benzyl)morpholine; FMPEP-D2: (3R,5R)-5-[3-
[dideuterio(fluoranyl)methoxy]phenyl]-3-[[(1R)-1-phenylethyl]amino]-1-[4-(trifluoromethyl)phenyl]pyrrolidin-2-one; FMZ: flumazenil; FLB457: 
(S)-(-)-5-bromo-N-((1-ethyl-2pyrrolidinyl)methyl)-2,3-dimethoxybenzamide; GABA: gamma-aminobutyric acid; GABAA: benzodiazepine 
receptor type A; GR205171: (2S,3S)-N-[[2-[11C]methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenyl-piperidin-3-amine; 
GSK215083: 3-(3-fluorophenyl)sulfonyl-8-(4-methylpiperazin-1-yl)quinoline; H1: histamine receptor type 1; HMPAO: hexamethyl propylene 
amine oxime; I-123: iodine-123; IBZM: iodobenzamide ; IOM: iomazenil; mAChR: muscarinic acetylcholine receptor; MAOA/B: monoamine 
oxidase A/B; McN5652:(6R,10bS)-6-(4-methylsulfanylphenyl)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline; MOR/KOR/DOR: μ-/κ-/δ-
opioid receptor; MPDX: 8-(dicyclopropylmethyl)-1-methyl-3-propyl-7H-purine-2,6-dione; nAChR: nicotinic acetylcholine receptor; NET: 
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noradrenaline (norepinephrine) transporter; NMPB: N-methyl-4-piperidylbenzilate ; NK1: neurokinin receptor 1; O-15: oxygen-15; PET: 
positron emission tomography; PIB: Pittsburgh compound B; PK11195: 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-
isoquinolinecarboxamide; SB207145: (4-{[(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)carbonyloxy]methyl}piperidin-1-yl)methylidyne; 
SCH 23390: 8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol; SPECT: single photon emission tomography; Tc-99m: 
technetium-99m; THK-5351: (2S)-1-fluoro-3-[2-[6-(methylamino)pyridin-3-yl]quinolin-6-yl]oxypropan-2-ol; TMSX: 7-methyl-(E)-8-(3,4,5-
Trimethoxystyryl)-1,3,7-trimethylxanthine; 1,3,7-tri(methyl)-8-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]purine-2,6-dione; TPH2: tryptophan 
hydroxylase-2; TRODAT-1: 2-[2-[[(1S,3S,4R,5R)-3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-4-yl]methyl-(2-
sulfanylethyl)amino]ethylamino]ethanethiol; TSPO: 18-kDa translocator protein; VMAT2: vesicular monoamine oxidase A transporter type 2; 
WAY-100635: N-[2-[4-(2-ethoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide; β-CIT: methyl 3β-(4-iodophenyl) tropane-
2b-carboxylate.  
 
 
Tracers marked with a (*) have previously been used in SAD research.  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 22 
 
Table 1.2 Comparison of MR and nuclear techniques to investigate regional neuronal activity (Arthurs and Boniface 2002; Detre and Wang 
2002; Hertz and Dienel 2002; Zang et al. 2004, 2007; Zou et al. 2008; Kameyama et al. 2016) 
 
 fMRI Nuclear  
BOLD ASL O-15 water PET Tc-99m HMPAO 
SPECT 
F-18 FDG PET 
Physiological target Blood flow; blood 
volume; oxygen 
consumption 
Blood flow Blood flow Blood flow  Glucose metabolism  
Tracer Difference in 
magnetization 
between 
oxyhaemoglobin and 
deoxyhaemoglobin 
Magnetically-labelled 
arterial water  
Radioactive water Radioactive, highly-
lipophilic molecule 
Radioactive glucose-
analogue 
Biological 
components of final 
signal  
Neuronal and glial 
cell activity; 
neurometabolic 
coupling; 
neurovascular 
coupling; blood flow; 
blood oxygenation; 
blood volume; 
haematocrit 
Neuronal and glial 
cell activity; 
neurovascular 
coupling; blood flow 
Neuronal and glial 
cell activity; 
neurovascular 
coupling; blood flow 
Integrated neuronal 
and glial cell activity; 
neurovascular 
coupling; blood flow 
Integrated neuronal 
and glial cell activity; 
neurometabolic 
coupling; 
neurovascular 
coupling; blood flow; 
endogenous glucose 
and insulin 
concentration 
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Signal proportional 
to regional neuronal 
activity 
 
No  Yes Yes  Yes Yes 
Ability to quantify 
regional neuronal 
reactivity to stimulus 
 
Excellent Excellent Good Limited Limited 
Network 
characterization 
 
Interregional 
temporal 
correlations 
Interregional 
temporal 
correlations 
Interregional 
temporal 
correlations 
Interregional cross-
subject correlations 
Interregional cross-
subject correlations 
Spatial resolution 
 
Excellent Excellent Fair Fair Good 
Temporal resolution  
 
Excellent Good Fair N/A N/A 
Sensitivity 
 
Fair Fair High High High 
Effective radiation 
dose (mSv) 
 
Nil Nil ~ 1.5 † ~ 5.5 †† ~ 2.5 ‡ 
Artefact concerns Susceptibility; 
motion; baseline 
drift; heterogeneity 
in magnetic field; 
noise (physiological; 
1/f) (Detre and Wang 
2002; Borogovac and 
Asllani 2012) 
 
Vascular artefact; 
motion (less than 
BOLD); baseline drift 
(less than BOLD); low 
SNR; (Borogovac and 
Asllani 2012) 
CT-based attenuation 
correction: artefact 
due to 
misregistration 
between CT and PET 
CT-based attenuation 
correction: artefact 
due to 
misregistration 
between CT and 
SPECT 
CT-based attenuation 
correction: artefact 
due to 
misregistration 
between CT and PET 
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Invasive No No No, but intravenous 
access 
No, but  intravenous 
access 
No, but intravenous 
access 
 
Abbreviations: ASL – arterial spin labelling; BOLD – blood oxygen level dependent; CT – (x-ray) computed tomography; EPI – echo-planar 
imaging; F-18 FDG – Fluorine-18 fluorodeoxyglucose; fMRI – functional magnetic resonance imaging; O-15 – oxygen-15; PET – positron 
emission tomography; SPECT – single photon emission tomography; Tc-99m HMPAO – Technetium-99m hexamethyl propylene amine oxime; 
TE – echo time; TR – repetition time; 
† Based on administered dose of 1500 MBq (Andersson 2015) 
††Based on administration of 555 MBq (Andersson 2015) 
‡  Based on administered dose of 150 MBq (Andersson 2015)
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A. 
 
 
B. 
 
 
Figure 1.1 Basic principles of nuclear imaging. A. In single photon emission tomography (SPECT), one or more detectors rotate around the 
subject, which due to absorptive collimation, register only photons traveling perpendicular to the detector plane (x) and exclude photons that 
travel at oblique angles (y). SPECT imaging results in multiple 2-D projection images from different angles which are then reconstructed into a 
single 3-D image. B. In positron emission tomography (PET), individual decay events result in two gamma photons, traveling in opposite 
directions which are then detected near simultaneously (coincidence event). A line connecting these to the detectors registering these 
coincident events is known as a line of response (LOR). A typical PET scan will image millions of such LORs and this information is reconstructed 
into a 3-D image to accurately localize regional radiotracer concentrations.
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A. 
 
  
B. 
 
 
Figure 1.2 Examples of nuclear imaging techniques. A: Cerebral perfusion study performed 
with Tc-99m HMPAO SPECT (transverse slices). B: Cerebral metabolism study performed 
with F-18 FDG PET. Note the higher resolution of the PET images.  
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Figure 1.3 LCModel analysis of an in vivo 1H MR spectrum acquired from the human brain at 
7T (STEAM, TE = 6 ms, TR = 5 s, NT = 160, grey-matter-rich occipital cortex). In vivo spectrum 
can be modelled as a linear combination of brain metabolite spectra from the LCModel basis 
set: macromolecules (MM), alanine (Ala), ascorbate (Asc), glycerophosphocholine (GPC), 
phosphocholine (PC), creatine (Cr), phosphocreatine (PCr), c-aminobutyric acid (GABA), 
glycine (Gly), glutamate (Glu), glutamine (Gln), glutathione (GSH), myo-inositol (myo-Ins), 
scyllo-inositol (scyllo-Ins), lactate (Lac), N-acetylaspartate (NAA), N-acetylaspartylglutamate 
(NAAG), phosphoethanolamine (PE), taurine (Tau). Figure and legend from (McKay and Tkáč 
2016). 
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Resting regional activity 
 
 
 
 
 
 
 
 
 
baseline  post-therapy 
Resting functional connectivity 
 
 
 
 
 
 
 
 
 
baseline  post-therapy 
Regional activity during provocation 
 
 
 
 
 
 
 
 
 
baseline  post-therapy 
 
Figure 1.4 Summary of neural activity changes in SAD reported in nuclear imaging 
experiments. In SAD at baseline compared to healthy controls (left) and in SAD post-therapy 
(right). Spheres centred on reported cluster maxima. Red = increased; blue = decreased; red 
spheres with solid line = increased RFC; blue spheres with dashed line = decreased RFC. 
Images generated in MRIcroGL (Chris Rorden, www.mricro.com).   
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Serotonergic system 
  
 
 
 
 
 
 
 
 
baseline  post-therapy 
 
Dopaminergic system 
  
 
 
 
 
 
 
 
 
baseline  post-therapy 
Substance P 
  
 
  
baseline   
 
Figure 1.5 Summary of changes in neurotransmitter systems in SAD reported in nuclear 
imaging experiments. In SAD at baseline compared to healthy controls (left) and in SAD 
post-therapy (right). Implicated regions and structures are illustrated. Red = increased; blue 
= decreased; purple = both increased and decreased depending on molecular target. Images 
generated using GNU Image Manipulation Program (GIMP) 2.8.14 (http://www.gimp.org/)  
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Abstract 
 
Neuroimaging research has reported differences in resting-state functional connectivity 
(RFC) between social anxiety disorder (SAD) patients and healthy controls (HCs). Limited 
research has examined the effect of treatment on RFC in SAD. We performed a study to 
identify differences in RFC between SAD and HC groups, and to investigate the effect of 
pharmacotherapy on RFC in SAD. Seed-based RFC analysis was performed on technetium-
99m hexamethylpropylene amine oxime (Tc-99m HMPAO) SPECT scans using a cross-
subject approach in SPM-12. Seeds were chosen to represent regions in a recently published 
network model of SAD. A second-level regression analysis was performed to further 
characterize the underlying relationships identified in the group contrasts. Twenty-three SAD 
participants were included, of which 18 underwent follow-up measures after an 8-week 
course of citalopram or moclobemide. Fifteen healthy control (HC) scans were included. 
SAD participants at baseline demonstrated several significant connectivity disturbances 
consistent with the existing network model as well as one previously unreported finding 
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(increased connectivity between cerebellum and posterior cingulate cortex). After therapy, 
the SAD group demonstrated significant increases in connectivity with dorsal anterior 
cingulate cortex which may explain therapy-induced modifications in how SAD sufferers 
interpret emotions in others and improvements in self-related and emotional processing.  
 
Keywords: anterior cingulate; pharmacologic effects; phobia, social; SPECT 
 
Introduction 
 
Social Anxiety Disorder (SAD) is characterized by excessive fear of social interactions and 
of scrutiny by others in which sufferers fear negative evaluation (American Psychiatric 
Association and DSM-5 Task Force 2013). The disorder is common(Kessler RC et al. 2005; 
Stein et al. 2010) and frequently results in significant disability (Wittchen and Beloch 1996). 
There is a growing interest in both anatomical and functional neuroimaging as means to 
investigate the biology of SAD. 
 
Recent neuroimaging research has established differences in resting-state functional networks 
in SAD sufferers compared to healthy controls. Ding et al, using brain parcellation and 
calculating a correlation matrix of all regions, reported increased connectivity in frontal 
regions and decreased connectivity between several frontal and occipital regions (Ding et al. 
2011). Liao et al used a seed-based method with amygdalar seeds and found evidence for 
disrupted connectivity between amygdala and distributed cortical regions, including default 
mode network (DMN) nodes (Liao et al. 2010b). Amygdalar connectivity disruptions using 
seed-based techniques have also been described by Hahn et al (Hahn et al. 2011), Prater et al 
(Prater et al. 2013) and Pannekoek et al (Pannekoek et al. 2013). The latter study also found 
dorsal attention network but not DMN disturbances. Arnold-Anteraper et al used seed-based 
methods and reported connectivity disturbances in subcortical networks (Arnold-Anteraper et 
al. 2014). Liao et al have used regions of gray matter volume reduction as seeds, including a 
medial prefrontal cortex seed which showed aberrant connectivity with several DMN regions 
(Liao et al. 2011). Independent component analysis (ICA) was used by Liao et al who 
reported disturbances in several components including increased connectivity in the self-
referential network and decreased connectivity in the DMN (Liao et al. 2010a). Qiu et al used 
regional homogeneity (ReHo) analysis and reported several ReHo abnormalities including 
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reductions in DMN components (Qiu et al. 2011). Finally, Liu et al used graph theory to 
identify disrupted cortical hubs in right fusiform gyrus and bilateral precuneus (Liu et al. 
2015b).  
 
Given the heterogeneity in analysis techniques and number of (occasionally inconsistent) 
connectivity disturbances reported in resting-state experiments, a recent neuroimaging review 
and meta-analysis of connectivity findings in SAD by Brühl and colleagues is particularly 
valuable (Brühl et al. 2014a). In their paper, the authors proposed a network model of SAD 
that provides a useful basis for generating hypotheses in SAD connectivity research. The 
model builds on preclinical work in that it implicates several structures of the previously 
described “fear-circuit”(LeDoux 2000) and proposes that SAD sufferers have disrupted 
connectivity between widely-distributed, functionally distinct regions of the brain. It is 
important to note however that this model is based on both resting-state and paradigm-driven 
activation and connectivity data. While many of the regions in this model have also been 
implicated in resting state studies in SAD, the applicability of this model to “baseline” mental 
processing (resting state), and to anxiety-provoking socially-focused experimental paradigms 
is still uncertain. The investigation of resting-state functional connectivity (RFC) is important 
since it contextualizes and refines our understanding of localized activation or deactivation 
(and connectivity) in paradigm-driven functional neuroimaging experiments (Greicius et al. 
2003), as well as network models such as that proposed by Brühl.  
A limited amount of RFC research has been conducted in SAD, and has exclusively been 
acquired using functional magnetic resonance imaging (fMRI). The high temporal resolution 
of this modality is eminently suited to functional connectivity research since it is possible to 
detect spatially distinct, temporally-correlated voxels or voxel clusters from a relatively short 
total scan duration. It is also possible to perform functional correlation analyses during the 
same time period, using positron emission tomography (PET) or single photon emission 
tomography (SPECT). Here a cross-subject approach is used to determine whether the signal 
intensity in remote brain regions are correlated across participants. Such a cross-subject 
approach has been used in prior PET, SPECT, and fMRI experiments, e.g. (Blumenfeld et al. 
2004; Lee et al. 2008; Di and Biswal 2012; Zhang et al. 2014). There are two main rationales 
supporting the use of PET and/or SPECT in connectivity research: Firstly, despite its many 
advantages, fMRI is prone to susceptibility artefacts which make it more difficult to study 
specific brain regions potentially significant to psychiatric studies such as the orbitofrontal 
and inferior and medial temporal cortices (Stenger et al. 2000). SPECT and PET do not suffer 
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from this problem. Secondly, the BOLD signal obtained in fMRI depends on a combination 
of several physiological factors (cerebral blood flow; cerebral blood volume concentration of 
deoxyhaemoglobin) and serves as an indirect measure (Steinbrink et al. 2006); whereas it 
may be argued that the signal obtained using perfusion SPECT or PET is more physiological, 
as a ‘pure’ perfusion measure. PET and SPECT are thus complementary to fMRI in 
functional brain imaging. 
 
In terms of behavioural correlates; in understanding the mechanisms by which drugs exert 
their effects; and as a biomarker of treatment effect, the translational relevance of 
disturbances in RFC in SAD remains largely speculative. There is evidence to suggest that 
the DMN plays a role in social cognition (Schilbach et al. 2008; Laird et al. 2011; Mars et al. 
2012), and that this network may be disordered in SAD (Gentili et al. 2009; Liao et al. 2010a; 
Liu et al. 2015a). In depression, the DMN’s role in maladaptive rumination (also a feature of 
social anxiety disorder) has previously been reported (Hamilton et al. 2011). This is 
noteworthy given the frequent comorbidity of depression and SAD (Merikangas and Angst 
1995). Very limited research has been conducted that examines the effect of treatment on 
RFC in SAD. Giménez and colleagues reported attenuation of connectivity in four 
components (using independent component analysis) using resting state fMRI in SAD 
patients treated with an 8-week course of paroxetine (a selective serotonin reuptake inhibitor 
- SSRI) (Giménez et al. 2014). That group reported attenuation (with therapy) in the DMN 
(produced in right thalamus); in a posterior insula component (produced in right insula as 
well as perigenual regions); in an anterior paralimbic component (produced in subgenual 
ACC); and in a fronto-parietal component (in left insula). No studies have been performed in 
SAD that test the effect of pharmacotherapy on seed-based RFC. Such analyses in healthy 
volunteers and in depressed patients have reported changes in RFC with therapy (McCabe et 
al. 2011; van Wingen et al. 2014; Yang et al. 2014; Wang et al. 2015).  
 
The objective of this study was to compare RFC in HCs and in SAD participants at baseline 
and to investigate the impact of pharmacotherapy on RFC in the SAD group. We 
hypothesized RFC differences between SAD and HCs would correspond to the existing 
network model of SAD proposed by Brühl and that pharmacotherapy effects would be 
consistent with normalization of connectivity disturbances predicted by the model. All 
participants in this study were included in a prior study conducted by our institution 
(Warwick et al. 2006). 
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Methods 
 
Participants 
 
The study was approved by the health research ethics committee of Stellenbosch University 
(Ref # S14/08/159). 
 
SAD participants: SAD participants had to meet DSM-IV criteria for SAD. They were 
screened using the Structured Clinical Interview for the Diagnosis of Axis-I disorders (SCID) 
(First et al. 1996). Left-handed participants as well as those with other primary (dominant) 
psychiatric disorders or significant medical illnesses/neurological conditions were excluded. 
Co-morbid anxiety spectrum disorders were not an exclusion criterion if these were 
considered secondary in terms of temporal course and severity. Highest level of education 
was recorded for all participants. Technically inadequate scans were excluded. Data for all 
SAD participants were used in a previous research study by our institution.  
Healthy controls: Healthy control participants underwent a psychiatric screening interview 
using the Mini International Neuropsychiatric Interview (v4.4) (Sheehan et al. 1998), 
physical examination and MRI scan prior to inclusion. Participants were excluded if they 
were left-handed, had any psychiatric diagnoses or significant medical/neurological 
conditions. Highest level of education was recorded in all participants. 
 
Group matching was assessed using appropriate statistical tests, with significance threshold 
of p<0.05: a two-tailed Welch’s t-test was used to detect differences in mean age; a Pearson’s 
Chi-square test was used to detect differences in gender proportions; and a Freeman-Halton 
extension of the Fisher exact test was used to detect differences in highest level of education. 
 
Pharmacotherapy 
 
After baseline measures, SAD participants received an 8-week course of pharmacotherapy 
with either moclobemide or citalopram (open label). No randomization was applied to assign 
which medication would be prescribed (the citalopram and moclobemide sub-groups 
originally consisted of independent datasets from separate studies). Citalopram was initiated 
Stellenbosch University  https://scholar.sun.ac.za
 35 
 
at a dose of 20 mg daily for two weeks followed by 40 mg daily thereafter. Moclobemide was 
initiated at a dose of 600 mg daily for two weeks followed by 900 mg daily thereafter. 
 
Clinical measures 
 
SAD participants were evaluated with the Liebowitz Social Anxiety Scale (LSAS) 
(Liebowitz 1987), Montgomery- Åsberg Depression Rating Scale (MADRS) (Montgomery 
and Asberg 1979), and Sheehan Disability Scale (SDS) (Sheehan 1983) at baseline and after 
a course of pharmacotherapy. The clinical global improvement (CGI) score (Guy 1976) was 
used to evaluate treatment response. Statistical significance of changes in clinical scores 
between baseline and follow-up was tested using a one-tailed, paired student t-test 
(significance threshold p<0.05). Differences in score improvement between the SAD 
subgroup treated with moclobemide and that treated with citalopram was calculated using a 
two-tailed Welch’s t-test. 
  
SPECT imaging 
 
Single photon emission tomography (SPECT) was performed in the resting state for all scans. 
After the placement of an intravenous catheter, participants lay in a quiet, dimly lit room with 
their eyes open, for 30 minutes prior to the injection of the radiopharmaceutical. A dose of 
555 MBq of technetium-99 m hexamethylpropylene amine oxime (Tc-99m HMPAO) was 
administered after which participants lay quietly for (at least) an additional 10 minutes, 
shortly whereafter imaging was performed. Brain SPECT imaging was conducted using a 
dual detector gamma camera (Elscint Helix, GE Medical Systems, USA) equipped with 
fanbeam collimators. A headrest was used for support and comfort. Data were acquired in the 
step-and-shoot mode (3 degree steps; 15 seconds per step), using a 360 degree circular orbit, 
with the detectors of the gamma camera as close as possible to the participant’s head. A 128 x 
128 image matrix was used. 
 
For the purposes of the study, original raw data were reconstructed using optimal 
reconstruction techniques (Hybrid ReconTM – Neurology v1.1.23, HERMES Medical 
Solutions, AB, Sweden). Iterative reconstruction (OSEM; 3 iterations; 30 subsets) was 
performed with uniform attenuation correction (μl = 0.15 cm-1, outline threshold 15%, outline 
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filter FWHM 1 cm), Monte Carlo-based scatter correction, and resolution recovery. Images 
were then smoothed using a 3D Gaussian post-filter (FWHM 1.2cm). The final reconstructed 
voxel size was 2.21 x 2.21 x 2.21 mm3.  
 
Spatial pre-processing 
 
DICOM image files were converted to SPM NIfTI format using MRIConvert v2.0 rev250 
(Jolinda Smith, Lewis Centre for Neuroimaging, University of Oregon, USA). Pre-processing 
of scans was performed using Statistical Parametric Mapping (SPM12, Wellcome Trust 
Centre for Neuroimaging, UCL, London; http://www.fil.ion.ucl.ac.uk/spm/). Scans were 
then spatially normalised to the Montreal Neurological Institute (MNI) standard anatomical 
space with 2 x 2 x 2 mm3 voxels. The images were then smoothed using a 3D Gaussian 
kernel with a FWHM of 8 mm. All images’ global brain counts were normalized to a mean 
value of 100 using a custom MATLAB script (P. Dupont). 
 
Analysis 
 
Whole brain, seed-based connectivity analyses were conducted using seeds representative of 
regions for which a priori interest existed based on the SAD network model of Brühl and 
colleagues (Brühl et al. 2014a). 
 
For regions that were anatomically distinct (bilateral insula; amygdala; thalamus) seed 
volumes of interest (VOIs) were extracted from the Automated Anatomical Labelling (AAL) 
atlas (Tzourio-Mazoyer et al. 2002) using the WFU PickAtlas tool v3.05 (ANSIR Laboratory, 
Wake Forest University School of Medicine, http://fmri.wfubmc.edu/cms/software) 
(Maldjian et al. 2003, 2004). To define left and right dorsolateral prefrontal cortex (dlPFC) 
seeds, we used a method based on that described by Takeuchi and colleagues(Takeuchi et al. 
2014a) using the WFU PickAtlas tool to intersect BA46 (extracted from Talairach Demon 
Brodmann areas+ atlas) (Lancaster et al. 1997, 2000); respective middle frontal gyri 
(extracted from Automated Anatomical Labelling (AAL) atlas) (Tzourio-Mazoyer et al. 
2002) and gray matter (extracted from Talairach Demon Type atlas) (Lancaster et al. 1997, 
2000). Each of these regions was dilated by a factor of 3 (to account for reduced spatial 
resolution of SPECT) before the intersection was applied to derive the final seed VOI. The 
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remaining seed VOIs consisted of spheres centred on coordinates of interest and were 
generated by a custom Matlab script (P. Dupont). For the medial prefrontal cortex (mPFC) 
seed we used the same MNI coordinates as reported by Takeuchi and colleagues (Takeuchi et 
al. 2014a); this same seed has been used to represent mPFC in several previous studies. A 
single (midline) seed VOI was also used for posterior cingulate cortex/precuneus 
(PCC/Precun), centred on the coordinates reported by Greicius and colleagues (Greicius et al. 
2003) which is frequently used to probe DMN. Talairach-Tournoux coordinates for this seed 
were converted to MNI coordinates using BrainMap GingerALE 2.3 (Research Imaging 
Institute UT Health Science Centre San Antonio, http://www.brainmap.org) (Eickhoff et al. 
2009, 2012; Turkeltaub et al. 2012) which uses the icbm_spm2tal transform validated by 
Lancaster and colleagues (Lancaster et al. 2007). While this VOI overlaps bilateral 
precuneus, we also defined an additional dedicated right precuneus seed centred on a cluster 
reported by Liu and colleagues in their work on disrupted cortical hubs in SAD (Liu et al. 
2015b). Right fusiform gyrus coordinates, also based on a cluster reported by Liu and 
colleagues (Liu et al. 2015b), were used to generate a right fusiform gyrus seed. The anterior 
cingulate cortex (ACC) was represented in our analysis by choosing representative seeds 
from both anterior dorsal (adACC) and subgenual (sgACC) sub-regions. Left and right 
adACC and sgACC seeds such as those published by Margulies and colleagues (Margulies et 
al. 2007) and used by several other researchers were insufficiently separated across the 
midline to use as separate seed VOIs in a SPECT analysis (limited spatial resolution). For this 
reason, we used single spherical seed VOIs centred on the midline to represent adACC and 
sgACC regions, effectively combining selected bilateral seeds as published by Margulies. 
Details of the various seed VOIs can be found in Table 2.1. 
 
Group contrasts (SAD baseline vs HC; and SAD baseline vs. after therapy) were performed 
on a voxel-wise basis using a cross-subject correlation approach in SPM12. Significance of 
group differences was calculated using a two-sample, two-tailed t-test. Results were 
thresholded on an uncorrected voxel level of p<0.001 and on a cluster-level at p<0.05, false 
discovery rate (FDR) corrected. Only results significant at cluster level were reported. A 
second-level analysis was performed to interrogate the relationships identified in the seed-
based contrast analysis. To do so, the seed and related cluster in question were used as VOIs 
in a linear regression analysis, again with a two-sample, two-tailed t-test (p<0.05) in SPM12.  
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Results 
 
Demographics 
 
Twenty-three SAD participants were included, of whom 18 also had follow-up (post-
treatment) scans. All participants in the final sample were medication-free except for one 
participant that was on alprazolam 0.25mg per day.  Fifteen healthy controls were selected for 
the final analysis. All controls were medication-free. No statistically significant differences 
were found between the demographics of the healthy control and SAD groups or between the 
subgroups of SAD patients treated with citalopram and moclobemide. Demographic data and 
details of group matching are summarized in Table 2.2.  
 
Clinical 
 
Baseline clinical scores and the effect of medication is summarized in Table 2.3. 
There were no statistically significant differences in baseline or follow-up clinical scores 
between the SAD subgroup treated with citalopram and that treated with moclobemide. In 
terms of improvement in clinical scores with therapy, moclobemide resulted in a greater 
reduction of social anxiety symptomatology as assessed by the LSAS than did citalopram 
(p=0.04). Differences in other clinical scores between the citalopram and moclobemide-
treated SAD subgroups were not statistically significant. 
 
Correlation analysis 
 
Results of the seed-based RFC analyses are summarized in Tables 2.4 and 2.5. 
 
SAD baseline vs HC 
 
Compared to the healthy control group, the SAD group at baseline had decreased 
connectivity between left amygdala and a cluster containing the right middle frontal gyrus. 
Second-level linear regression analysis between these two regions indicated that this decrease 
in connectivity represented a switch from a positive correlation (in HC) to a negative 
correlation (in SAD) (Fig 2.1).  
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Additionally, the SAD group showed decreased connectivity between the midline 
PCC/precuneus seed and a cluster in left cerebellar exterior (crus 1). This decrease was due to 
a switch from a positive correlation (in HC) to a negative correlation (in SAD) (Fig 2.2).  
Increased connectivity (in SAD compared to controls) between right thalamus and a cluster 
overlapping right middle frontal gyrus and adjacent white matter was due to a switch from a 
negative correlation (in HC) to a positive correlation (in SAD) (Fig 2.3).  
Second-level, linear regression analysis of relationships identified in the SAD baseline vs 
after therapy contrast (using respective seed and cluster) did not yield significant results 
(even with more liberal p values) in the SAD baseline vs HC contrast. 
 
SAD baseline vs after therapy 
 
Three significant contrasts were identified between the SAD group at baseline and after a 
course of pharmacotherapy. No decreases in connectivity were identified after therapy.  
Pharmacotherapy resulted in an increase in connectivity between the right fusiform gyrus 
seed and a cluster that involved the medial segment of superior frontal gyrus bilaterally. 
Second-level regression analysis indicated that this increase was due to a switch from a 
negative correlation pre-therapy to a positive correlation after therapy (Fig 2.4).  
After therapy there was an increase in connectivity between the adACC seed and a cluster 
including right precuneus, which was due to a switch from a negative correlation pre-therapy 
to a positive correlation after therapy (Fig 2.5).  
An increase in connectivity (after treatment) between the adACC seed and a cluster in right 
middle occipital gyrus was likely due to a switch from a negative correlation pre-therapy to a 
positive correlation after therapy (Fig 2.6). 
Second-level, linear regression analysis of relationships identified in the SAD baseline vs HC 
contrast (using respective seed and cluster) did not yield significant results (even with more 
liberal p values) in the SAD baseline vs after therapy contrast. 
 
Discussion 
 
In this study we identified several RFC differences between the SAD group at baseline and 
healthy controls, including a novel finding of decreased connectivity between cerebellum and 
posterior cingulate cortex. Furthermore, we demonstrated that pharmacotherapy has an effect 
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on RFC in SAD, particularly on connectivity of the anterior-dorsal region of the anterior 
cingulate cortex. These findings contribute to the limited number of RFC studies in SAD and 
are largely supportive of the current network model of the disorder, as well as providing 
novel data on the effects of therapy. The study also provides the first SPECT RFC data in 
SAD. 
 
Increased connectivity was found between the right thalamus and right middle frontal gyrus 
in SAD at baseline compared to healthy controls. These findings are consistent with the 
current network model of SAD (Brühl et al. 2014a), which predicts increased fronto-thalamic 
connectivity in SAD. Based on fear conditioning models, two routes exist to convey sensory 
information from the thalamus to the amygdala (LeDoux 1998). Rapid communication is 
achieved by a direct thalamo-amygdala pathway, whereas an indirect thalamo-cortico-
amygdala pathway enables external stimuli to be cognitively appraised and modulated by 
cortical regions en route to the amygdala. Increased thalamo-cortical connectivity may reflect 
excessive utilisation of the first part of this slower pathway in SAD, although it is unclear 
whether this change could be an underlying cause or a response to SAD. The prefrontal 
cluster identified in this study corresponded most closely to BA47, localized predominantly 
in the orbital portion of the middle frontal gyrus. This is compatible with the implication of 
this region in several processes potentially relevant to SAD, namely identification of 
emotional intonation (Wildgruber et al. 2005); behavioural inhibition (Del-Ben et al. 2005; 
Völlm et al. 2006); embarrassment at violation of social norms (Berthoz et al. 2002); 
attribution of intention to others (Brunet et al. 2000); and reward processing (Rogers et al. 
1999). Research by Giménez and colleagues in SAD participants has linked connectivity 
between these regions with the perception of social scrutiny (Giménez et al. 2012).  
 
Decreased connectivity was found between left amygdala and right superior frontal gyrus in 
SAD at baseline. Although this finding is not consistent with increased connectivity predicted 
by the Brühl network model for SAD, the authors of that meta-analysis did highlight 
inconsistency of this relationship in the literature, with fronto-amygdalar connectivity being 
either increased or decreased in SAD (Brühl et al. 2014a). Certainly decreased functional 
connectivity between these regions in SAD is consistent with preclinical models of anxiety in 
which there is failure by frontal cortex to dampen the highly sensitive subcortical 
(amygdalar) alarm system (i.e. failure of top-down control) (LeDoux 2000; Akirav and 
Maroun 2007). Inconsistency in connectivity findings between these regions in human SAD 
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research may be due to the fact that several amygdalo-frontal connectivity disturbances are 
present in SAD.  
The superior frontal gyrus (overlapping BA9/32) has previously been implicated in self-
focused reappraisal, i.e. emotionally detaching oneself from negative events by down-
regulation of arousal , or what Falquez and colleagues refer to as “adopting the role of a 
detached third-person observer during the presentation of emotional stimuli” (Falquez et al. 
2014). Such a regulatory role over negative emotion for this region is supported by studies 
that found decreased amygdalar activation during reappraisal (Banks et al. 2007). A negative 
correlation between these regions in SAD during rest may represent the tendency for these 
patients to spontaneously engage in emotional distancing; a behaviour reported by some SAD 
sufferers (Alden and Taylor 2004). While the significance of functional connectivity between 
contralateral structures (left amygdala; right prefrontal cortex) is uncertain, there is evidence 
for lateralization of amygdala function, with left amygdala more involved in ongoing 
appraisal of emotional stimuli and right amygdala preferentially activated by tasks requiring 
rapid orientation or ambiguous stimuli (Freitas-Ferrari et al. 2010). 
 
Diminished connectivity was found between a posterior cingulate/precuneus seed and left 
cerebellum in SAD at baseline. While this finding was no longer significant on the seed-
based analysis after excluding a participant on low-dose alprazolam, the finding remained 
highly significant using a seed x cluster linear regression (which demonstrated no outliers) 
and was likely real. A relationship between these regions may be related to findings in 
healthy participants that correlated cerebellar crus 1 activity with DMN activity (Buckner et 
al. 2011) (of which posterior cingulate/precuneus is a critical node) (Greicius et al. 2003); and 
with other work that suggests the cerebellum modulates DMN function (Bernard et al. 2012). 
This finding is of interest in SAD given evidence that the DMN plays a role in social 
cognition (Schilbach et al. 2008; Laird et al. 2011; Mars et al. 2012), and of DMN 
dysfunction in the disorder (Gentili et al. 2009; Liao et al. 2010a; Liu et al. 2015a). While a 
few RFC studies have reported cerebellar connectivity disturbances in SAD, as far as the 
authors are aware, a connectivity disturbance between cerebellum and posterior 
cingulate/precuneus has not previously been reported. This may in part be due to the limited 
attention cerebellum has received in investigative hypotheses to date. Our findings support 
closer scrutiny of cerebellar functioning in SAD, especially in the context of evidence for it 
playing a role in cognitive emotional processing (Schmahmann 2010), and renewed interest 
in disturbed cortico-cerebellar connectivity in anxiety states (Caulfield and Servatius 2013). 
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Evidence exists from neuroimaging research in healthy volunteers and in psychiatric 
disorders that pharmacotherapy affects RFC (McCabe et al. 2011; van Wingen et al. 2014; 
Yang et al. 2014; Wang et al. 2015). Only one study in SAD has tested for pharmacological 
effects on RFC: Giménez and colleagues used independent component analysis to identify 
paroxetine treatment effects in four different components (Giménez et al. 2014). That group 
reported reductions in connectivity with therapy in all components (in some cases produced 
by structures included in our own analysis – right thalamus; sgACC and insula). That we did 
not identify a treatment effect on connectivity of these regions may be due to differences in 
analysis methodology. The therapy-related connectivity changes we found were for seed 
regions outside of the components examined by Giménez and colleagues.  
Whether identified using seeds or clusters, our findings on how therapy influenced RFC in 
SAD all related to connectivity of the dorsal anterior cingulate cortex. A possible mechanism 
for an increase in connectivity following pharmacotherapy (frequently using selective 
serotonin reuptake inhibitors - SSRIs) is suggested by studies reporting downregulation of 5-
HT1A receptors (Lanzenberger et al. 2007) as well as increased serotonin synthesis and 
reuptake in dorsal anterior cingulate of untreated SAD patients compared to healthy controls 
(Frick et al. 2015a). The dorsal anterior cingulate cortex probably has a mainly evaluative 
role in emotion processing (Etkin et al. 2011), which is consistent with a recent model in 
which dorsal ACC integrates information about rewards and costs to estimate the value of 
allocating control (Shenhav et al. 2013). 
An increase in connectivity was found between right fusiform gyrus and dorsal anterior 
cingulate cortex in SAD after therapy. The subregion of right fusiform gyrus we used as our 
seed VOI closely corresponds to the fusiform face area (FFA) which is involved in the early 
visual processing of faces (Haxby et al. 2000; Li et al. 2009). Fusiform hyperactivity is a 
consistent finding that may reflect a specific aspect of SAD, such as altered processing of 
emotional facial expressions, or generally heightened emotional system reactivity (Frick et al. 
2013). Disturbed connectivity of this right fusiform subregion in SAD is suggested by prior 
resting-state fMRI research (Danti et al. 2010; Liu et al. 2015b), although connectivity 
abnormalities between right fusiform and dorsal anterior cingulate per se have not been 
reported. Contrary to our hypothesis, this finding did not represent a normalization of 
connectivity between these regions as predicted by the Brühl model, which suggests 
increased connectivity between prefrontal cortex and fusiform in SAD (Brühl et al. 2014a). 
Increased dorsal anterior cingulate connectivity with fusiform gyrus may therefore represent 
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a compensatory effect in SAD that is further enhanced by pharmacotherapy. We can 
speculate that a therapy-induced increase in connectivity between these regions may lead to 
modification of the process whereby we evaluate emotions in others. Certainly, neuroimaging 
studies in SAD using emotion recognition paradigms have previously reported differences 
after therapy (Schneier et al. 2011; Phan et al. 2013; Giménez et al. 2014; Pantazatos et al. 
2014). 
Our analysis also found an increase in connectivity between the adACC seed and a cluster in 
right middle occipital gyrus in the SAD group after therapy. This cluster was sufficiently 
removed from the right fusiform gyrus seed that we considered this to be a separate finding. 
While this result was no longer significant on the seed-based analysis after excluding the 
participant on low-dose alprazolam, no clear outlier was seen on the linear regression analysis 
using seed and cluster as VOIs and using that method the difference remained highly 
significant even after exclusion and was likely real. Once again, our finding did not represent 
a normalization of the connectivity disturbance between these regions predicted by the Brühl 
model (increased connectivity in SAD at baseline) and provides indirect evidence that 
baseline connectivity between these regions in SAD may be compensatory. Functional 
connectivity between dorsal anterior cingulate and a region involved in visual function once 
again highlights the role of visual processing in the disorder. Finally, the study also found an 
increase in connectivity between dorsal anterior cingulate cortex and the right precuneus in 
the SAD group following therapy. Once again, this finding was no longer significant on seed-
based analysis after excluding a participant on low-dose alprazolam, however clearly 
persisted on the linear regression analysis. The current SAD network model predicts 
generally decreased connectivity between prefrontal cortex and precuneus and as such our 
finding is consistent with a normalization of this relationship with pharmacotherapy. 
Functional connectivity of the precuneus is complex, likely underlying its many functions in 
visuo-spatial imagery, episodic memory retrieval, self-related processing and consciousness 
(Cavanna and Trimble 2006). It is also a component region of the DMN which is active at 
rest (Greicius et al. 2003).  It is possible that a strengthening of this connectivity deficit in 
SAD with therapy may underlie a synchronous improvement in self-related processing and 
emotion processing.  
 
Our study suffered from several limitations inherent to the type of functional connectivity 
analysis employed. The open label nature of the study did not allow control of expectancy 
effects in the SAD group. It may also be argued that lack of randomization in assignment of 
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moclobemide or citalopram therapy in the SAD group may introduce bias in our mixed 
sample but given that participants in the two SAD subgroups (i.e. treated with moclobemide 
and treated with citalopram) were all treated, were not recruited simultaneously, and did not 
differ in clinical severity measures at baseline, we do not consider this to be a major problem. 
The effect of non-randomized assignment is also less relevant in that a comparison of 
moclobemide and citalopram was not performed since these subgroups were too small. It is 
possible that RFC changes secondary to therapy were related to improved mood (evidenced 
by reduction in MADRS scores) or other pharmacotherapy effects rather than improvements 
in SAD, however we consider this unlikely given that none of the participants suffered from 
major depression as a dominant disorder and that in both the citalopram and moclobemide  
treated groups, baseline MADRS scores were in the mild clinical severity range (as per Table  
2.3), which further supports the argument that the RFC changes are unlikely to be primarily 
the result of improvement in depressive symptomatology. Furthermore, while it is possible 
that non-dominant psychiatric comorbidities may have affected the results, none of the SAD 
participants had any other dominant psychiatric disorder and we therefore consider this 
unlikely. Since a cross-subject correlation was used, clinical scores e.g. for depression or 
anxiety severity, could not be used as covariates or to correlate connectivity differences 
between groups. Similarly, because a cross-subject (group level) connectivity analysis was 
used (rather than intra-subject connectivity, as can be performed with fMRI) it was necessary 
to assume independence between baseline and post-therapy connectivity measures in the 
SAD group (i.e. a group-level, cross-subject approach prevented the use of a paired t-test 
which is more sensitive for detecting longitudinal differences). Other potential confounds 
include the potential effect of prior treatment or length of illness in the SAD group (not 
recorded). While SAD and HC participants did not undergo identical screening procedures, 
both diagnostic instruments used are known as accurate structured psychiatric interviews 
with sound psychometric properties and therefore it is unlikely that this confounded our 
results.  
 
Our study was significant in that, in addition to finding further support for several 
connectivity disturbances predicted by the recently published meta-analytic network model 
for SAD, it identified for the first time decreased connectivity between cerebellum and a core 
node of the default mode network in the disorder. Our work also adds to the limited literature 
on the effect of pharmacotherapy on resting-state functional connectivity in SAD; specifically 
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how therapy increases connectivity between dorsal anterior cingulate cortex and regions 
involved in self-related processing and the interpretation of facial emotion. 
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Tables and Figures 
 
Table 2.1 Description of seeds used in analysis 
 
Seed Description [MNI, xyz] 
 
Amygdala (L+R) Anatomical: extracted from AAL atlas 
Thalamus (L+R) Anatomical: extracted from AAL atlas 
Insula (L+R) Anatomical: extracted from AAL atlas 
dlPFC (L+R) Anatomical: intersect of middle frontal gyrus; BA 46; and 
gray matter (all dilated by factor of 3) 
mPFC Spherical VOI (radius 6mm) centred on [-1 47 -4] 
PCC/Precun Spherical VOI (radius 6mm) centred on [-1 -50 31] 
R Precuneus  Spherical VOI (radius 6mm) centred on [3 -48 63] 
adACC Spherical VOI (radius 12mm) centred on [0 19 28] 
sgACC Spherical VOI (radius 12mm) centred on [0 25 -10] 
R FFG Spherical VOI (radius 6mm) centred on [42 -60 -15] 
 
Abbreviations: MNI - Montreal Neurological Institute space; L – Left; R – Right; AAL – 
Automated Anatomical Labelling; dlPFC – dorsolateral prefrontal cortex; VOI – volume of 
interest; BA – Brodmann Area; mPFC – medial prefrontal cortex; PCC/Precun – posterior 
cingulate cortex/precuneus; adACC – anterior-dorsal anterior cingulate cortex; sgACC – 
subgenual anterior cingulate cortex; FFG –fusiform gyrus. 
  
Stellenbosch University  https://scholar.sun.ac.za
 47 
 
Table 2.2a Group matching; HC group vs SAD group at baseline 
 
 Group  
 HC SAD p 
Total (n) 15 23  
Mean age in years: 37.0  
(26.8 – 57.0) 
32.8  
(17.1 – 48.3) 
0.12† 
Gender: Male: 10, Female: 5 Male: 17, Female: 6 0.63‡ 
Highest level of 
education: 
 
 
  
Formal schooling 
not completed 
 
2 
 
5 
 
Formal schooling 
completed 
 
6 
 
10 
0.75ⱡ 
Formal schooling + 
additional 
qualification 
 
7 
 
8 
 
 
†Two-tailed Welch’s t-test 
‡Pearson’s Chi-square test 
ⱡFreeman-Halton extension of the Fisher exact test 
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Table 2.2b Group matching of SAD subgroup treated with citalopram vs SAD subgroup 
treated with moclobemide 
 
 Subgroup  
 Citalopram Moclobemide p 
Total (n) 11 7  
Mean age in years: 32.8 
(18.5 – 42.7) 
32.3 
(23.6 – 42.1) 
0.9† 
Gender: Male: 7, Female: 4 Male: 6, Female: 1 0.31‡ 
Highest level of 
education: 
   
Formal schooling 
not completed 
 
2 
 
1 
 
 
0.8ⱡ Formal schooling 
completed 
 
5 
 
5 
Formal schooling + 
additional 
qualification 
 
4 
 
1 
 
†Two-tailed Welch’s t-test 
‡Pearson’s Chi-square test 
ⱡFreeman-Halton extension of the Fisher exact test 
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Table 2.3 Effect of medication on mean clinical scores (±SD), in SAD participants with 
statistical measures of group matching 
 
 Subgroup  
 Citalopram (n=11) Moclobemide (n=7)  p† 
 
Mean duration of 
therapy 
 
8.4 weeks 
(8.0 – 10.9) 
8.0 weeks 
(8.0) 
0.15 
LSAS    
Baseline 93.1 (±24.0) 112 (±17.6) 0.07 
Post-therapy  74.8 (±30.0) 74.6 (±22.4) 0.98 
Mean % change -21.1(±20.3) -33.8 (±15.4) 0.04 
p‡ 0.003 
 
0.0007  
MADRS    
Baseline 14.7 (±3.4) 10.7 (±7.8) 0.24 
Post-therapy  7.0 (±3.8) 4.9 (±2.3) 0.16 
Mean % change -50.2 (±28.9) -38.5 (±34.1) 0.56 
p‡ 0.0003 
 
0.04  
SDS    
Baseline 16.8 (±5.2) 19.1 (±4.8) 0.35 
Post-therapy  12.2 (±7.5) 16.0 (±3.7) 0.17 
Mean % change -31.3 (±32.4) -14.6 (±15.3) 0.44 
p‡ 0.004 0.02  
 
CGI-S 
 
4.8 (±0.8) 
 
5 (±0.8) 
 
0.64 
CGI-I 3.2 (±1.5) 3.4 (±0.5) 0.63 
 
Abbreviations: LSAS: Liebowitz Social Anxiety Scale; MADRS: Montgomery-Åsberg 
Depression Rating Scale; SDS: Sheehan Disability Scale; CGI: Clinical Global Impression; -S: 
Severity; -I: Improvement 
†Two-tailed Welch’s t-test 
‡One-tailed paired Student’s t-test 
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Table 2.4 Functional correlation seed-based analysis results (statistically significant 
contrasts) in the SAD group compared to the HC group 
 
Seed connectivity findings Cluster size 
(mm3) 
p* Peak voxel location 
(mm) MNI 
x y z 
 
L Amygdala seed showed 
reduced connectivity with 
cluster overlapping right 
SFG/adACC (BA9/ BA32)  
 
 
776 
 
0.04 
 
20 
 
28 
 
36 
PCC/Precun seed showed 
reduced connectivity with 
cluster in left cerebellar crus 1 
 
594 0.05 -48 -78 -44 
 
R Thalamus seed showed 
increased connectivity with 
cluster overlapping right MFG 
and MFGorb (BA47/11)  
 
 
756 
 
0.01 
 
26 
 
42 
 
0 
 
*Cluster-level threshold of p<0.05 (FDR corrected), at voxel-level threshold of p<0.001 
(uncorrected) 
Abbreviations: MNI - Montreal Neurological Institute space; L – Left; R – Right; SFG – 
superior frontal gyrus; PCC/Precun – posterior cingulate cortex/precuneus; BA – Brodmann 
area;  adACC – anterior-dorsal anterior cingulate cortex; MFG – middle frontal gyrus; 
MFGOrb – middle frontal gyrus, orbital part.  
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Table 2.5 Functional correlation seed-based analysis results (statistically significant 
contrasts) in the SAD group after therapy compared to baseline  
 
Seed connectivity findings Cluster size 
(mm3) 
p* Peak voxel location 
(mm) MNI 
x y z 
R FFG seed showed increased 
connectivity with cluster in 
bilateral adACC (mSFG; BA32) 
 
668 0.01 -6 44 30 
adACC seed showed increased 
connectivity with cluster in right 
precuneus (BA7)  
 
371 
 
0.04 
 
14 
 
-62 
 
42 
 
adACC seed showed increased 
connectivity with cluster in right 
MOG (BA19) 
 
390 0.04 36 -74 4 
 
*Cluster-level threshold of p<0.05 (FDR corrected), at voxel-level threshold of p<0.001 
(uncorrected) 
Abbreviations: MNI - Montreal Neurological Institute space; R FFG – right fusiform gyrus; 
mSFG – superior frontal gyrus medial segment; BA – Brodmann area;  adACC – anterior-
dorsal anterior cingulate cortex; MOG – middle occipital gyrus.  
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Figure 2.1 Connectivity result 1. Left amygdala seed (x=-24; y=0; z=-18) (A) and right 
superior frontal gyrus (R SFG) cluster (x= 20; y=28; z=36) (B) in the SAD baseline vs HC 
contrast. Results of the regression analysis (C) demonstrate that decreased connectivity 
between these regions in the SAD group compared to healthy controls (p<0.001) was due to 
a switch from a positive correlation in HC (p=0.002) to a negative correlation in SAD 
(p<0.001). Axes in arbitrary units.  
 
 
 
 
Figure 2.2 Connectivity result 2. Posterior cingulate cortex/precuneus (PCC/Precun) seed 
(x=-1; y=-50; z=31) (A) and left cerebellar crus 1 cluster (x=-48; y=-78; z=-44) (B) in the SAD 
baseline vs HC contrast (cerebellar cluster only appears to extend outside brain on the MRI 
template used for illustrative purposes). Results of the regression analysis (C) demonstrate 
that decreased connectivity between these regions in the SAD group compared to healthy 
controls (p<0.001) was due to a switch from a positive correlation in HC (p<0.001) to a 
negative correlation in SAD (p=0.007). Axes in arbitrary units. While results of seed-based 
analysis did not meet statistical significance after excluding a patient on low-dose 
alprazolam (p=0.71), difference on linear regression remained significant (p<0.001).  
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Figure 2.3 Connectivity result 3. Right thalamus seed (x=12; y=-20; z=8) (A) and right middle 
frontal gyrus (R MFG) cluster (x=26; y=42; z=0) (B) in the SAD baseline vs HC contrast. 
Results of the regression analysis (C) demonstrate that increased connectivity between 
these regions in the SAD group compared to healthy controls (p<0.001) was due to a switch 
from a negative correlation in HC (p=0.005) to a positive correlation in SAD (p<0.001). Axes 
in arbitrary units.  
 
 
 
 
Figure 2.4 Connectivity result 4. Right fusiform gyrus (R FFG) seed (x=42; y=-60; z=-15) (A) 
and bilateral anterior-dorsal anterior cingulate cortex (adACC) cluster (x=-6; y=44; z=30) (B) 
in the SAD contrast before (SAD) and after (SAD(PT)) therapy. Results of the regression 
analysis (C) demonstrate that increased connectivity between these regions after therapy 
(p<0.001) was due to a switch from a negative correlation in SAD at baseline (p=0.017) to a 
positive correlation post-therapy (p=0.001). Axes in arbitrary units.  
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Figure 2.5 Connectivity result 5. Anterior-dorsal anterior cingulate cortex (adACC) seed (x=-
5; y=19; z=28) (A) and right precuneus cluster (x=14; y=-62; z=42) (B) in the SAD contrast 
before (SAD) and after (SAD(PT)) therapy. Results of the regression analysis (C) demonstrate 
that increased connectivity between these regions after therapy (p<0.001) was due to a 
switch from a negative correlation in SAD at baseline (p=0.012) to a positive correlation 
post-therapy (p=0.002). Axes in arbitrary units (arb. unit). While results of seed-based 
analysis did not meet statistical significance after excluding a patient on low-dose 
alprazolam (p=0.28), difference on linear regression remained significant (p<0.001).  
 
 
 
 
Figure 2.6 Connectivity result 6. Anterior-dorsal anterior cingulate cortex (adACC) seed (x=0; 
y=19; z=28) (A) and right middle occipital gyrus (R MOG) cluster (x=36; y=-74; z=4) (B) in the 
SAD contrast before (SAD) and after (SAD(PT)) therapy. Results of the regression analysis (C) 
demonstrate that the statistically significant (p<0.001) increase in connectivity after therapy 
was likely due to a switch from a negative correlation in SAD at baseline (p<0.001) to a 
positive correlation post-therapy (p=0.06; borderline significant). Axes in arbitrary units (arb. 
unit). While results of seed-based analysis did not meet statistical significance after 
excluding a patient on low-dose alprazolam (p=0.28), difference on linear regression 
remained significant (p<0.001).   
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Abstract 
 
Many psychiatric disorders are characterized by altered social cognition. The importance of 
social cognition has previously been recognized by the NIMH Research Domain Criteria 
project, in which it features as a core domain. Social task-based functional magnetic 
resonance imaging (fMRI) currently offers the most direct insight into how the brain 
processes social information, however resting-state fMRI may be just as important in 
understanding the biology and network nature of social processing. Resting-state fMRI 
allows researchers to investigate the functional relationships between brain regions in a 
neutral state: so-called resting functional connectivity (RFC). There is evidence that RFC is 
predictive of how the brain processes information during social tasks. This is important since 
it shifts the focus from possibly context-dependent aberrations to context-independent 
aberrations in functional network architecture. Rather than being analysed in isolation, the 
study of resting-state brain networks shows promise in linking results of task-based fMRI 
results, structural connectivity, molecular imaging findings, and performance measures of 
social cognition – which may prove crucial in furthering our understanding of the social 
brain. 
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Text 
 
Functional magnetic resonance imaging (fMRI) offers unique insights into brain function. A 
particular avenue of interest is how functional connectivity (FC) techniques are employed to 
map relationships between spatially distant brain regions during a variety of cognitive tasks 
(Bressler & Menon, 2010; Fox et al., 2005). The same techniques have been applied to scans 
acquired during a sustained period of rest, i.e. the resting state (rs-fMRI). Note that while it is 
possible to generate “pseudo” resting-state data derived from task-based series (Fair et al., 
2007), and such techniques make valuable contributions to social cognitive research (e.g. 
Iacoboni et al., 2004; Spunt, Meyer, & Lieberman, 2015), these data are not entirely 
equivalent to that obtained with rs-fMRI (Fransson, 2006) and are not the focus of this 
communication. Alterations in resting functional connectivity (RFC) have been described in 
multiple psychiatric and neurological disorders (Bressler & Menon, 2010; Buckner, 
Andrews-Hanna, & Schacter, 2008; Kennedy & Adolphs, 2012). While such work is 
important, in isolation it has little relevance to understanding the fundamental workings of the 
brain, disruptions in the context of disorder, or biological basis of treatment effects. A deeper 
understanding requires insight into how variations in RFC relate to cognitive constructs, 
operations, and performance (Bilder et al., 2009; Kelly, Biswal, Craddock, Castellanos, & 
Milham, 2012).  
 
The social brain hypothesis suggests that our brains evolved to navigate complex social 
systems (Dunbar, 1998). Social cognition, or “the mental operations that underlie social 
interactions, including perceiving, interpreting, and generating responses to the intentions, 
dispositions, and behaviours of others” (Green et al., 2008) may therefore be considered as 
fundamental to our nature. Impairments in social cognition are found in most psychiatric 
conditions (Kennedy & Adolphs, 2012) and constitute a significant component of the 
morbidity associated with these diagnoses. Recognizing its trans-diagnostic importance, 
social processing has been included as one of the domains in the NIMH Research Domain 
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Criteria (RDoC) project for classifying mental illnesses (Cuthbert & Insel, 2013). While the 
relationship between RFC and social cognition remains relatively understudied, several 
recent initiatives have begun to address this, with the inclusion of both social cognition 
measures and rs-fMRI in open databases in which participants also undergo deep phenotypic 
characterization and genetic sampling (for instance McDonald et al., 2017; Miller et al., 
2016). There are numerous advantages to research using such large datasets, including the 
option to use normative modelling as an alternative to the more traditional clustering used in 
case-control studies (Marquand, Rezek, Buitelaar, & Beckmann, 2016). In this 
communication we briefly discuss strategies in which rs-fMRI can contribute to social 
cognition research with some examples. Further examples are found in Table 3.1. 
 
The social cognitive significance of RFC findings is frequently speculated upon when 
analyses reveal functional connectivity between regions for which there is independent 
evidence of social function (Schilbach, Eickhoff, Rotarska-Jagiela, Fink, & Vogeley, 2008). 
Regions implicated in such experiments include the temporoparietal junction, inferior frontal 
gyrus, anterior insula, anterior cingulate cortex and medial prefrontal cortex (Frith & Frith, 
2007; van Veluw & Chance, 2014). Most research attempting to link RFC and social 
cognition has been directed at identifying overlaps between resting networks identified by 
independent component analysis (ICA) or seed-based correlation techniques and networks 
activated by social task fMRI. Observations of similarity between the default mode network 
(DMN) – an RFC network, and networks activated by social tasks (Buckner et al., 2008) have 
for example been confirmed by using meta-analytic connectivity modelling approaches (Amft 
et al., 2015; Jack et al., 2013; Laird et al., 2011; Schilbach, Bzdok, Timmermans, Fox, & 
Laird, 2012). While informative, conjunction analyses using the data of multiple independent 
research samples only imply shared spatial distribution of networks. This offers at best 
indirect evidence of shared function. Two approaches that more directly link social cognition 
and RFC are outlined below, which allow direct investigation of the relation between RFC 
and social cognition on an individual subject level. 
  
The first approach combines rs-fMRI and non-imaging phenotypic measures in the same 
participants. RFC between brain regions on a per-subject level can then be correlated with 
scores on validated psychological instruments that test social cognitive domains of interest. 
For example, RFC measures of the medial prefrontal cortex have been correlated with self-
reported empathic capacity in healthy volunteers (Takeuchi et al., 2014). The approach of 
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correlating RFC to phenotypic measures is also well-suited to exploratory multivariate 
analyses of large datasets, wherein multiple RFC measures can be linked to multiple domains 
of social cognition. The availability of publicly available, large databases represent great 
opportunities in this regard (McDonald et al., 2017; Miller et al., 2016; Nooner et al., 2012). 
At the network level, graph theory metrics from RFC data can be used to mine large datasets 
for significant correlations (Zanin et al., 2016). While correlations have been performed 
between graph metrics (e.g. clustering coefficient, characteristic path length, etc.) and more 
traditional cognitive domains (Alavash, Doebler, Holling, Thiel, & Gießing, 2015; 
Santarnecchi, Galli, Polizzotto, Rossi, & Rossi, 2014), there are limited studies in which 
graph metrics have been correlated with social cognition measures. In one such study, 
decreased network centrality within a fronto-temporo-insular network in patients with 
probable behavioural variant frontotemporal dementia was associated with impairments in 
social cognition scores (Sedeño et al., 2016). 
 
In the second approach, rs-fMRI and social-task fMRI are performed in the same participants. 
In such approaches, RFC is either correlated to regional activations or to FC during social 
tasks. An example of such a comparative FC approach is to be found in research by Hyatt et 
al, who related three DMN subnetworks to FC during a mentalizing task in healthy volunteers 
(Hyatt, Calhoun, Pearlson, & Assaf, 2015). In a fascinating study that offers further evidence 
of the benefit of large databases, RFC data from the Human Connectome Project were 
successfully used to train a model to predict individual differences in regional activation on 
task-based fMRI (including social cognitive tasks) in the same subjects (Tavor et al., 2016). 
That RFC can be used to successfully predict the brain’s activity during tasks is perhaps the 
most compelling rationale for the value of RFC in social cognition research. This is important 
since it shifts the focus from possibly context-dependent aberrations (activity or FC on task) 
to context-independent aberrations in functional network architecture (RFC) when 
investigating social cognition in the normal or abnormal ranges. The future inclusion of RFC 
measures in innovative hyperscanning experimental designs, in which multiple subjects are 
scanned simultaneously, allowing the direct study of social interactions (Montague et al., 
2002), or in experience sampling studies, in which subjects undergo intensive longitudinal 
sampling during daily life social interactions (Hurlburt, 1997), may also be beneficial in 
contextualizing scan results. 
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Inclusion of rs- fMRI in addition to task-based fMRI potentially clarifies the spatiotemporal 
relationships between RFC and task-dependent FC, and allows RFC (sub)networks to be 
functionally characterized and segregated. While rs-fMRI has its pitfalls (Kelly et al., 2012), 
the inclusion of rs- fMRI sequences in social cognition research holds several advantages, 
especially in a multimodal imaging context. In addition to contextualizing findings from task-
based fMRI, the combination of RFC with structural and molecular imaging measures in the 
same subjects has the potential to provide sophisticated models of social cognition in relation 
to both the architecture and function of the brain in health and disease.  
 
Social cognition is innate to what makes us human. It is clear that the biological basis for 
social cognitive processing is complex and is best investigated with multiple complementary 
measures. Recognizing the valuable contributions of previous studies in the field, we suggest 
there is a compelling case motivating the increased use of rs-fMRI in future social cognition 
research.  
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Table 
 
Table 3.1 Summary of studies that have correlated RFC and social cognition measures.  
 
 
Study 
reference 
Participants RFC measure Social cognition 
domain 
 
Summary of relevant findings 
 
Research correlating RFC measures with non-imaging measures of social cognition 
 
Non-clinical samples: 
 
   
(Takeuchi 
et al., 
2014) 
Healthy adults 
(n=248) 
Seed-based analysis of a 
priori ROIs 
Empathizing Higher empathizing was associated with 
greater RFC between the mPFC and dorsal 
ACC; precuneus; and left STS. 
 
(Takeuchi 
et al., 
2013) 
Healthy adults 
(n=248) 
Seed-based analysis of a 
priori ROIs 
Emotional processing  The intrapersonal factor of TEI was negatively 
correlated with RFC between mPFC and right 
dlPFC. The interpersonal factor of TEI was 
positively correlated with RFC between mPFC 
and lingual gyrus. Total TEI was positively 
correlated with RFC between mPFC and the 
precuneus as well as between the left AI and 
the middle part of the right dlPFC.  
 
(Wu et al., 
2016) 
Healthy adults 
(n=258) 
Seed-based analysis of a 
priori ROIs 
Emotional processing  Women with higher trait-level emotion 
regulation exhibited stronger negative RFC 
between right CM and mSFG as well as 
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stronger positive RFC between CM and AI and 
STG. Men with higher trait-level emotion 
regulation exhibited weaker negative RFC of 
right CM-mSFG and positive RFC of right CM-
left AI, right CM-right AI/STG, and right CM-
left STG. 
 
(Cox et al., 
2012) 
Healthy adults 
(n=38) 
Seed-based analysis of 
experimentally-derived 
ROIs (regions 
demonstrating 
correlation between 
fALFF and empathy 
scores) 
Empathizing Dominance of affective empathy was 
associated with greater RFC among social–
emotional regions. Dominance of cognitive 
empathy was associated with greater RFC 
among regions implicated in interoception, 
autonomic monitoring and social–cognitive 
processing. 
 
(Marchetti 
et al., 
2015) 
Healthy adults 
(n=670) 
ROI x ROI correlation of 
atlas-derived 
parcellations (Harvard-
Oxford atlas) 
ToM In participants with high ToM scores, a 
network with greater RFC with a dominance 
of the left hemisphere; as well as an 
increased within-lobe RFC in frontal and 
insular lobes was identified. 
 
 
Clinical samples: 
 
   
(Cao et al., 
2015) 
Oesophageal cancer 
with ToM deficits 
(n=25) 
Oesophageal cancer 
controls (n=25) 
 
ROI x ROI correlation of a 
priori ROIs 
ToM In the ToM deficit group, reduced RFC was 
found between several DMN regions. 
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(Caminiti 
et al., 
2015) 
bvFTD (n=12) 
HC (n=30) 
Components identified 
on ICA 
ToM In the bvFTD group, higher affective 
mentalizing performance correlated with 
greater RFC between medial prefrontal 
sectors of DMN and attentional/performance 
monitoring networks, as well as with 
increased RFC between components of the 
executive, sensorimotor and fronto-limbic 
networks. 
 
(Sedeño et 
al., 2016) 
Probable bvFTD 
(n=14) 
HC (n=12) 
Frontoinsular stroke 
(n=10) 
ROI x ROI correlations of 
atlas-derived 
parcellations (AAL atlas).  
Network centrality within 
different networks 
 
Emotional processing 
and ToM 
In the bvFTD group, decreased network 
centrality in frontotemporoinsular network 
was associated with impaired social 
cognition. 
(Peeters et 
al., 2015) 
Psychotic disorder 
(n=63) 
Unaffected siblings 
(n=73) 
HC (n=59) 
 
Seed-based analysis of a 
priori ROIs  
Emotional processing 
and ToM 
In the total sample, reduced dlPFC-insula RFC 
was associated with lower social cognition 
scores. 
(Fox et al., 
2017) 
Schizophrenia (n=28) 
HC (n=32) 
Inter-component 
connectivity metrics 
calculated from 
components identified on 
ICA 
 
Emotional processing 
and ToM 
In the schizophrenia group, social cognition 
did not mediate the association between 
DMN connectivity and social functioning  
(Abram et 
al., 2017) 
Schizophrenia (n=28) 
HC (n=31) 
Inter-component 
connectivity metrics 
calculated from 
Empathizing In the schizophrenia group, the medial-
fronto-temporal metric and an orbito-fronto-
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components identified on 
ICA 
 
temporal metric were related to cognitive 
empathizing. 
(Jastorff et 
al., 2016) 
bvFTD (n=14) 
HC (n=19) 
Seed-based analysis of 
experimentally-derived 
ROIs (regions in which 
VBM results correlated 
with non-imaging task 
measure) 
Emotional processing In the bvFTD group, there was reduced RFC 
between several ROIs defined on the basis of 
the emotional processing measure: between 
ATL and mid and posterior temporal cortex, 
IFG, and mOFC. Left IFG demonstrated 
reduced connectivity with contralateral AI, 
contralateral amygdala and contralateral ATL. 
 
(Mothersill 
et al., 
2016) 
Schizophrenia or 
schizoaffective 
disorder (n=27) 
HC (n=25) 
Seed-based analysis of a 
priori ROIs 
ToM In the schizophrenia/schizoaffective disorder 
group, higher ToM scores were associated 
with increased RFC between left precuneus 
and right middle cingulate/right inferior 
frontal gyrus and between left TPJ and right 
calcarine gyrus/right lingual gyrus. Lower 
ToM scores were associated with higher RFC 
between left precuneus and right insula/left 
STG. 
 
(Serra et 
al., 2016) 
DM1 (n=20) 
HC (n=18) 
ROI x ROI correlation of 
atlas-derived 
parcellations (AAL atlas) 
ToM In the DM1 group, ToM deficits were 
associated with abnormal connectivity 
between the left inferior temporal and 
fronto-cerebellar nodes.  
 
(Wang, 
Song, 
Zhen, & 
Liu, 2016) 
Healthy adults 
(n=268) 
Seed-based analysis of 
experimentally-derived 
ROIs (regions identified 
on localizer fMRI) 
ToM Individuals with stronger within-network 
connectivity of the right pSTS performed 
better on the ToM task. Further, RFC between 
the right pSTS and right OFA, EVC, and 
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bilateral STS were positively correlated with 
the scores of ToM. RFC of EVC-pSTS and OFA-
pSTS contributed independently to ToM 
ability. 
 
(Joshua T. 
Kantrowitz 
et al., 
2015) 
Schizophrenia or 
schizoaffective 
disorder (n=84) 
HC (n=66) 
Seed-based analysis of 
experimentally-derived 
ROIs (regions identified 
on localizer fMRI) 
 
Emotional processing  In the schizophrenia group, decreased 
auditory-insula RFC was associated with 
reduced scores of auditory emotion 
regulation. 
(Sawaya et 
al., 2015) 
MDD (n=21) 
HC (n=21) 
Seed-based analysis of a 
priori ROIs 
Emotional processing  There was a positive correlation between 
emotional intelligence score and RFC 
between BA25 and BA24. 
 
(J. T. 
Kantrowitz, 
Hoptman, 
Leitman, 
Silipo, & 
Javitt, 
2014) 
Schizophrenia (n=76) 
HC (n=72) 
Seed-based analysis of a 
priori ROIs 
Social perception In the schizophrenia group, sarcasm 
discrimination correlated with RFC within 
primary auditory regions. For controls, 
sarcasm discrimination correlated with RFC 
within core-mentalizing regions. 
 
(Dodell-
Feder, 
Delisi, & 
Hooker, 
2014) 
Familial high risk of 
schizophrenia (n=20) 
HC (n=17) 
 
ROI x ROI correlation of a 
priori ROIs 
Empathizing Across all participants, no RFC between ROIs 
predicted empathic subscores.  
(Fan et al., 
2013) 
Schizophrenia (n=27) 
HC (n=15) 
Seed-based analysis of a 
priori ROI 
Emotional processing In the schizophrenia group, RFC between 
vmPFC and right middle temporal lobe; 
parahippocampal cortex and amygdala was 
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positively correlated with the performance of 
emotional regulation. 
 
 
Research correlating RFC measures with fMRI task-based measures of social cognition 
 
Non-clinical samples: 
 
   
(Hyatt, 
Calhoun, 
Pearlson, & 
Assaf, 2015) 
Healthy adults 
(n=53) 
Components identified 
on ICA 
ToM Spatial correlation between subnetworks that 
supported mentalizing and DMN subnetworks 
derived from rs-fMRI. 
 
(Simmons & 
Martin, 
2012) 
Healthy adults 
(n=25) 
Seed-based analysis of 
experimentally-derived 
ROIs (regions identified 
on localizer fMRI) 
 
Social knowledge RFC of social knowledge regions different to 
RFC of tool knowledge regions (domain-
specific networks). 
(Tavor et al., 
2016) 
Human Connectome 
Project subjects 
(n=98) 
Components identified 
on ICA 
ToM RFC and structural data used to train a model 
that successfully predicted social-task based 
activations. 
 
(Andrews-
Hanna, 
Saxe, & 
Yarkoni, 
2014) 
Healthy adults 
(n=33) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI) 
 
ToM Left TPJ exhibited positive correlations with a 
network of medial and lateral regions 
throughout the DMN. 
(Kanske, 
Böckler, 
Trautwein, 
Healthy adults 
(n=178) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI) 
Empathizing and ToM Separable networks were demonstrated for 
empathy and ToM on task-based fMRI. These 
distinct networks could be replicated in RFC 
analysis. 
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& Singer, 
2015) 
 
(Bzdok et 
al., 2013) 
Healthy adults 
(n=139) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on MACM analysis of 
task-fMRI) 
 
ToM Convergent connectivity results across task-
based FC and RFC of the vmPFC and dmPFC 
seed ROIs. 
(Morawetz 
et al., 2016) 
Healthy adults 
(n=60) 
Seed-based analysis of a 
priori ROIs 
Emotional processing Greater RFC between ventrolateral prefrontal 
cortex and the amygdala was associated with 
emotion regulation success. 
 
 
Clinical samples: 
 
   
(Alaerts et 
al., 2014) 
ASD (n=15) 
HC (n=15) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI) 
Emotional processing  In the ASD group, pSTS hypoactivity (on task) 
was related to reduction in RFC of pSTS and 
both measures were predictive of emotion 
recognition performance. 
 
(Radke et 
al., 2017) 
MDD (n=22) 
HC (n=22) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI)  
 
Emotional processing Differences on task-based fMRI did not 
extend to RFC. 
(Ho et al., 
2015) 
MDD (n=26) 
HC (n=37) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI) 
 
Emotional processing In the MDD group, there was increased FC 
between PCC and subcallosal cingulate during 
emotional face processing and at rest. 
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(Mier et al., 
2016) 
Schizophrenia (n=22) 
HC (n=22) 
Seed-based analysis of 
experimentally-derived 
ROI (significant cluster on 
task-fMRI) 
 
ToM and emotional 
processing 
In the schizophrenia group, reduced FC 
between right and left pSTS was revealed for 
affective ToM but not at rest.  
(Prater, 
Hosanagar, 
Klumpp, 
Angstadt, & 
Phan, 2013) 
SAD (n=20) 
HC (n=17) 
Seed-based analysis of 
experimentally-derived 
ROIs (significant clusters 
on task-fMRI) 
 
Emotional processing In the SAD group, reduced FC between 
amygdala and rostral ACC and dlPFC while 
viewing fearful faces and at rest. 
 
Note: in this table we have focused on empathizing, and the social cognitive domains defined by Green et al (Green et al., 2008), namely 
theory-of-mind; emotional processing; social knowledge; social perception; and attributional style (none). Other topics, such as self-referential 
processing; self-other processing; moral competence; agreeableness; etc. while relevant to social cognition, have not been included here.  
 
Abbreviations: (d/v)mPFC: (dorso-/ventro-)medial prefrontal cortex; (m)SFG: (medial) superior frontal gyrus; (p)STS: (posterior) superior 
temporal sulcus; (R)FC: (resting) functional connectivity AAL: automated anatomical labelling; ACC: anterior cingulate cortex; AI: anterior 
insula; ASD: Autism spectrum disorder; ATL: anterior temporal lobe; BA24/25: Brodmann Areas 24/25; bvFTD: behavioural variant of fronto-
temporal dementia; CM: centromedial amygdala; dlPFC: dorsolateral prefrontal cortex; DM1: Myotonic dystrophy type-1; DMN: default mode 
network; EVC: early visual cortex; fALFF: fractional amplitude of low-frequency fluctuations; fMRI: functional magnetic resonance imaging; HC: 
Healthy controls; ICA: independent component analysis; IFG: inferior frontal gyrus; MACM: meta-analytic connectivity modelling; MDD: Major 
Depressive Disorder; mOFC: medial orbitofrontal cortex; mSFG: medial superior frontal gyrus; OFA: occipital face area; PCC: posterior cingulate 
cortex; ROIs: regions of interest; SAD: Social Anxiety Disorder; STG: superior temporal gyrus; TEI: trait emotional intelligence; ToM: Theory-of-
mind; TPJ: temporoparietal junction.  
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Abstract 
Introduction: Social anxiety disorder (SAD) is associated with deficits in emotional 
processing and attribution. Given evidence that causal attribution of social events relies 
heavily on theory of mind (ToM) and given the spatial homology between the default mode 
network (a resting-state network) and the ToM network, a case can be made for studying the 
neural correlates of social attribution in SAD using resting-state fMRI. In addition, relatively 
little is known about the effect of pharmacotherapy on resting-state networks in SAD or about 
the behavioural correlates of any therapy-induced changes. 
Methods: A graph theory approach was used to compare resting-state graph metrics within 
the ToM network in patients with a primary diagnosis of SAD (n=12) and a group of case-
matched healthy controls (n=12) (effect of group: SAD vs HC) as well as in a subset of SAD 
participants (n=9) before and after a 8-9 week course of moclobemide (600mg daily) (effect 
of condition: baseline vs post-therapy). Clinical measures of disease severity, depressive 
symptoms, and disease improvement were also collected. Subject-specific graph metrics were 
correlated with individual scores on the Internal, Personal and Situational Attributions 
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Questionnaire (IPSAQ) at baseline. An exploratory analysis that investigated the nodal graph 
metrics and partial correlations of five a priori nodes within the ToM network was also 
performed.  
Results: Compared to HCs, SAD participants exhibited reduced global efficiency and 
increased clustering coefficients within the ToM network as well as demonstrating evidence 
of disrupted social attributional style. No statistically significant relationship could be 
identified between individual graph metrics and IPSAQ scores. After therapy, SAD 
participants exhibited several changes in social attribution scores but no changes in graph 
metrics. In the exploratory nodal level analysis we found no group difference in graph 
metrics of the a priori nodes but did find changes in nodal metrics after therapy. Differences 
in partial correlations of several a priori nodes were detected for both comparisons.  
Conclusion: We report the first evidence of disrupted global efficiency and clustering 
coefficients within the ToM network in SAD, supporting existing work of resting functional 
connectivity disruptions in the disorder. While findings of social attribution bias in SAD were 
consistent with previous studies, we were unable to correlate these changes with disrupted 
graph metrics. We found no evidence that moclobemide therapy resulted in network-level 
modifications within the ToM network in SAD but did provide novel evidence of altered 
attributional style post-therapy. Exploratory analysis of several a priori nodes within the ToM 
network with a putative role in social attribution yielded findings which merit further 
research.  
 
Keywords: social anxiety disorder, graph theory, social attribution, attributional style, 
therapy, resting functional connectivity, resting-state fMRI 
 
Introduction 
 
Social anxiety disorder (SAD) is characterized by excessive fear and anxiety about, and 
avoidance of, social and/or performance situations (American Psychiatric Association and 
DSM-5 Task Force 2013). Several deficits have been identified in how people with SAD 
process social information (Plana et al. 2014). One domain of social cognition that remains 
relatively understudied in SAD is how sufferers attribute socially-relevant outcomes (i.e. 
causal attribution, or social attributional style).  
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There is evidence that SAD participants are prone to social attributional bias (Heimberg et al. 
1989) and that SAD participants exhibit deficits in two related social cognitive domains, 
namely social interpretation (Amir et al. 1998; Stopa and Clark 2000; Franklin et al. 2005) 
and theory of mind (ToM) (Hezel and McNally 2014; Washburn et al. 2016). The neural 
correlates of social attribution in healthy volunteers has been studied using task-based 
functional magnetic resonance imaging (fMRI) and has implicated several brain regions 
including the temporoparietal junction, precuneus, superior temporal sulcus and medial 
prefrontal cortex (Seidel et al. 2010; Kestemont et al. 2012, 2015). These activations share 
considerable spatial homology with the ToM network which is activated by ToM tasks, and 
with the default mode network (DMN) which is active at rest (Laird et al. 2011). As 
previously posited, such similarities provide indirect evidence that a functionally distinct 
network, which is also active at rest, underlies the social cognitive processes of both ToM 
and social attribution (Mars et al. 2012). Disrupted resting functional connectivity (RFC) 
within the DMN or of its core nodes has previously been reported in SAD (Liao et al. 2010a; 
Liu et al. 2015b; Doruyter et al. 2016; Cui et al. 2017). There is limited evidence that 
pharmacotherapy affects RFC of the DMN in SAD (Giménez et al. 2014; Doruyter et al. 
2016; Yuan et al. 2016). 
 
The neural bases for deficits in social attribution in SAD are unknown and represent a target 
for further research. While such neural correlates can be investigated directly using social 
attribution task-based fMRI, they can also be studied by correlating resting-state fMRI (rs-
fMRI) findings with behavioural measures. One technique well-suited to describing 
characteristics of complex brain networks is graph theory (Bullmore and Sporns 2009). 
Graphs can be constructed using either binary techniques (whereby edges are categorized as 
being either present or absent depending on weight) or weighted techniques (whereby edges 
are weighted along a continuum, depending on the strength of the connection between nodes) 
(Rubinov and Sporns 2010). There is evidence to suggest that weighted graphs are more 
robust than binary graphs since the threshold for binarization is largely arbitrary and binary 
graphs may not be reproducible at the single subject level (Wang et al. 2014). Graph metrics 
may be used to characterize global graph properties (the network as a whole) and also local 
properties, down to the individual nodal level. In addition to analysing graphs at the group 
level, it is possible to construct individual (subject-specific) weighted graphs, the metrics of 
which can then be correlated with clinical measures. Only a few experiments using graph 
theory have been conducted in SAD (Liao et al. 2010a; Zhu et al. 2017; Yun et al. 2017), 
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none of which limited their analysis to a distinct functional network or investigated the 
behavioural correlates of graph findings. While there is evidence that pharmacotherapy 
improves symptoms in SAD, no research has investigated whether pharmacotherapy has any 
effect on social attributional style or resting graph metrics in the disorder. 
 
We hypothesized the following: firstly, compared to controls, SAD participants would 
demonstrate differences in graph metrics of the ToM network at rest; secondly, the SAD 
group would exhibit evidence of social attribution bias; and thirdly, that a correlation would 
be found between disrupted graph metrics and social attribution scores. Finally, we also 
hypothesised that pharmacotherapy would modify graph metrics and improve any social 
attribution deficits in the SAD group. 
 
Methods 
 
The study was approved by the health research ethics committee of Stellenbosch University 
(ref # S14/09/191). 
 
Participants 
 
Patients with SAD were recruited through the MRC Unit on Risk and Resilience in Mental 
Disorders. Volunteers were invited to join the study in advertisements on local radio stations 
and in print media, as well as online and through email campaigns. Potential volunteers were 
screened in an interview setting. Participants had to be between the ages of 18 and 55 years of 
age; right-handed; and fluent in English. SAD participants had to meet DSM-5 criteria for 
SAD and not have any comorbid mood or anxiety disorders, substance use or psychotic 
disorders. Volunteers were excluded from participation if they had any metal implants or 
claustrophobia that would preclude MRI; had any current or prior neurological illness, any 
current or prior psychiatric condition, or prior head injury resulting in loss of consciousness; 
had any serious medical conditions; or were heavy caffeine users (>600mg per day). All SAD 
participants were free of psychotropic medication (other than the study medication) at study 
visits. SAD participants already on medication were not excluded from the study, provided 
they were willing to taper and discontinue their medication and then commence with 
moclobemide 600mg after a suitable washout period. SAD participants who could not safely 
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stop medications known to interact with moclobemide were excluded. SAD and healthy 
control (HC) participants were matched for age and sex. 
 
Screening, clinical and social cognition measures 
 
All participants were telephonically screened. HC participants subsequently attended a total 
of 3 study visits, which included a comprehensive clinical interview; as well as separate visits 
for neuroimaging and social cognition measures. SAD participants attended 5 study visits, 
comprising a visit for the clinical interview; a visit for neuroimaging; a visit for the social 
cognition measure; a follow-up neuroimaging session; and a final visit in which the social 
cognition measure was repeated. All participants underwent a structured clinical interview for 
DSM-IV (SCID) (First et al. 1996) and completed the Edinburgh Handedness Inventory 
(Oldfield 1971) as part of the screening process. A separate checklist was used to ensure SAD 
participants also met criteria on DSM-5. In addition, participants completed the Liebowitz 
Social Anxiety Scale (LSAS) (Liebowitz 1987) and Beck Depression Inventory (BDI-II) 
(Beck et al. 1996) to assess the severity of social anxiety and depressive symptoms, 
respectively. 
 
At each study visit participants completed the state version of the State Trait Anxiety 
Inventory (STAI-S) which measures levels of anxiety at the time of the measure (Spielberger 
1983). The efficacy of pharmacotherapy was studied with the Clinical Global Impressions 
Improvement scale (CGI-I) (Guy 1976).  
 
Social attributional style was measured with the Internal, Personal, and Situational 
Attributions Questionnaire (IPSAQ). This measure was completed once by healthy controls 
and twice (at baseline and post-therapy) by SAD participants. Participants were asked to read 
an equal number of negative (16) and positive (16) hypothetical scenarios in which they 
imagine themselves interacting with someone else. They were then asked to record what 
caused the event and then record whether the cause was “something about you”; “something 
about the other person or other people”; or “something about the situation (circumstances or 
chance)”. The attributions recorded in the responses were categorized as either internal, 
external (personal) or external (situational) (Kinderman and Bentall 1996). Several derived 
measures were also calculated. Externalizing bias (EB) was calculated by subtracting the 
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number of internal attributions for negative events from the number of internal attributions 
for positive events and is indicative of either a self-serving bias (positive score) or self-
effacing bias (negative score). Personalizing bias for negative events (PBn) was calculated by 
dividing the number of personal attributions for negative events by the sum of both 
personalizing and situational attributions for negative events and represents the degree to 
which participants attribute negative events to external personal (scores greater than 0.5), 
rather than external situational causes (scores less than 0.5). Similarly, personalizing bias for 
positive events (PBp) was calculated by dividing the number of personal attributions for 
positive events by the sum of both personalizing and situational attributions for positive 
events and represents the degree to which participants attribute positive events to external 
personal (scores greater than 0.5), rather than external situational causes (scores less than 0.5) 
(Kinderman et al. 1998). 
 
Pharmacotherapy 
 
After baseline measurements were completed, SAD participants commenced with a course of 
moclobemide according to clinical prescribing guidelines for SAD (300 mg PO once daily for 
3 days, followed by 300 mg PO twice daily thereafter). After at least 8 weeks of therapy, 
follow-up measures were completed whereafter participants either opted to continue on 
moclobemide or discontinue the medication in favour of other management strategies. SAD 
participants were closely monitored for adverse effects during the trial period and for 
symptoms of discontinuation in the event that the study medication was stopped. 
 
Neuroimaging 
 
SAD participants were scanned both at baseline and at the end of therapy. Participants were 
instructed not to ingest any caffeine-containing food or beverages in the 2 hours preceding 
the scan. MRI scanning was initially performed on a 3 tesla (3T) Siemens Magnetom Allegra 
camera (Siemens Medical Systems, Erlangen, Germany). Midway through the project, this 
scanner was decommissioned and imaging was switched to a 3T Siemens Magnetom Skyra. 
Acquisition parameters across the two systems were optimized to reduce scanner-related bias.  
Scan parameters for the functional resting-state T2-weighted sequence on the Allegra system: 
single-shot gradient echo planar imaging (EPI); 300 volumes; repetition time (TR) = 1600 
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ms; echo time (TE) = 23 ms; flip angle = 73°; number of slices = 30; slice gap = 0.2 mm; 
field of view = 255 x 255 mm; voxel size = 4mm x 4mm x 4mm. On the Skyra system: same 
settings except TR = 1740 ms. Additional structural scans (T1-weighted ME-MPRAGE; T2; 
FLAIR) were acquired for anatomical co-registration and to exclude relevant intracranial 
pathology. 
 
Before imaging, participants completed the STAI-S measure and received an explanation of 
the scanning procedure. They were instructed to lie still and to keep their eyes open during 
the scan. After being comfortably positioned in the scanner participants viewed a black 
screen with the word “RELAX”, centred in their field of view. After a few seconds this 
screen was replaced by a blank black screen and the scan session was commenced. After the 
scanning patients were debriefed on their experience and questioned as to whether they kept 
their eyes open during the functional sequence. 
 
Pre-processing 
 
In addition to radiologist review for structural abnormalities, all scans were reviewed visually 
for artefacts. DICOM images were converted to NIfTI format and pre-processing was 
performed using SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) and MATLAB (Mathworks 
R2014b). Functional images were realigned and checked for significant motion using a 
custom script. Functional scans in which there was more than 2 mm translation overall; or 
more than 1 mm momentary translation; or more than 2° rotation were excluded from the 
analysis. Functional scans were slice time corrected and co-registered to the T1-weighted 
structural image using the normalized mutual information estimation option. For follow-up 
scans of the same participants (SAD group) a second co-registration was performed in which 
follow-up scans were co-registered to the baseline structural scan. The SPM Segment 
function was used to extract tissue classes from the structural scan and calculate a 
deformation field to a standardized template (SPM Average sized template). Functional 
images were then warped using the relevant deformation field and written to a final voxel 
size of 4x4x4 mm. No additional smoothing was performed. All images were bandpass 
filtered at a frequency range of 0.009 – 0.1 Hz. 
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Network nodes 
 
Procedures for node definition and graph analysis were performed using customized scripts 
for SPM12 and MATLAB. For nodes in the ToM network, we first created 17 volumes of 
interest (VOIs; spheres with radii of 6mm). These VOIs were centred on activation peaks for 
ToM tasks reported in a meta-analysis by Bzdok et al. (Bzdok et al. 2012), the names, 
abbreviations, and MNI coordinates of which appear in Table 4.1 and are illustrated in 
Figure 4.1. 
 
Five of these VOIs, i.e. left and right temporoparietal junction (L TPJ, R TPJ); left and right 
posterior superior temporal sulcus (L pSTS; R pSTS), and precuneus (Precun) were selected 
to represent regions of a priori interest in social attribution (Kestemont et al. 2016), for a 
secondary exploratory analysis of individual nodal graph metrics and connectivity. 
 
Subject-specific VOIs were then generated by calculating the intersection of the relevant 
spherical VOI and corresponding gray matter map. In the event that the final subject-specific 
VOI was smaller than 10 voxels, additional neighbouring voxels were included to form a 
single cluster, until the minimum VOI size threshold was reached. The time series of every 
VOI was then extracted and corrected by regressing out white matter and CSF signal, as well 
as the 6 motion regressors. The partial correlation coefficient between the averaged (across 
voxels) time series of each node-pair was calculated for each participant and transformed to a 
Z-score using a Fisher’s r-to-Z transform for partial correlations. 
 
Graph construction 
 
We performed weighted, undirected graph constructions at two levels: at the group level, and 
at the individual level. At the group level, edges (a) were defined by weights obtained after 
transforming the absolute value of the average Z-scores 𝑍𝑖𝑗 (across subjects in the group) to a 
weight using the power law transformation 𝑤𝑖𝑗 = (2𝜑(𝑍𝑖𝑗) − 1)
4where 𝜑 is the cumulative 
distribution function of the standard normal distribution (Wang et al. 2017). The graphs were 
constructed for each participant group. A comparable method was used to construct weighted 
graphs on the individual level (subject-specific). Metrics derived from these graphs were used 
for correlation with clinical measures. 
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Graph measures 
 
We calculated the following graph metrics at both group and individual levels: 
 
Global metrics 
 
Mean clustering coefficient (C) is a measure of network segregation (based on the number of 
triangles in the network, with a high value implying network segregation). The mean 
clustering coefficient reflects on average, how clustered connectivity is around individual 
nodes in the network. The method for calculation of the mean clustering coefficient for 
weighted graphs was as described by Wang et al (Wang et al. 2017). 
 
Mean characteristic path length (λ) is the average shortest path length (where length refers to 
the number of connections linking any two nodes) between all network nodes. It is a measure 
of network integration in connected networks.  
 
Mean global efficiency (E) is related to the average inverse shortest path length between all 
network nodes. Like characteristic path length, it is a measure of network integration.  
 
Mean betweenness centrality (BC) refers to the fraction of all shortest paths that pass through 
a node in the network. It is a measure of the average importance of nodes within the network. 
Both binary and weighted networks were calculated.  
 
λ, E and BC were calculated as described by Rubinov and Sporns (Rubinov and Sporns 
2010). 
 
Local nodal metrics 
 
As a secondary, exploratory analysis, individual nodal metrics were calculated for five VOIs, 
selected a priori as regions for which there was evidence in social attribution (references on 
calculation methods in parentheses).  
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Nodal clustering coefficient (Ci) (Wang et al. 2017). 
Nodal characteristic path length (λi) (Rubinov and Sporns 2010). 
Nodal local efficiency (Eloci) (Wang et al. 2017). 
Nodal betweenness centrality (BCi) (Rubinov and Sporns 2010). 
 
Global and nodal graph metrics were normalized by the average value obtained in 10 
equivalent random graphs, i.e. graphs with the same number of nodes and the same 
distribution of weights but which are randomly assigned to each node-pair. 
 
Statistical analysis 
 
Two broad comparisons were made. In the first, we compared two groups: SAD and HCs 
participants (effect of group: SAD vs HC). In the second comparison we investigated the 
effect of therapy within the SAD group (effect of condition: baseline vs post-therapy).  
 
All statistical analyses were performed using MATLAB (Mathworks R2014b). A statistical 
threshold for significance of p = 0.05 was used throughout. No corrections for multiple 
testing were applied.    
Group matching for age was tested using a two-tailed Welch’s t-test while matching for 
education level was tested with the Freeman-Halton extension of the Fisher exact test.  
Differences in clinical scores and social cognition scores were tested with a two-tailed 
Welch’s t-test (effect of group: SAD vs HC comparison) and a single-tailed paired t-test 
(effect of condition: SAD baseline vs post-therapy).  
Differences in group-level graph metrics for both comparisons (effect of group; effect of 
condition) were evaluated using non-parametric group-membership permutation testing. 
These methods have an advantage over parametric methods in that they better account for 
complexity within networks (Simpson et al. 2013). As part of this analysis, the graph 
constructs were compared to 500 randomly generated equivalent graphs and compared to 500 
random assignments to group or condition. 
Individual (subject-specific) graph measures shown to be disrupted in the group comparison 
were correlated with social attribution measures found to be statistically different in the group 
comparison using simple linear regressions. These were conducted for both HC and SAD 
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groups combined and for the SAD group. Similar analyses were used to test whether disease 
severity (LSAS) had any effect on these measures in the SAD group.  
A secondary, exploratory analysis comparing local nodal graph metrics of five VOIs (for 
which there was strong a priori evidence of relevance to social attribution) was performed 
using two-tailed Welch’s t-tests (effect of group: SAD vs HC comparison) and two-tailed 
paired t-tests (effect of condition: baseline vs post therapy). The same tests were used to 
detect differences in partial correlations between these nodes and other nodes within the ToM 
network. 
 
Results 
 
Participants 
 
Fifteen participants with SAD and 15 age- and sex-matched healthy controls (HC) were 
recruited.  
 
In the group analysis, the rs-fMRI of two SAD participants and one HC (and their matched 
counterparts) were excluded due to excessive motion while in the scanner. Final group size 
was thus SAD (n=12) and HC (n=12). 
 
In the condition (effect of therapy) analysis, baseline and follow-up measures were available 
for 12 SAD participants, however three participants were excluded due to excessive motion 
during either the baseline or follow-up scan. One SAD participant included in this analysis 
was excluded from the SAD vs HC analysis due to excessive motion of their matched control. 
Final group size in this comparison was thus (n=9).  
 
Demographics 
 
The demographics of participants appear in Table 4.2. No significant differences were 
detected between groups in terms of age and sex. 
 
In the effect of therapy analysis, the 9 SAD participants consisted of 5 males and 4 females 
with a mean age of 30 years (range: 21.4 – 42.6).  
Stellenbosch University  https://scholar.sun.ac.za
  
80 
 
 
Clinical characteristics 
 
In the group (SAD vs HC) comparison, SAD participants had a significantly higher mean 
(±SD) LSAS score of 87.5 (±26.7) compared to the HC participants’ 19.0 (±10.6) 
(p<0.0001). Mean (±SD) BDI-II score in the SAD group at baseline was 12.1 (±8.8) 
compared with 4.0 (±5.1) in the HC group, which also reflects a significant difference 
(p=0.013). Despite not having any psychiatric comorbidity based on the SCID-assessment, 
several participants fell into the clinical ranges for depression based on self-report BDI-II 
scores: one participant in the HC group met BDI-II criteria for mild depression, while in the 
SAD group there were 3 participants whose depressive symptoms were mild, 1 with moderate 
depressive symptoms, and 1 with severe depressive symptoms. There were no significant 
intragroup differences in STAI-S scores across baseline visits. There were significant 
intergroup differences in STAI-S scores across baseline visits: in the effect of group (SAD vs 
HC) comparison, SAD participants had significantly higher state anxiety compared to HCs (p 
< 0.0001). 
 
In the effect of condition (baseline vs post-therapy) comparison SAD participants received a 
mean of 8.9 weeks (range: 8.0 – 12.1) of moclobemide therapy between baseline and follow-
up measures. The effects of therapy on clinical measures are summarized in Table 4.3. There 
were no significant difference in STAI-S scores across baseline visits, nor across follow-up 
visits. There was however a significant reduction in state anxiety scores when comparing 
STAI-S scores pre-treatment to STAI-S scores post-treatment (p=0.0001). 
 
Social cognition 
 
On the IPSAQ, SAD participants were more likely than HCs to attribute negative items to an 
internal cause and less likely to attribute negative items to a situational cause. This also 
resulted in lower EB scores in the SAD group. When SAD participants did attribute negative 
events to external causes, these were more frequently personal as opposed to situational, as 
reflected by the higher PBn score in the patient group. There was no correlation between 
disease severity as measured by the LSAS and EB (p=0.91) or PBn (p=0.496) scores in the 
SAD group.  
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After pharmacotherapy, SAD participants attributed fewer positive events to an external 
personal cause, as reflected by the significant reduction in their PBp score. There were no 
other statistically significant changes in IPSAQ scores from pre- to post-therapy. 
 
Results of the IPSAQ scores for the two comparisons are summarized in Table 4.4. 
 
Graph measures 
 
Global metrics 
 
Partial correlation matrices used for the global graph analysis are presented in Figure 4.2. 
 
In the effect of group (SAD vs HC) comparison, SAD participants exhibited reduced global 
efficiency (E) (p = 0.02) and increased clustering coefficients (C) (p=0.04) within the ToM 
network when compared to controls.  
For SAD participants, no statistically significant differences in graph metrics were detected 
when comparing baseline to post-therapy conditions. A summary of group differences in 
graph metrics is presented in Table 4.5. 
 
Local nodal metrics and connectivity of a priori VOIs 
 
In the effect of group (SAD vs HC) comparison, no significant differences were detected in 
nodal graph metrics of the selected a priori VOIs.  
 
In the effect of condition (baseline vs post-therapy) comparison, SAD participants exhibited a 
reduction in local efficiency of the left temporoparietal junction (p=0.042), as well as an 
increase in the node degree of the right posterior superior temporal sulcus (p=0.047).  
 
Significant differences in partial correlations, between selected a priori nodes and other nodes 
within the network for both comparisons are summarized in Table 4.6. 
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Correlates between subject-specific graph metrics and social attribution scores 
 
No significant correlations between disrupted graph metrics (E, C) and either externalizing 
bias (EB), or personalizing bias (PBn) were found. 
 
Discussion 
 
A graph theory approach was used to compare resting-state graph metrics within the ToM 
network in patients with SAD and a group of case-matched healthy controls, as well as for a 
subset of SAD participants before and after an 8-9 week course of moclobemide. In addition, 
an exploratory analysis that investigated the nodal graph metrics and partial correlations of 
five a priori nodes within the ToM network was performed. We found evidence of social 
attribution bias and differences in graph metrics within the ToM network at rest in SAD. No 
statistically significant relationship could be identified between disrupted graph metrics and 
social attribution scores, either in the SAD group alone or in the larger group (HC and SAD 
participants combined). A secondary analysis of graph metrics of five a priori nodes 
potentially relevant to social attribution and of the partial correlations between these a priori 
nodes and other nodes in the ToM network, found several differences between SAD and HC 
groups. Compared to baseline, SAD participants after a course of moclobemide demonstrated 
changes in social attributional style, but no changes in graph metrics within the ToM. There 
were however changes in local nodal graph metrics and partial correlations of a priori nodes 
after therapy. 
 
In our study we found that SAD participants were more likely than HCs to attribute negative 
scenarios to themselves (internal attribution), which was also manifested by lower EB scores 
(reflecting a self-effacing bias, attributing negative events more and positive events less to 
oneself) in the patient group. When SAD participants in our sample did attribute negative 
events to external causes, they were more likely to attribute them to personal rather than 
situational causes (as manifest by the higher PBn scores in the SAD group). Attributions have 
previously been defined as causal statements; i.e. any statement that includes or implies the 
cause of an event (Green et al. 2008). Typically such attributional statements are categorized 
as either external situational (something about the situation resulted in the outcome); external 
personal (something that someone else did resulted in the outcome); or internal (something I 
Stellenbosch University  https://scholar.sun.ac.za
  
83 
 
did resulted in the outcome) (Kinderman and Bentall 1996). Our findings are consistent with 
work by Heimberg et al who reported that compared to controls, SAD participants more 
frequently attributed negative events and less frequently attributed positive events to internal 
causes (Heimberg et al. 1989). Our results are also consistent with earlier experiments on 
social interpretation in SAD which found that not only were SAD participants more likely to 
classify ambiguous social scenarios as negative (Stopa and Clark 2000; Franklin et al. 2005) 
but they were more likely to do so when the scenarios were self-relevant (Amir et al. 1998). 
There are no studies that have directly investigated social attribution in SAD using task-based 
fMRI, as has for example been performed in depressed patients (Seidel et al. 2012; Hao et al. 
2015). A task-based fMRI experiment that used a ToM task has however been performed in 
SAD. Sripada et al reported differences in brain activation in SAD participants (n=26) 
compared to HCs (n=26) while mentalizing during a simulated economic exchange task (trust 
game). In that study, SAD participants showed reduced activation in medial prefrontal cortex 
during mentalizing (Sripada et al. 2009). As already discussed, there is a rationale for 
investigating the neural correlates of ToM and related processes such as social attribution 
using RFC measures on rs-fMRI. Several studies have investigated RFC within the 
DMN/ToM network in SAD which have found various disruptions in connectivity in SAD 
participants (Liao et al. 2010a; Liu et al. 2015b; Doruyter et al. 2016; Cui et al. 2017), 
although one study (Pannekoek et al. 2013) reported no difference between patients and HCs. 
None of these studies correlated RFC findings with behavioural measures. 
 
We found that in SAD, there was reduced mean global efficiency (a measure of how 
integrated a network is) and increased mean clustering coefficient (a measure of how 
segregated individual network nodes are from one another) within the ToM network at rest. 
Graph analysis, which focuses on various characteristics of complex networks, is a promising 
tool for studying interactions within distributed brain regions (Wang et al. 2014) yet only 
limited research using graph theory has been conducted in SAD. In one study, researchers 
compared whole brain, voxel-to-voxel resting functional connectivity strength (FCS) in SAD 
and HC groups and defined network hubs as regions with the highest FCS (Liu 2011). That 
study found disruptions in SAD in two cortical hubs, one of which was the precuneus, which 
is commonly considered as the core node of the DMN (Greicius et al. 2003) and by extension 
the ToM network.  This is consistent with our own finding of a reduction in global efficiency 
within the ToM network at rest. Two other studies that used all 90 regions from the 
automated anatomical labelling atlas (AAL), to construct graphs in both SAD and HC groups 
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reported abnormalities relating to the middle temporal gyrus (Yun et al. 2017) and the 
temporal pole (mid) (Zhu et al. 2017) which are also nodes of the ToM network. Unlike these 
previous studies, rather than using all voxels in the brain, or a large number of atlas-based 
parcellations, our graph analysis was confined to a much more limited set of nodes (Stanley 
et al. 2013), to probe a specific network. 
 
While we found independent evidence of ToM network disruption and social attribution bias 
in SAD, we were unable to detect any correlation between either of the graph metrics 
identified as disrupted in SAD and individual IPSAQ scores, either in the SAD group or 
when combining both HC and SAD participants used in the group comparison. Only limited 
research has investigated the social cognitive correlates of RFC findings in SAD. Prater et al 
performed both rs-fMRI and an emotional processing task fMRI (viewing of fearful faces) 
and reported reduced FC between amygdala and rostral anterior cingulate and dorsolateral 
prefrontal cortex both at rest and during the task (Prater et al. 2013). That study directly 
linked RFC with brain activation during complex social cognitive processes. Resting graph 
metrics are also suited to investigating the neural underpinnings of social cognition as shown 
by a study that correlated network centrality with impairments in emotional processing and 
ToM in patients with behavioural variant frontotemporal dementia (Sedeño et al. 2016). Ours 
is the first study investigating the relationship between graph metrics and a social cognition 
measure in SAD.  
 
This is the first report to focus on the effects of pharmacotherapy on graph metrics in SAD. 
We did not identify any changes to graph metrics within the ToM network in a group of SAD 
participants treated with moclobemide, despite clinical evidence of therapeutic effect. We did 
however find evidence in our exploratory analysis that such effects might exist. That therapy 
might have an effect on resting graph measures within the ToM network in SAD is suggested 
by evidence of therapy effects on RFC of regions overlapping with this network’s 
distribution. Our group has for example previously reported on changes in perfusion SPECT-
based RFC of the anterior cingulate and precuneus after pharmacotherapy in SAD (Doruyter 
et al. 2016), while other groups have reported therapy-related RFC changes in dorsomedial 
prefrontal cortex and dorsal anterior cingulate (Giménez et al. 2014; Yuan et al. 2016). The 
use of a graph approach to understanding the impact of pharmacotherapy is promising, and is 
being applied to other disorders (Shin et al. 2014; Wang et al. 2015, 2016; Haneef et al. 2015; 
Hadley et al. 2016). 
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In our secondary, exploratory analysis we identified several group differences in partial 
correlations of several a priori nodes within the ToM network. We also found changes to both 
nodal graph metrics and partial correlations of these nodes after therapy. In addition to their 
involvement in ToM, these regions all share a putative role in social attribution (Kestemont et 
al. 2016). We limited ourselves to these five regions in this analysis, since it was not possible 
to correct for multiple comparisons. While the results of this exploratory enquiry are 
interesting, they were not the primary aim of the experiment. Our findings may serve to 
generate hypotheses for future experiments. 
 
Our study had several limitations. Despite screening for depressive symptoms, six 
participants, all but one from the SAD group, scored in the clinical range on the self-report 
BDI-II questionnaire. While we cannot exclude the possibility that the effects seen were 
driven by depressive symptoms, rather than social anxiety, this is unlikely given that in all 
cases SAD was the dominant condition in terms of severity, and none of the patients were 
diagnosed with major depressive disorder using the SCID. Furthermore, it may be argued that 
this distinction is in many respects artificial, given the frequent comorbidity of SAD and 
depression (Ohayon and Schatzberg 2010) and evidence that they stem from a shared 
underlying genetic vulnerability (Langer and Rodebaugh 2014). Another limitation of our 
study was the small group sizes, potentially increasing the risk of over-representing the 
contribution of statistical outliers, and reducing sensitivity for small effect sizes. Two 
approaches in our study design partly mitigate against the risk of false positives imposed by 
small group sizes: first, we carefully matched (on a per subject level) our SAD and HC 
samples, thus reducing the risk of outliers; and second, we limited our analysis to RFC in a 
set of confined regions in a network with strong internodal correlations, making the risk of 
false positives much lower than in a whole-brain analysis (Cremers and Roelofs 2016). Such 
measures do not however address the reduction in sensitivity inherent to analyses using small 
groups, and as such our negative result for the effect of condition (baseline vs post-therapy) 
comparison might simply imply that the effect sizes of any changes in graph metrics after 
therapy were too small to detect with our sample sizes.  Our choice of moclobemide as a 
therapeutic agent might be criticized given that most guidelines currently recommend a 
selective serotonin reuptake inhibitor (SSRI) as first-line pharmacological intervention 
(National Collaborating Centre for Mental Health (UK) 2013). It should be noted however 
that the rationale for this recommendation is largely based on the observation that 
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monoamine oxidase inhibitors (MAOIs) as a class are associated with more drug interactions, 
dietary restrictions and side effects; and not based on evidence of their therapeutic inferiority 
to other pharmacological interventions. Moclobemide is a reversible MAOI which does not 
have the same risk profile or dietary restrictions as other members of its class and several 
studies have confirmed its safety and tolerability (Stein et al. 2002; Bonnet 2003). There is no 
evidence that when used at therapeutic doses, moclobemide is inferior to SSRIs when treating 
SAD and it remains an established therapeutic option in managing SAD. The final limitation 
of our study relates to the fact that because we did not include a placebo group in our therapy 
effect comparison, or obtain repeat measures in our HC group, we were not able to 
distinguish true therapeutic effects from expectancy effects or effects related to subject 
familiarity with the measures at follow up.  
 
Conclusion 
 
The study findings were concordant with existing evidence on social attribution bias in SAD, 
providing further support for social cognitive deficits in the disorder. In addition, disrupted 
RFC within the ToM network in SAD, as evidenced by differences in global efficiency and 
clustering coefficient supports existing work suggesting RFC disruptions in the DMN in 
SAD. We were however unable to link individual graph metrics to behavioural measures of 
social attribution. Our study adds to the existing knowledge of how pharmacotherapy affects 
social attribution in SAD although we could not detect changes in global graph metrics within 
the ToM network. Exploratory analysis of several a priori nodes within the ToM network 
with a putative role in social attribution, yielded findings which merit further research. 
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Tables and Figures 
 
Table 4.1 Network nodes used to construct graphs. A sphere of r=6mm was centred on each 
coordinate to generate the relevant VOI. Coordinates from (Bzdok et al. 2012). The 5 a priori 
nodes are indicated in bold text. 
 
MNI coordinates Abbreviation Region 
 x y z 
0 52 -12 vmPFC Ventromedial prefrontal cortex 
2 58 12 fPOC Frontopolar cortex 
-8 56 30 dmPFC1 Dorsomedial prefrontal cortex 1 
4 58 25 dmPFC2 Dorsomedial prefrontal cortex 2 
2 -56 30 Precun Precuneus 
56 -50 18 R TPJ Right temporoparietal junction 
-48 -56 24 L TPJ Left temporoparietal junction 
54 -2 20 R TPO Right temporal pole 
-54 -2 -24 L TPO Left temporal pole 
52 -18 -12 R MTG Right middle temporal gyrus 
-54 -28 -4 L MTG1 Left middle temporal gyrus 1 
-58 -12 -12 L MTG2 Left middle temporal gyrus 2 
50 -34 0 R pSTS Right posterior superior temporal sulcus 
-58 -44 4 L pSTS Left posterior superior temporal sulcus 
54 28 6 R IFG Right inferior frontal gyrus (Area 45) 
-48 30 -12 L IFG Left inferior frontal gyrus 
48 -72 8 R MTV5 Right MT/V5 (middle temporal visual area 5) 
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Table 4.2 Demographics and group matching in the SAD vs HC baseline analysis 
 
 Group  
 HC SAD p 
Total (n) 
 
12 12 - 
Mean age in years 
 
31.0 (21.2 – 46.8) 30.5 (21.0 – 45.6) 0.88a 
Sex 
 
Female: 8, Male: 4 Female: 8, Male: 4 - 
Highest level of education: 
 
   
 
 
0.07b 
Formal schooling 
incomplete 
1 1 
Additional training college 
or technical qualification 
0 4 
Additional University 
degree 
11 7 
 
a Two-tailed Welch’s t-test  
b Freeman-Halton extension of the Fisher exact test  
 
 
Table 4.3 Clinical measures in SAD participants (n=12) used for the effect of therapy 
analysis, mean and standard deviation (SD): 
 
 Condition  
 Baseline Post-therapy  
 mean SD mean SD p* 
LSAS 
 
88.9 30.3 68.0 40.9 0.02 
BDI-II 
 
10.8 6.7 9.3 7.9 0.37 
CGI-S 
CGI-I 
4.67 1.4 3.25 
2.75 
2.1 
1.0 
0.04 
 
* single-tailed paired student t-test 
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Table 4.4a IPSAQ scores for the SAD vs HC comparison, mean and standard deviation (SD): 
 
 
Group 
 
HC SAD 
mean SD mean SD p* 
Positive items 
     
Internal 6.92 2.54 7.83 3.01 0.429 
Personal 4.33 2.10 4.58 2.39 0.788 
Situational 4.75 2.30 3.58 2.81 0.278 
 
Negative items 
     
Internal 3.58 2.61 8.25 4.14 0.004 
Personal 5.83 2.92 5.00 2.30 0.446 
Situational 
 
6.58 3.06 2.75 2.83 0.004 
      
EB 3.33 3.58 -0.42 4.96 0.046 
PBn 0.47 0.21 0.72 0.21 0.009 
PBp 0.48 0.18 0.56 0.25 0.390 
 
*Two-tailed Welch’s t-test 
EB: Externalizing bias; PBn: personalizing bias, negative; PBp: personalizing bias, positive. 
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Table 4.4b IPSAQ scores for the therapy effect comparison, mean and standard deviation 
(SD): 
  
Condition 
 
 
Baseline Post-therapy 
 
 
mean SD mean SD p* 
Positive items 
     
Internal 7.33 2.60 6.67 3.16 0.284 
Personal 5.11 2.42 3.33 2.92 0.007 
Situational 3.56 2.51 6.00 4.44 0.071 
 
Negative items 
     
Internal 7.89 4.11 5.33 3.87 0.064 
Personal 5.44 2.24 6.11 3.98 0.313 
Situational 2.67 3.04 4.56 5.27 0.163 
      
EB -0.56 5.79 1.33 3.81 0.080 
PBn 0.73 0.21 0.64 0.37 0.234 
PBp 0.59 0.25 0.38 0.32 0.010 
 
* single-tailed paired student t-test 
EB: Externalizing bias; PBn: personalizing bias, negative; PBp: personalizing bias, positive.  
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Table 4.5a Differences in graph metrics in the group comparison (HC minus SAD), 
normalized values only. 
  
Group  
HC SAD p 
C 0.958 1.022 0.04 
λ 1.038 1.844 0.13 
E  1.004 0.993 0.02 
BC 1.018 0.998 0.28 
 
Abbreviations: C: clustering coefficient; λ: characteristic path length; E: global efficiency; BC: 
betweenness centrality. 
 
 
Table 4.5b Differences in graph metrics in the effect of condition comparison (SAD 
participants: baseline minus post-therapy), normalized values only. 
  
Condition  
Baseline Post-therapy p 
C 0.958 1.022 0.09 
λ 1.038 1.844 0.29 
E  1.004 0.993 0.42 
BC 1.018 0.998 0.50 
 
Abbreviations: C: clustering coefficient; λ: characteristic path length; E: global efficiency; BC: 
betweenness centrality. 
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Table 4.6a Significant group differences in partial correlations between a priori nodes (in 
bold) and other ToM network nodes in the SAD group, compared to HCs. 
 
 Group   
 HC SAD   
 mean SD mean SD t p 
 
Reduced functional 
connectivity in SAD 
      
       
Precun and L IFG 
 
-1.65 1.49 -6.53 3.86 4.09 0.001 
Increased functional 
connectivity in SAD 
 
      
R pSTS and vmPFC 
 
-2.33 5.43 2.16 4.24 -2.26 0.03 
 
Abbreviations: Precun: precuneus; L IFG: left inferior frontal gyrus; R pSTS: right posterior 
superior temporal sulcus; vmPFC: ventromedial prefrontal cortex. Further information on 
nodes appears in Table 4.1. 
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Table 4.6b Significant therapy-related differences in partial correlations between a priori 
nodes (in bold) and other ToM network nodes in the SAD participants post-therapy, 
compared to baseline. 
 
 Condition   
 Baseline Post-therapy   
 mean SD mean SD t p 
 
Reduced functional 
connectivity post-
therapy 
      
R TPJ and L TPJ 
 
6.27 3.37 4.57 2.84 3.02 0.02 
Increased functional 
connectivity post-
therapy 
 
      
R pSTS and fPOC -1.08 3.74 2.79 2.19 -2.8 0.02 
Precun and L IFG -6.94 3.63 -2.15 4.89 -2.55 0.03 
R TPJ and L MTG2 -0.37 2.53 4.13 4.26 -2.41 0.04 
L TPJ and R TPO -2.42 3.74 1.02 4.28 -3.00 0.02 
L pSTS and L TPO -3.29 4.71 1.82 4.75 -2.56 0.03 
 
 
Abbreviations: R TPJ: right temporoparietal junction; L TPJ: left temporoparietal junction; R 
pSTS: right posterior superior temporal sulcus; fPOC: frontopolar cortex; Precun: precuneus; 
L IFG: left inferior frontal gyrus; L MTG2: left middle temporal gyrus 2; R TPO: right temporal 
pole; L pSTS: left posterior superior temporal sulcus; L TPO: left temporal pole. Further 
information on nodes appears in Table 4.1. 
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Figure 4.1 Selected network nodes for the ToM network. Full names and MNI coordinates 
appear in Table 4.1. BrainNet Viewer (http://www.nitrc.org/projects/bnv/) (Xia et al. 2013). 
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A. 
  
B. 
  
 
Figure 4.2 Relevant partial correlation matrices for groups used in the group (SAD vs HC) 
comparison (A) and in the condition (therapy effect) comparison (B). Each matrix element is 
colour-scaled to mean group partial correlation coefficient for the relevant node-pair. The 5 
a priori nodes are indicated in bold text. 
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Abstract 
 
Introduction: While there is mounting evidence of abnormal reactivity of several brain 
regions in social anxiety disorder (SAD), and disrupted functional connectivity between these 
regions at rest, relatively little is known regarding resting regional neural activity in these 
structures, or how such activity is affected by pharmacotherapy. 
Methods: Using 2-deoxy-2-(F-18)fluoro-D-glucose positron emission tomography, we 
compared resting regional brain metabolism between SAD and matched healthy control 
groups; and in SAD participants before and after moclobemide therapy. Voxel-based analyses 
were confined to a predefined search volume. A second, exploratory whole-brain analysis 
was conducted using a more liberal statistical threshold. 
Results: Fifteen SAD participants and fifteen matched controls were included in the group 
comparison. A subgroup of SAD participants (n=11) was included in the therapy effect 
comparison. No significant clusters were identified in the primary analysis. In the exploratory 
analysis, the SAD group exhibited increased metabolism in left fusiform gyrus and right 
temporal pole. After therapy, SAD participants exhibited reductions in regional metabolism 
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in a medial dorsal prefrontal region and increases in right caudate, right insula and left 
postcentral gyrus.  
Conclusion: This study adds to the limited existing work on resting regional brain activity in 
SAD and the effects of therapy. The negative results of our primary analysis suggest that 
resting regional activity differences in the disorder, and moclobemide effect on regional 
metabolism, if present, are small. While the outcomes of our secondary analysis should be 
interpreted with caution, they may prove valuable in formulating future hypotheses or in 
pooled analyses.  
 
Keywords: social anxiety disorder; moclobemide therapy; positron emission tomography; 
fluorodeoxyglucose; regional metabolism; resting state 
 
Introduction 
 
Several brain regions are consistently implicated in SAD. Functional disruptions in 
amygdala, insula, precuneus, fusiform gyrus, thalamus and striatum have been demonstrated 
in SAD by task-based fMRI work that reported abnormal reactivity (to task) in these regions 
and resting-state fMRI work that reported abnormal functional connections of these structures 
(Freitas-Ferrari et al. 2010; Arnold-Anteraper et al. 2014; Brühl et al. 2014a; Manning et al. 
2015). There is mounting evidence that pharmacotherapy to some degree reverses some of 
these abnormalities or results in compensatory changes in reactivity or connectivity (Brühl et 
al. 2014a). Moclobemide is a selective monoamine oxidase A (MAO-A) inhibitor approved 
for the therapy of SAD in several countries, including in South Africa. It has a similar 
tolerability profile to SSRIs, and some evidence indicates that they may be as efficacious as 
these more widely used agents (National Collaborating Centre for Mental Health (UK) 2013), 
and studies show it is a safe and well-tolerated therapeutic option in SAD (Stein et al. 2002; 
Bonnet 2003). 
 
Relatively little is known about regional brain activity at rest in SAD. Only three studies 
investigating resting regional brain activity in SAD have been published (Stein and Leslie 
1996; Warwick et al. 2008; Evans et al. 2009), of which only one (Evans et al. 2009) used 
FDG PET. None of these studies have been performed using a case-control study design. 
Findings of these studies have been inconsistent, and have thus far failed to document 
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abnormality in several regions implicated by MRI-based work. Similarly, the effects of 
pharmacotherapy on resting regional brain activity in SAD have been investigated in only a 
handful of studies (van der Linden et al. 2000; Warwick et al. 2006; Evans et al. 2009; Crippa 
et al. 2011). While MAO-A inhibitors rapidly raise central concentrations of several 
neurotransmitters relevant to anxiety and depression, the clinical effects take several weeks to 
manifest. This suggests that the anxiolytic effects of moclobemide are likely the result of 
mechanisms of neural adaptation that remain poorly-understood, rather than simply increases 
in neurotransmitters (Bonnet 2003). Only one SAD study (Warwick et al. 2006) has 
investigated the effect of moclobemide on resting regional brain activity. 
 
The investigation of resting regional neural activity in SAD, as well how this may be 
impacted by moclobemide therapy merits further investigation. Using FDG PET, we 
compared a group of non-medicated SAD participants to a group of case-matched healthy 
controls, and obtained follow-up measures in the SAD group after a course of moclobemide 
therapy. We hypothesized that there would be regional differences in resting metabolism in 
SAD compared to healthy controls and that a course of moclobemide would result in 
alterations in resting regional metabolism in regions previously implicated in SAD.  
 
Methods 
 
Ethical approval 
 
The study was approved by the health research ethics committee of Stellenbosch University 
and was performed in accordance with the ethical standards of the 1964 Declaration of 
Helsinki and its later amendments, the guidelines of the International Conference on 
Harmonisation Good Clinical Practice (ICH/GCP, 2002) and the Medical Research Council 
of South Africa’s guidelines (2002) on the ethical conduct of research studies in humans. 
Informed consent was obtained from all individual participants included in the study. 
 
Participants 
 
SAD participants were recruited through the MRC Unit on Risk and Resilience in Mental 
Disorders. Healthy controls (HCs) were invited to join the study in various advertisements on 
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local radio stations and in print media, as well as online and through email campaigns. 
Volunteers were screened in an interview setting to assess their suitability for inclusion. 
Participants had to be between the ages of 18 and 55 years of age; right-handed; and fluent in 
English. SAD participants had to meet DSM-V criteria for SAD and not have any comorbid 
mood or anxiety disorders, or psychotic or substance disorders. Volunteers were excluded 
from participation if they had any metal implants or claustrophobia that would preclude MRI; 
had any current or prior neurological or psychiatric illness (healthy controls), or prior head 
injury resulting in loss of consciousness; had any serious medical conditions; or were heavy 
caffeine users (>600mg per day). All participants were free of psychotropic medication (other 
than the study medication) at study visits. SAD participants already on medication were not 
excluded from the study, provided they were willing to taper and discontinue their medication 
and then commence the study after a suitable washout period. SAD participants who could 
not safely stop medications known to interact with moclobemide were excluded. SAD and 
HC participants were matched for age and sex. 
 
Screening and clinical measures 
 
In total, HC participants attended three study visits. Including visits for follow-up measures, 
the SAD participants attended five study visits. All participants underwent a structured 
clinical interview for DSM-IV (SCID) (First et al. 1996) and completed the Edinburgh 
Handedness Inventory (Oldfield 1971) as part of the screening process. In addition, 
participants completed the Liebowitz Social Anxiety Scale (LSAS) (Liebowitz 1987) and 
Beck Depression Inventory (BDI-II) (Beck et al. 1996) to assess the severity of social anxiety 
and depressive symptoms respectively. 
 
At each FDG PET scanning visit participants completed the state version of the State Trait 
Anxiety Inventory (STAI-S) which measures levels of anxiety at the time of the measure 
(Spielberger 1983). The efficacy of pharmacotherapy was studied with the Clinical Global 
Impressions Improvement scale (CGI-I) (Guy 1976).  
 
Pharmacotherapy 
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After baseline measurements were completed, SAD participants commenced a course of 
moclobemide according to clinical prescribing guidelines for SAD (300 mg PO once daily for 
3 days, followed by 300 mg PO twice daily thereafter). After at least 8 weeks of therapy, 
follow-up measures were completed whereafter participants either opted to continue on 
moclobemide or discontinue the medication in favour of other management strategies. SAD 
participants were closely monitored for adverse effects during the study and for symptoms of 
discontinuation in the event that the study medication was stopped. 
 
Neuroimaging 
 
PET and MR imaging were performed on separate days and repeated in the SAD group after 
therapy. 
  
Prior to the FDG PET scan appointment, participants were given verbal and written 
instructions on correct preparation. Subjects were requested to remain fasting (nil per mouth 
other than plain unflavoured water and permitted medications) for a minimum of 6 hours 
prior to the injection time. After the placement of an intravenous cannula and blood glucose 
check, participants were seated in a comfortable chair, in a dimly lit cubicle and instructed to 
relax with their eyes open.  During the subsequent 20-30 minutes, participants sat quietly 
without engaging in activities such as reading or electronic device use and without 
conversation. After this time, a technologist injected a ±150 MBq dose of FDG through the 
pre-sited cannula. After a further 20 minutes of relaxation, the cannula was removed and 
participants encouraged to make use of the toilet before being placed on the scanner bed of a 
Philips Gemini TF PET/CT camera (Philips Medical Systems, Best, the Netherlands). Head 
restraints were used and participants were reminded to remain still throughout the entire 
acquisition. At approximately 30 minutes post-injection brain scanning was commenced. This 
consisted of a low-dose CT scan (16-slice; 0.5 sec rotation; 140 kVp; 20mAs) for attenuation 
correction, followed by 30 minutes of dynamic PET scanning. PET data were acquired over a 
FOV of 18 cm (90 slices with 2mm separation); voxel size: 2x2x2 mm. Scatter and CT-based 
attenuation correction were applied during reconstruction. List mode data were re-binned into 
15 frames of 2 minutes each. 
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MRI scanning was performed on either a 3T Siemens Magnetom Allegra or 3T Siemens 
Magnetom Skyra camera (Siemens Medical Systems, Erlangen, Germany). Acquisition 
parameters across the two systems were selected to minimise scanner-related bias.  Scan 
parameters for a T1-weighted ME-MPRAGE acquisition on the Allegra system: four coil; 
repetition time (TR) = 2530 ms; echo time (TE) = 1.533-6.57 ms; flip angle = 9°; slices = 
160; slice gap = 0.5 mm; field of view = 256 x 256 mm; voxel size = 1x1x1 mm; duration = 
10min 49 sec. On the Skyra system: same settings except TE = 1.69-7.27 ms; parallel 
imaging mode (iPAT) active. Additional structural scans (T2; FLAIR) were acquired to 
exclude relevant intracranial pathology. 
 
Before PET imaging, participants completed the STAI-S measure to measure state anxiety. 
 
Pre-processing 
 
All DICOM scans were reviewed visually for artefacts. DICOM images were converted to 
NIfTI format using the dcm2nii program packaged with MRIcron version 1 June 2015 (Chris 
Rorden, http://people.cas.sc.edu/rorden/mricron/index.html). Further pre-processing was 
performed using SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) and MATLAB (Mathworks 
R2014b). PET frames were realigned and checked for significant motion using a custom 
script. PET frames in which there was more than 2 mm translation or more than 2° rotation in 
reference to the first frame or serial frames were excluded from the analysis. Consecutive 
frames that met these criteria were summed and the resultant image checked for correct 
registration with the low-dose CT used for attenuation correction. Summed PET images were 
required to have a minimum of 100 million counts for inclusion. Summed FDG scans for 
each participant were co-registered to the subject-specific T1-weighted structural image using 
the mutual information estimation option. For follow-up scans in the same participants (SAD 
group) a second co-registration was performed in which follow-up scans were co-registered 
to the baseline structural scan. The T1-weighted structural image was segmented using the 
SPM segmentation function. During this step, the forward and inverse deformation field 
between the subject space and MNI space was calculated. PET images were then warped to 
MNI space using the forward deformation field and written to a final voxel size of 2x2x2 
mm3. Finally, PET images were normalized to a total global count value of 100 using a 
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customized script, before being smoothed with a 3-D Gaussian filter with a 12 mm isotropic 
kernel. Pre-processing steps are illustrated in Fig 5.1. 
 
Statistical analysis 
 
Two principal comparisons were made. In the first, we compared two groups: HCs and SAD 
participants (effect of group: HC vs SAD). In the second comparison we investigated the 
effect of therapy within the SAD group (effect of condition: baseline vs post-therapy). All 
statistical analyses were performed in MATLAB (Mathworks R2014b).  
 
Group matching for age was tested using a two-tailed Welch’s t-test. Differences in level of 
education level were tested with the Freeman-Halton extension of the Fisher exact test.  
Differences in clinical scores were tested with a two-tailed Welch’s t-test (HC vs SAD 
comparison) and single-tailed paired t-test (for the therapy effect comparison in the SAD 
group).  
 
For the brain analyses, a voxel-level statistical threshold for significance of p = 0.001 
(uncorrected) and a cluster-level threshold of 0.05 (family-wise error corrected) was used. To 
increase power, the analyses were confined to a subset of regions of a priori interest through 
the use of an inclusive mask. These regions were identified as potentially important in SAD 
in a previous meta-analysis of MRI studies (Brühl et al. 2014a). We also included cerebellum 
as an additional region of interest in this mask given evidence of its potential role in anxiety 
disorders (Caulfield and Servatius 2013; Phillips et al. 2015) and social cognition (van 
Overwalle et al. 2015). The mask was generated by first summing and then binarizing regions 
of interest defined in the WFU PickAtlas tool v3.05 (ANSIR Laboratory, Wake Forest 
University School of Medicine, http://fmri.wfubmc.edu/cms/software) (Maldjian et al. 2003, 
2004). Further details on the mask image can be found in Table 5.1 and Fig 5.2. In addition 
to our primary analysis, we also performed a second, explorative whole-brain analysis at the 
same liberal statistical threshold used by Evans et al, i.e. at a voxel-level uncorrected 
threshold of p=0.001 and a cluster extent threshold of 15 voxels. 
FDG images for the group and therapy condition comparisons were compared using two-
sample t-tests and paired t-tests respectively (unequal variance). As an exploratory measure 
in the SAD participants, subject-specific regional metabolism values were extracted for any 
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clusters identified in the effect of group analyses and correlated with disease severity scores 
(LSAS) using linear regression. Similarly, subject-specific regional metabolism values were 
extracted from the baseline SAD scans for any clusters identified in the effect of condition 
(therapy) analyses and correlated with the percentage change in disease severity with therapy 
(Δ%LSAS). A statistical threshold of p=0.05 was used in the linear regressions. 
 
Results 
 
Groups 
 
Fifteen (n=15) participants with SAD and fifteen (n=15) case-matched healthy controls (HC) 
were recruited in the study. 
 
In the effect of group comparison (HC vs SAD), all scans were suitable for analysis (n=15 
both groups). 
 
In the effect of condition comparison (baseline vs post-therapy), of the original group of 
fifteen, one SAD participant could not be scanned due to a PET scanner problem; two 
patients withdrew from the study due to lack of early therapeutic effect; and one participant 
withdrew due to scheduling issues. Follow-up measures for a treated SAD group were thus 
available in eleven (n=11) participants.  
 
Demographics 
 
The demographics of participants and matching in the group analysis appear in Table 5.2. 
While no significant differences were detected in terms of age, there was a statistically 
significant difference in level of education (p=0.04). SAD duration varied between 3.1 years 
and 33.1 years (mean 13.5 years).  
 
In the effect of therapy analysis, the 11 SAD participants consisted of 6 males and 5 females 
with a mean age of 30.5 years (range: 21.5 – 42.7).  
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Clinical 
 
In the group comparison, the SAD group had a mean LSAS score of 91.1 (range: 57-135, SD: 
25.4) and a mean BDI-II score of 14.8 (range: 2-35, SD: 10.9). The HC group, by comparison 
had a mean LSAS of 16.2 (range: 0-45, SD: 11.2) and a mean BDI-II score of 3.7 (range: 0-
16, SD: 4.6).The difference in LSAS and BDI-II scores between the groups was significant 
(p<0.001 and p=0.002 respectively). 
 
SAD participants in the effect of condition (effect of therapy) analysis demonstrated an 
overall improvement in clinical scores after a mean duration of therapy of 9.2 weeks (range: 
8.3 – 11.1). Changes in clinical scores are summarized in Table 5.3. No major adverse events 
occurred during the study. 
 
At the time of PET scanning SAD participants had higher state anxiety on the STAI-S (mean: 
44, SD: 15.8) than HC participants (mean: 27.7, SD: 9.5) which was significantly different 
(p=0.002). In the effect of therapy comparison there was no statistically significant difference 
in STAI-S scores at baseline (mean: 40, SD: 15.7) and at follow-up (mean: 30.8, SD: 8.0) 
(p=0.37). 
 
Regional metabolism 
 
No clusters were identified in our primary analysis confined to regions of a priori interest. 
 
In the second, explorative whole brain analysis at a more liberal statistical threshold, several 
clusters were identified. In the group comparison, SAD participants demonstrated 
hypermetabolism in a left fusiform gyrus cluster as well as in a right temporal pole cluster. In 
the therapeutic condition comparison, SAD participants after therapy demonstrated a 
metabolism decrease in bilateral superior frontal gyrus (medial regions); and an increase in 
metabolism in the insula, left postcentral gyrus and right caudate. No significant correlation 
between extracted cluster values and LSAS or Δ%LSAS were demonstrated on the linear 
regressions. Differences in whole brain regional metabolism for the group and therapy 
condition comparisons are summarized in Table 5.4 and illustrated in Fig 5.3 and 5.4. 
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Discussion 
 
In this study we compared resting regional metabolism between SAD and healthy control 
groups, as well as investigating whether there were any differences in regional resting 
metabolism in the SAD group after a course of moclobemide therapy. Confining our analysis 
to regions of a priori interest, we detected no significant differences in these comparisons. We 
then performed a second, exploratory analysis of whole brain differences. In that analysis, we 
observed several differences for each comparison. No correlations were found between 
regional metabolism within clusters and either disease severity or improvement in disease 
severity.  
 
Nuclear neuroimaging offers alternative windows into biological processes to those available 
through magnetic resonance imaging (MRI). One such process is regional glucose 
metabolism. Since the vast majority of the brain’s energy demands are met by glucose, the 
molecular imaging of glucose metabolism offers an attractive target to research. 
 
Positron emission tomography (PET) using 2-deoxy-2-(F-18)fluoro-D-glucose (FDG) is 
effectively an in vivo measurement of hexokinase activity within the brain (Hertz and Dienel 
2002). Due to neurometabolic coupling, FDG PET studies provide a summed representation 
of brain activity during the 15-20 minutes it takes for most of the uptake to occur, in the 
interval between injection and scanning. Despite this sacrifice in temporal resolution, there 
are strong rationales for the use of nuclear techniques such as FDG PET as a complementary 
tool to fMRI in neuropsychiatric research. Foremost amongst these is PET’s robustness with 
respect to susceptibility artefacts (Devlin et al. 2000); its resilience to small amounts of head 
motion  and its more direct measurement of biological processes. While fMRI’s better 
temporal resolution makes it ideal for studying resting-state networks it is at a disadvantage in 
measuring regional brain activity while at rest. We have previously motivated the importance 
of understanding baseline (resting) conditions in psychiatric disorders (Doruyter et al. 2017c) 
and in this sense, nuclear techniques such as FDG PET, that offer insight into regional neural 
activity at rest, are well-suited to provide biological information complementary to that 
obtained with fMRI.  
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In our primary analysis we did not detect any differences in regional resting metabolism 
between control and SAD groups, nor in the SAD group before and after a course of 
pharmacotherapy. This is in contrast to previous studies on resting regional brain activity 
which did report group differences (Warwick et al. 2008; Evans et al. 2009) and others that 
reported a change in regional brain activity in SAD participants after therapy (van der Linden 
et al. 2000; Warwick et al. 2006; Evans et al. 2009; Crippa et al. 2011). There are several 
possible methodological reasons for this inconsistency. The first reason relates to differences 
in study design. Early studies on resting regional activity in SAD (Stein and Leslie 1996) and 
the effect of pharmacotherapy in the disorder (van der Linden et al. 2000) used ROI-based 
techniques rather than voxel-based analyses and are therefore not comparable to subsequent 
studies including our own. Neither of the two previous studies that used voxel-based 
approaches to compare SAD and HC groups (Warwick et al. 2008; Evans et al. 2009) used 
case-control matching, as we did. While case-control approaches have their problems 
(Marquand et al. 2016), it can be argued that they remain the optimal study design for studies 
with small group sizes, since they reduce intergroup heterogeneity that may give rise to false 
positives. The second reason relates to differences in the analysis methods, principally in the 
statistical threshold used. Other studies have consistently set their statistical threshold at a 
more liberal level of p<0.001 uncorrected at the voxel level, sometimes combined with a 
cluster size threshold of 10-15 voxels. Without correcting for the effects of multiple 
comparisons (for example through the use of family-wise error correction or false-discovery 
rate correction), the risks of false positives at these statistical thresholds are high, and the 
results should be treated with caution (Bennett et al. 2009). As long as too much emphasis is 
not placed on the results of individual experiments conducted at these liberal thresholds, these 
studies remain valid and their findings contributory when replicated. In line with this we 
performed our own exploratory analysis. Even when using a more liberal statistical threshold, 
there are two additional considerations that should be born in mind when comparing our 
results to those of previous studies. Firstly, while there is a tight coupling between neuronal 
activity and metabolism, and neuronal activity and blood flow, the relationship between 
regional metabolism and blood flow is not absolute and imaging of these processes (glucose 
metabolism in the case of FDG PET; regional perfusion in the case of Tc-99m hexamethyl 
propylene amine oxime single photon emission tomography), is not expected to yield 
identical results (Wehrl et al. 2013); and secondly, the effects of different therapeutic agents 
(in our effect of condition analysis) are unlikely to be identical, given their different 
mechanisms of action.   
Stellenbosch University  https://scholar.sun.ac.za
  
108 
 
 
In our secondary analysis at a more liberal statistical threshold, we identified several 
differences in the group analysis. The finding of increased resting glucose metabolism in a 
fusiform gyrus cluster in SAD was interesting given several fMRI experiments that reported 
aberrant resting functional connectivity of this region in SAD (Ding et al. 2011; Qiu et al. 
2011; Manning et al. 2015; Liu et al. 2015b; Zhu et al. 2017). The cluster identified in our 
analysis closely corresponded to the posterior fusiform face area/FFA-1, which is a 
component of the distributed region of cortex involved in the visual processing of faces 
(Weiner and Grill-Spector 2012). Other work has implicated this region as playing a potential 
role in social interpretation (Schultz et al. 2003). Neither Warwick et al, nor Evans et al found 
any abnormality in the fusiform gyrus in SAD participants in their group comparison 
although the study by Warwick et al did find a positive correlation between resting fusiform 
perfusion and disease severity (Warwick et al. 2008). We also identified a cluster of increased 
regional resting glucose metabolism in the right temporal pole in our SAD group. This 
finding is consistent with MRI-based research that has found both reduced grey matter 
volume (Brühl et al. 2014b) and disrupted resting functional connectivity (Zhu et al. 2017) of 
this region in the disorder. That resting neural activity in this region may be abnormal is 
interesting, given the temporal pole’s importance in conceptual information processing (Frith 
2007; Olson et al. 2007); theory of mind (Frith and Frith 2006; Spreng et al. 2009; Bzdok et 
al. 2012); causal attribution (Kestemont et al. 2015); self-other referential processing (Murray 
et al. 2012); and empathy (Schulte-Rüther et al. 2007; Takeuchi et al. 2014b). Activity in the 
temporal pole has also been linked to anticipatory anxiety in both healthy (Chua et al. 1999) 
and SAD samples (Tillfors et al. 2002) scanned with O-15 water PET. No abnormality in 
resting regional activity was reported in this region in the studies by Evans et al and Warwick 
et al. We were unable to detect a correlation between regional resting activity in either of 
these clusters and disease severity, which might have strengthened the evidence (albeit 
indirectly) of their intrinsic abnormality in SAD. Importantly, we were unable to replicate the 
findings of either Warwick et al or Evans et al in our group comparison. 
 
We also performed an exploratory analysis to look for differences in regional resting activity 
between baseline and post-therapy scans in our SAD participants who were treated with a 
course of moclobemide therapy. In this analysis we found a decrease in resting activity to 
several medio-frontal regions after therapy. Again, such a finding has not been reported in 
nuclear neuroimaging experiments that investigated the effect of moclobemide (Warwick et 
Stellenbosch University  https://scholar.sun.ac.za
  
109 
 
al. 2006) or other therapies (Warwick et al. 2006; Evans et al. 2009; Crippa et al. 2011) on 
resting regional brain activity in SAD. Nevertheless, our finding is plausible, given this 
region’s importance in subjective experience of fear (Etkin et al. 2011). It may be that 
reduced activity after therapy in this region is related to reductions in anxiety. It is also of 
interest that dorsal medial prefrontal cortex has high cortical expression of MAO-A receptors, 
the target for moclobemide therapy (Tong et al. 2013). Our finding of an increase in resting 
right insular activity after therapy is apparently at odds with that of Warwick et al, who 
reported decreased resting perfusion in bilateral insula after courses of both moclobemide and 
citalopram. Certainly, the findings by Warwick et al of changes in bilateral insula makes it 
unlikely that those results were spurious. Whether our own result represents a false positive, 
or a more complex physiological process is present that explains this disparity is uncertain. 
Therapy-related increase in resting regional caudate activity in our study has also not been 
reported by the few comparable experiments conducted, but is interesting given evidence of 
increased striatal dopamine transporter binding after escitalopram therapy in SAD (Warwick 
et al. 2012). Our finding of increased metabolism within the primary somatosensory cortex, 
in left postcentral gyrus cluster after therapy is of uncertain significance.  
We failed to detect any correlation between resting metabolic activity within any of these 
clusters on the baseline scans), and degree of improvement on the disease severity measure.  
 
This study has a number of limitations. Firstly, we could not correct for two potential 
confounders: our SAD group was generally more anxious while being scanned (on STAI-S), 
and several SAD participants scored in the clinical range for depression. Due to the high risk 
of multicollinearity, we opted not to use STAI-S or BDI scores as nuisance regressors, since 
doing so would likely regress out the effect of group. Our approach of avoiding correction for 
these potential confounds may draw the criticism that our results are not specific to SAD (and 
may represent effects of either depression or anxiety related to scanning), however it is our 
view that this is unlikely, given that in all cases SAD was the dominant condition in terms of 
severity. Moreover, SCID-assessments did not suggest any comorbidity. Also, it may be 
argued that this distinction is artificial, given the frequent comorbidity of SAD and depressive 
symptomatology (Ohayon and Schatzberg 2010), and evidence that they stem from a shared 
underlying genetic vulnerability (Langer and Rodebaugh 2014). A second limitation, inherent 
to our study design, was related to our investigation of therapy effect. Since we did not 
perform follow-up imaging in the HC group, we cannot exclude the possibility that 
familiarity with the procedure (and not SAD improvement) resulted in the regional metabolic 
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changes seen on our exploratory analysis. Also, since there was no placebo arm, we cannot be 
certain whether regional metabolic changes were driven by moclobemide or the result of a 
non-specific expectancy effect. 
 
Conclusion 
 
This study adds to the limited existing work on resting regional brain activity in SAD and the 
effects of therapy. The negative results of our primary analyses with a strict statistical 
threshold, suggest that both resting regional activity differences in the disorder, as well as 
therapy effects on regional resting metabolism, if present, are small. At a more liberal 
statistical threshold, in line with previous studies, we identified several findings of interest, 
mostly in biologically relevant regions. While the outcomes of such a secondary analysis 
should be interpreted with caution, they may prove valuable in formulating future hypotheses 
or in pooled analyses. Our findings are complementary to research performed using fMRI and 
contribute to current understanding of baseline neurobiology in SAD.  
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Tables and Figures 
 
Table 5.1 Regions of a priori interest used to generate the mask image used in the primary 
analysis (from WFU PickAtlas tool v3.05) 
 
Description Atlas Union of (region labels) 
 
anterior cingulate cortex IBASPM 116 Cingulum_Ant (L+R) 
cerebellum IBASPM 116 All cerebellar regions including vermis 
dorsolateral prefrontal cortex IBASPM 116 Frontal_Mid (L+R) 
fusiform gyrus IBASPM 116 Fusiform (L+R) 
insula IBASPM 116 Insula (L+R) 
medial temporal cortex IBASPM 116 Hippocampus (L+R); Parahippocampal 
(L+R); Amygdala (L+R) 
posterior cingulate cortex IBASPM 116 Cingulum_Post (L+R) 
precuneus IBASPM 116 Precuneus (L+R) 
striatum IBASPM 71 caudate nucleus (L+R); putamen (L+R); 
nucleus accumbens (L+R) 
thalamus IBASPM 116 Thalamus (L+R) 
ventromedial prefrontal 
cortex 
IBASPM 116 Frontal_Mid_Orb (L+R); Rectus (L+R) 
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Table 5.2 Demographics and group matching in the HC vs SAD baseline analysis 
 
 Group  
 HC SAD p 
Total (n) 
 
15 15 - 
Mean age in years 
 
30.6 (21.2 – 46.9) 30.5 (21.0 – 45.7) 0.97* 
Gender 
 
Female: 9, Male: 6 Female: 9, Male: 6 - 
Highest level of education: 
Formal schooling 
incomplete 
 
1 
 
1 
 
 
 
0.04** Additional training college 
or technical qualification 
0 5 
Additional University 
degree 
14 9 
 
* Two-tailed Welch’s t-test  
** Freeman-Halton extension of the Fisher exact test  
 
 
Table 5.3 Clinical measures in SAD participants (n=11) included in the effect of therapy 
analysis. 
 
 Condition  
 Baseline Post-therapy  
 mean SD mean SD p* 
LSAS 
 
90.4 27.4 70.3 35.0 0.002 
BDI-II 
 
14.8 10.9 11.9 8.8 0.13 
CGI-S 
CGI-I 
4.6 1.3 3.5 
2.9 
1.9 
0.9 
0.02 
 
* single-tailed paired student t-test  
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Table 5.4 Significant regions identified in the secondary, whole brain analyses 
  
Number 
of 
voxels 
t Local maxima Region 
 
 
 
x y z 
 
Effect of group 
HC > SAD 
      
 Nil      
       
HC < SAD        
59 4.31 -34 -46 -22 Left fusiform gyrus  
26 3.96 36 16 -34 Right temporal pole (mid)        
Effect of condition  
(treated SAD group, 
n=11) 
 
 
    
Baseline > Post-
therapy 
      
 271 7.49 -16 62 30 Frontal superior left  
134 6.48 -2 38 54 Frontal superior medial 
left  
27 5.90 -12 28 60 Frontal superior medial 
left   
4.57 -6 24 56 Frontal superior medial 
left Supplementary motor 
area left  
56 5.78 10 70 18 Frontal superior medial 
right  
80 4.84 8 56 42 Frontal superior medial 
right 
 
Baseline < Post-
therapy 
 
59 
 
5.16 
 
46 
 
16 
 
-6 
 
Insula right  
18 5.04 -58 -6 22 Postcentral left  
42 4.72 10 12 6 Caudate right   
4.64 12 2 6 Caudate right 
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Figure 5.1 Pre-processing steps performed. 
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Figure 5.2 Mask image used in the primary analysis. The mask was generated by summing 
and binarizing a priori regions of interest in Table 5.1. Image generated in MRIcroGL 
(http://www.mccauslandcenter.sc.edu/mricrogl/).  
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a.  
 
 
b. 
 
 
 
Figure 5.3 Effect of group in the secondary analysis. (a) Voxels showing significantly higher 
FDG activity in SAD participants compared to healthy controls. Slices between z= -38 and z = 
-16. Image generated in MRIcroGL (http://www.mccauslandcenter.sc.edu/mricrogl/). (b) 
Scatter plots of extracted cluster values per group for left fusiform gyrus (left) and right 
temporal pole (right) (x-position jittered for better visualization of similar y-values). Cluster 
sizes 59 and 26 voxels respectively. Image generated in Matlab (Mathworks R2014b). 
Abbreviations: FFG: fusiform gyrus; TPO: temporal pole. 
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a.  
 
 
b. 
 
 
 
Figure 5.4 Effect of condition in the secondary analysis. Voxels showing increases (a) and 
decreases (b) in FDG activity in SAD participants following a course of moclobemide. Slices 
between z = -12 and z = 25 (a), and z = 14 and z = 63 (b). Image generated in MRIcroGL 
(http://www.mccauslandcenter.sc.edu/mricrogl/). 
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Abstract 
 
Introduction: Reward processing is a key construct in translational neuroscience, and may be 
key to understanding approach-avoidance decision-making. There is emerging evidence that 
social anxiety disorder (SAD) may be associated with disruptions in reward processing. Little 
is yet known about what aspects of reward processing may be disrupted in SAD, and whether 
reward processing in SAD is altered by pharmacotherapy.  
Methods: Patients with a primary diagnosis of SAD as well as age- and gender-matched 
healthy controls (HC) were recruited. All participants underwent functional magnetic 
resonance imaging during a modified monetary incentive delay task. SAD participants then 
received a minimum of 8 weeks of moclobemide therapy before undergoing repeat scanning. 
Group (SAD vs HC at baseline) and condition (SAD at baseline vs post-therapy) comparisons 
were performed in an event-related design, and both reward anticipation and reward outcome 
analysed.  
Results: Activation of reward centres known to be important in the processing of reward 
anticipation and reward outcome could not be demonstrated in either group. No main effect 
of group or of condition could be demonstrated in either the primary or secondary analysis. 
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Conclusion: While the negative findings here may reflect a lack of statistical power, they 
may be consistent with the view that alterations of reward processes in SAD are restricted to 
social reward.  Further research to address whether social reward processing is present in 
SAD, and is altered by pharmacotherapy, may be useful. 
Keywords: reward, monetary reward, social anxiety disorder, functional magnetic resonance 
imaging. 
 
Introduction 
 
Reward processing is a key construct in translational neuroscience (Cuthbert and Insel 2013). 
In both animals and humans, reward circuitry is distributed across specific brain regions, 
including nucleus accumbens, caudate, putamen, and orbitofrontal cortex (Haber and 
Knutson 2009; Liu et al. 2011). Several fMRI-based experiments have demonstrated that 
tasks that involve social interactions result in very similar activations in these reward centres 
to those elicited by other reward types such as money, food, sex and drugs of addiction (Koob 
and Le Moal 1997; Schultz 1997; Rilling et al. 2002; Zink et al. 2004; Delgado et al. 2005; 
McClure et al. 2007; Spreckelmeyer et al. 2009). The observation that individuals with social 
anxiety disorder (SAD) tend to avoid social interactions (and the sense of reward these 
interactions may confer) has led some researchers to posit that disrupted reward processing 
may be a feature of the condition (Stein 1998; Mathew et al. 2001). 
 
There is indirect evidence of disrupted reward processing in SAD. Resting functional 
connectivity (performed on resting-state fMRI) within the reward circuit has been shown to 
be altered in SAD (Arnold-Anteraper et al. 2014; Manning et al. 2015). There is also 
evidence from nuclear neuroimaging studies that implicate aberrant dopamine (a core 
neurotransmitter system in reward) signalling in the disorder (Tiihonen et al. 1997; Schneier 
et al. 2000; van der Wee et al. 2008b; Plavén-Sigray et al. 2017) although conflicting 
evidence exists in this regard (Schneier et al. 2009). Also contributory, given the hypothesis 
of a social anxiety spectrum (Stein et al. 2004; Kashdan 2007), is evidence of abnormality in 
reward processing in non-clinical social anxiety samples, predominantly in paediatric 
populations (Kashdan 2007; Caouette and Guyer 2014).  
 
Direct investigation of reward processing in SAD has also been undertaken. Task- or 
questionnaire-based studies have found no evidence of abnormality in reward dependence 
Stellenbosch University  https://scholar.sun.ac.za
  
121 
 
(Kampman et al. 2014) or in temporal discounting of reward (Steinglass et al. 2017) in SAD. 
Neuroimaging studies have largely relied on the Monetary Incentive Delay Task (MID) 
(Knutson et al. 2000), a task that allows assessment of neural processing of both anticipation 
and outcome of monetary reward (Knutson and Heinz 2015), or on variations of the MID task 
which employ social rewards (Spreckelmeyer et al. 2009), to study reward processing in 
SAD. This work has consistently demonstrated abnormalities in reward processing in SAD. 
 
Nevertheless, there are inconsistencies in the data, with results that appear to vary on the 
basis of which component (anticipation, outcome) of reward processing is disrupted, the 
valence of reward (positive or negative) affected, and the specificity of dysfunction in terms 
of reward type (monetary, social) (Guyer et al. 2012; Richey et al. 2013, 2017; Cremers et al. 
2015). Whether aberrant reward processing in SAD is specific to social reward, or whether 
there exists a more general dysfunction that extends to the processing of other reward types 
such as monetary reward remains undecided. In addition, while there is indirect evidence that 
pharmacotherapy influences striatal dopaminergic function (Warwick et al. 2012), no studies 
have previously investigated the effect of pharmacotherapy on reward processing in SAD.  
 
In this study, we used a modified version of the MID task to investigate whether SAD was 
associated with dysfunction in the processing of monetary reward. We hypothesized that 
there would be differences in reward processing between SAD participants at baseline and 
matched healthy controls (HCs), as well as in the SAD group before and after a course of 
pharmacotherapy. 
 
Methods 
 
The study was approved by the Health Research Ethics Committee of Stellenbosch 
University. 
 
Participants 
 
Volunteers were recruited through the MRC Unit on Risk and Resilience in Mental 
Disorders. Advertisements calling for both SAD and HC research participants were placed in 
local print media and online; as well as through local radio stations. Volunteers were eligible 
Stellenbosch University  https://scholar.sun.ac.za
  
122 
 
if they were between the age of 18 and 55 years old; right-handed; and fluent in the language 
of the measuring instruments (English). SAD participants had to meet DSM-V criteria for the 
disorder and had to be free of comorbid mood or anxiety disorders; psychotic disorders; and 
substance use disorders. SAD participants were not taking any psychotropic medications at 
commencement of the trial and were not on any other medications that interacted with the 
study medication (i.e. moclobemide). Volunteers were excluded from the study if there were 
any contraindications to MRI (metal implants, claustrophobia); had any current or prior 
neurological illness; prior head injury resulting in loss of consciousness; or serious medical 
condition. Case-control matching for age and sex was performed. 
 
Screening and clinical measures 
 
Clinical evaluation and neuroimaging were performed on separate days. All participants 
underwent a structured clinical interview for DSM-IV (SCID) (First et al. 1996) and 
completed the Edinburgh Handedness Inventory (Oldfield 1971) as part of their screening. 
Participants also completed questionnaires used to measure the severity of depressive and 
social anxiety symptoms, namely the Beck Depression Inventory (BDI-II) (Beck et al. 1996) 
and Liebowitz Social Anxiety Scale (LSAS) (Liebowitz 1987). 
 
On the day of scanning, all participants completed the state version of the State Trait Anxiety 
Inventory (STAI-S) which measures levels of anxiety at the time of the measure (Spielberger 
1983).  
 
Pharmacotherapy 
 
Both healthy controls and SAD participants completed baseline clinical and neuroimaging 
measures. Following this, SAD participants commenced a course of moclobemide therapy 
according to recommended guidelines for SAD (300 mg PO daily for 3 days, followed by a 
300 mg PO twice daily for a minimum of 8 weeks). At least 8 weeks after commencing 
therapy, clinical measures and neuroimaging (including task) were repeated in the SAD 
group. During this time they were closely monitored for adverse effects of the therapy. After 
completing the study, SAD participants were monitored for discontinuation symptoms in the 
event that they chose not to continue with maintenance therapy. 
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Neuroimaging 
 
Imaging was performed during a dedicated study visit. SAD participants repeated the 
neuroimaging session after a course of moclobemide. 
 
MRI scanning was initially performed on a 3 tesla (3T) Siemens Magnetom Allegra camera 
(Siemens Medical Systems, Erlangen, Germany). Midway through the project, this scanner 
was decommissioned and imaging was switched to a 3T Siemens Magnetom Skyra. 
Acquisition parameters across the two systems were optimized to reduce scanner-related bias.  
Scan parameters for the functional T2-weighted sequence on the Allegra system: single-shot 
gradient echo planar imaging (EPI); 382 volumes; repetition time (TR) = 1600 ms; echo time 
(TE) = 23 ms; flip angle = 73°; number of slices = 30; slice gap = 0.2 mm; field of view = 
255 x 255 mm; voxel size = 4mm x 4mm x 4mm. On the Skyra system: the same settings 
were used except TR = 1740 ms. Additional structural scans (T1-weighted ME-MPRAGE; 
T2; FLAIR) were acquired for anatomical co-registration and to exclude significant 
intracranial pathology. 
 
Before imaging, participants received an explanation of the scanning procedure and on how 
to perform the monetary incentive delay (MID) task. Participants were informed before the 
task that all money they won during the task was real and would be paid to them after the 
scanning session, in addition to the money they received to cover travel costs. 
 
fMRI task 
 
Participants completed a single run of an adapted version of the original MID task (Knutson 
et al. 2000). This task has been well-validated in probing monetary reward processing and 
had been previously set up at our site for other research projects (du Plessis et al. 2015). 
During the task, participants performed 60 trials, in each of which they were presented with 
five serial images: an anticipation cue consisting of either a neutral (n=30) or smiling (n=30) 
face; a fixation star; a target during which a button should be pressed; a fixation point; and a 
feedback screen, which informed participants of their success or failure and on any reward 
gained. This was followed by a variable inter-trial delay before the next trial began. 
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Participants were informed that only trials preceded by a smiling face were potentially 
rewarding but that they should push the button with their right index finger when they saw 
the target, regardless of trial type. When participants pushed the button while the target was 
still on screen, a “correct” response was recorded; otherwise an “incorrect” response was 
recorded. The feedback screen indicated to the participant whether they had had pressed the 
button in time (green text) or not (red text) as well as whether they had won any money, 
together with a running total. Potentially rewarding and neutral trials were randomly 
interspersed. Participants were warned prior to the task that timings would vary and that they 
would not be able to time their responses. The anticipation cue, and feedback screen were 
displayed for standard durations of 750 ms and 1000 ms respectively while display duration 
of the fixation star (mean 3286 ms, range: 779-6729 ms), and inter-trial interval (mean: 3535 
ms, range: 1029-6979 ms) were varied in order to reduce collinearity of reward anticipation 
and reward feedback. Target display duration was varied to favour either trial success or trial 
failure (half of all neutral and potential reward trials each), by respectively adding 200 ms or 
subtracting 150 ms from the participant’s fastest response time recorded during a preceding 
practice session. Display of the fixation point varied such that the duration of target and 
fixation point display together equalled 1000 ms. The complete task thus consisted of 60 
trials, each of which had a mean duration of 9571 ms (range: 4946-16107), resulting in a total 
task duration of 9 min 35 sec. 
 
Correct responses to potentially rewarding trials were rewarded with R10 (ten South African 
rand), resulting in a target reward amount for the entire task of R150. 
 
A schematic representation of the reward task is presented in Fig 6.1. 
 
Pre-processing 
 
Anatomical scans were reviewed for structural abnormalities by a qualified radiologist. All 
images were reviewed for artefacts. DICOM files were converted to NIfTI format before 
undergoing further pre-processing in SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) and 
MATLAB (Mathworks R2014b). After realignment of functional images, a custom script was 
used to check for significant motion. Only functional sequences in which there was less than 
2 mm translation overall; less than 1 mm momentary translation; and less than 2° rotation 
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were included in the analysis. Functional scans were time slice corrected and the ME-
MPRAGE image was co-registered to the mean functional image using normalized mutual 
information estimation. A second co-registration was performed in which follow-up images 
were co-registered to baseline images for the SAD group. The SPM Segment function was 
used to extract tissue classes from the structural scan and calculate a deformation field to the 
standardized SPM Average sized template. This deformation field was then used to warp the 
functional images, which were written to a final voxel size of 4x4x4 mm3. The final 
functional images were smoothed using an isotropic 3D Gaussian kernel with FWHM = 8 
mm. 
 
A schematic diagram of pre-processing steps appears in Fig 6.2. 
 
Analysis 
 
Two types of analysis were performed. In the first, we compared two groups: SAD and HC 
participants (effect of group: SAD vs HC). In the second, we compared the effect of therapy 
within the SAD group (effect of condition: baseline vs post-therapy).  
 
Statistical analysis was performed in Matlab (Mathworks 2104b). Group matching for age 
was tested using a two-tailed Welch’s t-test. Group differences in level of education level was 
tested with the Freeman-Halton extension of the Fisher exact test.  Differences in clinical 
scores were tested with a two-tailed Welch’s t-test (SAD vs HC comparison) and single-
tailed paired t-test (for the therapy effect comparison in the SAD group).  
 
Behavioural data were analysed using SPSS (IBM SPSS Statistics, Version 25). Mixed 
design (for effect of group: SAD vs HC) and two-way repeated measures (for effect of 
condition: baseline vs post-therapy) analyses of variance (ANOVA) were performed to test 
for effects of valence (reward vs neutral) and either group (SAD vs HC) or condition 
(baseline vs post-therapy) on response accuracy and reaction time. Differences in total reward 
amount for the task were compared using a two-tailed Welch’s t-test (SAD vs HC 
comparison) and single-tailed paired t-test (therapy effect comparison in the SAD group). 
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Time series data of the functional scans were analysed using a general linear model 
regression analysis with an event-related design in SPM12 (first level analysis). Similar to 
previous studies using this task (Hoogendam et al. 2013; du Plessis et al. 2015), our design 
model consisted of 6 factors representing haemodynamic responses to 1.) anticipation of 
reward; 2.) anticipation neutral; 3.) feedback of reward; 4.) feedback of missed reward; 5.) 
feedback correct neutral; 6.) feedback of missed neutral. Onset of the factors modelling 
anticipation were set to correspond to the presentation of the anticipation cue; while feedback 
onsets were set to the time of presentation of the target. Motion parameters obtained during 
alignment were included as nuisance regressors. A default high-pass filter cut-off of 128 
seconds was used. Two contrasts (and their reverse) were defined: 1.) anticipation reward vs 
anticipation neutral (reward anticipation); and 2.) feedback reward vs feedback correct 
neutral (reward outcome). 
 
Random effects analyses (second level) were performed using the contrast images generated 
during the first-level (subject-specific) analysis. These analyses were restricted to a limited 
set of brain regions known to play a role in reward processing, including striatum, nucleus 
accumbens, orbitofrontal cortex and anterior cingulate cortex. Similar to a previous study 
(Cremers et al. 2015), an inclusive mask for these regions was generated by summing the 
reverse inference statistical map obtained from the Neurosynth meta-analytic database 
(Yarkoni et al. 2011) for the terms “reward”, “reward anticipation” and “monetary reward”. 
This summed image was then binarized and clusters smaller than 10 voxels removed to 
generate the final mask. Generation of the mask image is illustrated in Fig 6.3. Since 
functional-anatomical variability in our groups could potentially result in effects just outside 
the mask region (and which would then be missed), we also performed a second, whole brain 
analysis in order to identify any activations in known reward structures. 
In our primary analysis we used a statistical threshold of p=0.001 (uncorrected) at the voxel 
level, and p=0.05 (family-wise error corrected) at the cluster level. In our secondary, 
exploratory analysis of whole brain we used an uncorrected voxel-level threshold of p=0.001. 
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Results 
 
Participants 
 
Fifteen participants with SAD and 15 age and sex-matched HCs were recruited. 
 
In the group (SAD vs HC) analysis, 2 of the SAD participant scans (as well as those of 
matched counterparts) and 5 of the HC participant scans (and their SAD counterparts) were 
excluded due to excessive motion. The final group size was thus 9 matched SAD participants 
and healthy controls. 
 
In the effect of condition (baseline vs post-therapy) analysis, two SAD participants were 
excluded due to excessive motion on the baseline scan. Another two patients withdrew from 
the study due to lack of early therapeutic effect; and one participant withdrew due to 
scheduling issues (new job). Baseline and follow-up measures were thus available for 10 
SAD participants. 
 
Demographics 
 
The demographics of participants included in the group analysis appear in Table 6.1. No 
significant differences were found in age, gender or level of education. 
 
In the effect of condition (baseline vs post-therapy y) analysis, the 10 SAD participants 
consisted of 5 females and 5 males with a mean age of 29.2 years (range: 21 – 39). 
 
Clinical characteristics 
 
In the group (SAD vs HC) comparison, SAD participants had a mean LSAS score (±SD) of 
88.6 (±25.0) compared to the HC participants, who had a mean LSAS of 18.0 (±13.2). This 
difference was statistically significant (p<0.0001). Despite not meeting diagnostic criteria for 
major depressive disorder (MDD) on the SCID, several SAD participants (n=5) fell into the 
clinical ranges for depression based on their BDI-II scores: one who met criteria for mild 
depression, 3 with moderate depression, and 1 with severe depression. BDI-II scores were 
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significantly higher in the SAD group (14.4 ±9.0) than in the HC group (2.0 ±2.1) (p=0.003). 
SAD participants were significantly more anxious than controls immediately before scanning, 
with a mean STAI-S score of 48.9 (±14.9) compared to 25.6 (±5.6) respectively (p=0.001). 
 
In the effect of condition (baseline vs post-therapy) comparison, SAD participants received a 
mean of 8.9 weeks (range: 8.0 – 12.1 weeks; mode: 8.0) of moclobemide therapy at a fixed 
dosage of 600mg daily between baseline and follow-up measures. Differences between pre- 
and post-therapy clinical measures are summarized in Table 6.2. STAI-S scores at time of 
scanning were significantly higher at baseline (43.6 ±13.9) than after therapy (34.1 ±8.4) 
(p=0.007). 
 
Reward processing: behavioural results 
 
In the SAD vs HC comparison, there were no significant main effects of group or valence nor 
was there evidence of a group-by-valence interaction on response time or on accuracy. In the 
baseline vs post-therapy comparison effect of valence on response accuracy [F(1, 9) = 6.68, p 
= 0.03], reflecting higher accuracy across both conditions when completing potentially 
rewarding trials. No other significant effects of condition or valence, nor evidence of 
condition-by-valence interactions, were found on accuracy or response time. There was no 
significant difference between groups (SAD vs HC) or conditions (baseline vs post-therapy) 
in total reward amount won in the task. 
 
Reward processing: fMRI results 
 
No activations related to reward anticipation or reward outcome were observed within the a 
priori regions of interest in either group, or in the SAD group after therapy. No significant 
differences were observed between groups or conditions. In our second, exploratory analysis, 
in which we looked for activations in reward structures that may have been obscured by 
masking, the SAD group exhibited activation in anterior cingulate cortex during reward 
outcome, but again, no significant group or condition effects were detected. 
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Discussion 
 
In this study, we investigated whether there was any difference in how participants with SAD 
anticipated and subsequently processed reward feedback when compared to a group of 
healthy controls. We also tested whether reward anticipation and processing of reward 
outcome differed after a course of moclobemide in the SAD participants. We did not detect 
any significant activations during reward anticipation or reward outcome in regions of a 
priori interest in either the HC group or the SAD group. Nor did we identify any group or 
condition effect in these regions. While an exploratory (whole-brain) analysis did detect 
activations (in the HC group: in precuneus, during reward anticipation; in the SAD group, in 
anterior cingulate cortex during reward outcome), no differences were detected in either 
group or condition comparisons in this analysis either. 
 
While our negative findings in both the group and condition analyses may point to the 
absence of an effect, the lack of any activation in reward regions in either our SAD or HC 
groups suggests there may be technical reasons for these results. The detection of statistically 
significant activations depends on two factors: sample size and effect size. In terms of sample 
size, not only were our final group sizes smaller than anticipated due to excessive motion on 
a high proportion of scans, but we only performed one run of the task per participant, 
reducing our statistical power still further. In terms of effect size, it has been shown that this 
is influenced by the size of the financial reward (Wu et al. 2014), and it may be that the 
relatively low reward amount (R10) used in our experiment contributed to the absence of 
detectable activations. Given that a previous study at our centre (du Plessis et al. 2015) 
detected reward activations when using a single run of the same MID task (with group sizes 
of 16-18 participants) and the same reward amount, we plan to conduct a repeat analysis once 
we have included more participants. Data collection for this experiment has therefore been 
extended. 
In addition to being underpowered, our study had some other limitations. The first is that our 
modified MID task can only investigate components of positively-valenced monetary reward. 
Other groups have designed MID-based tasks that include both positive and negative rewards 
and have combined social and monetary rewards in the same task (Richey et al. 2017). Such 
approaches are accepted to be more powerful in that they make full benefit, through mixed 
effects models, of disruptions in several reward components as well as interactions between 
Stellenbosch University  https://scholar.sun.ac.za
  
130 
 
monetary and social reward processing. Unfortunately we lacked the resources to set up such 
a task in our setting, and thus chose to use an existing version of the task that had been 
trialled successfully (du Plessis et al. 2015). Another limitation relates to the design of the 
therapy effect component of our experiment. Once again, due to resource limitations, we used 
an uncontrolled design, whereas such research is optimally performed in a randomised 
control trial. Consequently, even if an effect was present when comparing post-therapy scans 
to baseline scans in the SAD group, we would be unable to distinguish a therapy-specific 
effect from a placebo effect. Our study is however predominantly exploratory in nature and 
should suspected therapy-related effects be identified in a future analysis using a larger 
group, this will motivate for future experiments with more targeted designs.  
 
Nevertheless, our study had several strengths. Firstly, we have used case-control matching 
(unlike previous studies). This is arguably the recommended approach to limit false positives 
due to group heterogeneity. We have also chosen to focus on a relatively understudied 
component of reward processing in SAD for which there is currently conflicting evidence of 
abnormality, motivating for further study. In the context of accumulating evidence for 
disrupted reward processing in SAD, the distinction between general reward system 
dysfunction and an isolated specific (social) reward system dysfunction is an important one. 
For example, the former scenario suggests a model of SAD in which core reward circuitry 
(principally dopaminergic system) is affected as a “final common pathway” resulting in the 
aberrant processing of multiple reward types. In contrast, if reward processing dysfunction is 
limited to social reward, it might support a model in which this final common pathway is 
intrinsically normal, but “upstream” modulatory systems such as the oxytocinergic or 
endocannabinoid systems, which have been implicated in the experience of social reward 
(Skuse and Gallagher 2011; Harari-Dahan and Bernstein 2014; Karhson et al. 2016; Wei et 
al. 2017), are not. These two models would have different implications for developmental 
theories in SAD, for research into comorbid substance and mood disorders, and for current 
and novel therapeutic targets.  
 
Conclusion 
 
While there is emerging evidence of aberrant reward processing in SAD, it is uncertain 
whether reward processing in general is affected in SAD, or whether dysfunction is limited to 
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specific reward types. Using a modified version of the MID task, we performed an 
investigation of monetary reward processing in the SAD. We found no differences in 
monetary reward processing between SAD and HC groups, nor evidence that therapy with 
moclobemide influences monetary reward processing in SAD. Given the limitation of our 
small sample sizes, we plan to repeat our analyses once additional data are collected. 
Knowledge on disruptions in reward processing, as well as on the specificity of such 
disruptions to reward type, has potentially important implications in our understanding of the 
neurobiology of SAD and in the investigation of future therapeutic targets. 
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Tables and Figures 
 
Table 6.1 Demographics and group matching in the SAD vs HC baseline analysis. 
 
 Group  
 HC SAD p 
Total (n) 
 
9 9 - 
Mean age in years 
 
30.3 (21.2 – 46.8) 30.1 (21.0 – 45.6) 0.96a 
Sex 
 
Female: 7, Male: 2 Female: 7, Male: 2 - 
Highest level of education:    
 
 
0.10b 
Formal schooling 
incomplete 
0 1 
Additional training college 
or technical qualification 
0 2 
Additional University 
degree 
9 6 
 
a Two-tailed Welch’s t-test  
b Freeman-Halton extension of the Fisher exact test  
 
 
Table 6.2 Clinical measures in SAD participants (n=10) used for the effect of therapy 
analysis. 
 
 Condition  
 Baseline Post-therapy  
 mean SD mean SD p* 
LSAS 
 
97.6 25.3 76.7 34.7 0.003 
BDI-II 
 
16.3 10.3 13.6 8.0 0.18 
CGI-S 
CGI-I 
4.5 1.4 4.0 
3.0 
1.5 
0.9 
0.13 
 
* single-tailed paired student t-test 
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Figure 6.1 Schematic representation of the adapted monetary incentive delay task (Knutson 
et al. 2001) used in this study. Graphic adapted from Hoogendam et al (Hoogendam et al. 
2013). 
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Figure 6.2 Pre-processing steps performed. 
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Figure 6.3 Generation of mask. Analysis was confined to brain regions known to play a role 
in reward processing. For this purpose, an inclusive mask was generated by summing the 
reverse inference statistical maps obtained from the meta-analytic database Neurosynth 
(Yarkoni et al. 2011) using the search terms “reward”; “reward anticipation” and “monetary 
reward”. This summed image was then binarized and clusters smaller than 10 voxels were 
removed to generate the final mask image.  
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Conclusion 
 
Summary of findings  
 
In this thesis are presented the findings of several neuroimaging experiments in social anxiety 
disorder (SAD).  
 
In a retrospective experiment using single photon emission tomography, as hypothesized, 
several differences in perfusion-based, resting functional connectivity (RFC) in SAD were 
detected, which were broadly consistent with a network model of the disorder. This is 
important, since concordant findings using a nuclear imaging technique strengthen the 
evidence supporting the contemporary network model of SAD, which is based on fMRI 
experiments. The experiment also reported a novel finding of disturbed RFC of the 
cerebellum, a structure that is not currently included in network models of SAD, but for 
which there is independent evidence of dysfunction in anxiety disorders. It was also 
hypothesized that changes in RFC would be detected in the SAD group post-therapy. The 
finding that RFC of the anterior cingulate cortex strengthened after pharmacotherapy 
suggests the importance of this region in the therapeutic response, although further research 
will be needed to confirm that this is indeed a therapy effect and whether such a finding can 
be directly correlated with clinical improvements with treatment. The finding of increased 
RFC between anterior cingulate and both fusiform gyrus and middle occipital gyrus post-
therapy was interesting given that the current network model predicts increased RFC between 
these regions in SAD at baseline. That this connectivity should strengthen after therapy, 
coupled with an overall reduction in anxiety severity, invites speculation that this baseline 
disturbance may represent a compensatory effect, enhanced by therapy.  
 
In a second experiment it was hypothesized that an SAD group would demonstrate 
differences in resting graph metrics within the theory-of-mind network, would display 
evidence of social attribution bias on a psychological measure, and that these findings would 
be correlated. In line with these hypotheses, the SAD group demonstrated several differences 
to controls in terms of both resting graph metrics within the theory of mind network as well 
as evidence of social attribution bias. No correlation between imaging findings and 
behavioural measures could be demonstrated however. While the absence of such a 
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correlation may indicate the absence of a relationship, this might also be explained by a small 
sample size and the high-interconnectedness of the network under study. It was also 
hypothesized that moclobemide therapy would influence resting graph metrics and social 
attributional style. While no changes in graph metrics within this network were detected in 
response to moclobemide therapy, there was evidence of altered attributional style after 
treatment. This work was important for several reasons. Firstly, it strengthened the limited 
evidence of social attribution biases in SAD and presented new evidence that 
pharmacotherapy might change these. Secondly, it sought to investigate the neuroimaging 
correlates of a behavioural measure. Although no correlation was identified in this study, it is 
important that such work is conducted, since a fundamental interest of social neuroscience is 
not merely how subjects brains differ, but also how neuroimaging features translate into 
behaviour. Future analyses similar to those used in this experiment but applied to larger 
groups, may be better powered to detect group differences and pharmacotherapy effects in the 
strongly interconnected theory-of-mind network. 
 
Positron emission tomography-based measures of brain metabolism added to the limited 
existing work on resting regional neural activity in SAD. In this study it was hypothesized 
that brain regions implicated as important in the disorder in MRI-based work, would 
demonstrate resting-state differences between SAD and control subjects and that 
moclobemide therapy would result in changes in resting regional metabolism in the SAD 
group. Contrary to these hypotheses, no group differences or post-therapy effects were 
detected: a finding most likely explained by the stringent statistical thresholds despite careful 
case-control matching employed in the experiment. This explanation is supported by the 
results of a secondary analysis, at a more liberal statistical threshold similar to that employed 
by other studies, which did detect group differences and post-therapy changes in several 
biologically relevant regions. While the implications based on the results of this secondary 
analysis are necessarily speculative, these findings do contribute to the existing knowledge of 
the disorder, albeit with a lesser weighting. Importantly, this experiment suggests that 
regional metabolic differences in SAD as well as post-therapy changes, are small, and/or that 
inter- and intra-subject variability of FDG PET scans are large enough to conceal these 
effects. Given the drive to perform experiments with more stringent control of false positive 
results, requiring stricter statistical thresholds, the current work becomes important in 
planning future experiments, which will need to utilize larger sample sizes. The sample sizes 
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of future studies on resting regional metabolism will also be informed by additional research 
quantifying measurement and biological variability between FDG PET scans.  
 
Finally, in an experiment on reward processing, it was hypothesized that SAD participants 
would demonstrate differences to controls in the processing of monetary reward, and that 
changes in reward processing would be found in SAD participants post-therapy. Due to 
greater than anticipated exclusion of participant scans due to excessive motion, data 
collection for this experiment has been extended. A preliminary analysis of data collected to 
date found no evidence of disrupted monetary reward processing in the condition, or of a 
therapy effect on reward processing. While preliminary negative findings of this experiment 
may well reflect a lack of statistical power, they are consistent with the view that alterations 
of reward processes in SAD may be restricted to social reward. Given that there is mounting 
evidence of aberrant reward processing in SAD, the distinction between a general deficit in 
reward processing, and an isolated abnormality in the processing of social reward is 
important as it may inform future SAD research into ancillary neurotransmitter systems 
beyond the dopaminergic system, such as oxytocinergic and endocannabinoid systems, which 
may play a more specific role in social reward. If confirmed, the presence of reward 
processing disturbances in SAD, and the nature of the components involved, may also have 
prognostic implications in terms of the frequent comorbidity of SAD with mood and 
substance use disorders and may, potentially, guide future therapeutic strategies. 
 
Summary of limitations 
 
The experiments contained in this work had several limitations. Due to both financial 
constraints as well as limited SAD referrals, group sizes were relatively small. Stringent 
quality control of the scan data meant that several participants and their matched controls had 
to be excluded from the analyses, decreasing sample sizes still further. While the limitations 
of small group sizes in neuroimaging research are well-known, it can be argued that 
experiments such as these still contribute to existing knowledge. One of the main drawbacks 
of research using small groups is that sample heterogeneity results in a higher chance of 
positive findings being false. To mitigate against this in prospective work, case-control 
matching for age and gender was performed, an approach that other studies in SAD (many 
with similar sample sizes) have not utilized. Primary analyses were also confined to a priori 
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regions of interest, which further limited the risk of false positives (Cremers and Roelofs 
2016).  
 
Resource constraints also necessitated that therapy effects (in the SAD group) be investigated 
with an uncontrolled study design rather than a randomised control type design, and 
prevented the collection of repeat measures in the HC group. While this weakened the quality 
of evidence that the effects reported were therapy-specific (as opposed to, e.g. a placebo 
effect), such provisional results form the foundation of further study. Finally, it should be 
noted that the retrospective experiment, on resting functional connectivity on perfusion 
SPECT, was performed using different SAD and HC participant samples, with different 
therapy and measurement instruments, to those in the other experiments, which relied on 
prospectively acquired data on different subjects. This introduces a degree of heterogeneity 
which prevents the direct comparison of results across these experiments. 
 
Conclusions and future directions 
 
The goal of a comprehensive model that links the pathophysiology and behavioural features 
of SAD, from genotype to phenotype, is extremely ambitious. To date, piecemeal 
contributions from multiple studies, while valuable, have prevented definitive conclusions 
regarding all but the most rudimentary components of a unified model of the disorder. There 
is for example independent evidence in support of a genetic contribution to SAD (but few 
candidate genetic markers); developmental evidence that behaviourally-inhibited children 
have a high risk of developing SAD (but uncertainty regarding the mechanisms of this 
progression); evidence of hyperactivity in limbic and paralimbic fear circuitry in response to 
provocation (characterizing SAD by its negative valence features, but not by other research 
domains that might be important in its pathophysiology); and evidence of disturbances in 
resting-state networks (but uncertainty how these disturbances predict differences in regional 
activity during various tasks and how they correlate with behaviour).  
 
To further refine models of SAD, substantial investment will be required. Initiatives in this 
regard will almost certainly heavily rely on the analysis of large collaborative databases. The 
advantages to these databanks are two-fold. Firstly, due to the large number of participants 
they contain, it is possible to conduct mega-analyses, which are geared for high power and 
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are able to better deal with participant heterogeneity. Secondly, these databases are frequently 
characterized by the variety of subject-specific measures they contain. This “deep 
phenotyping”, combined with genetic profiling, allows researchers to build links between 
different components of hypothesized models, e.g. between genetic markers and behavioural 
data, or between resting neural networks and task-based neural activations.  These advantages 
make the results obtained both more reliable and more generalizable to wider clinical 
populations. The benefits of “big data” approaches in psychiatry research raise the question 
of whether small studies still have a role to play. For several reasons, the investigators 
involved in this work believe they do. Firstly, the data acquired in small studies comprises a 
significant proportion of the large databases upon which mega-analyses, frequently with 
different research questions, are performed. It can be argued that a key component of small-
scale experiments should be to acquire high-quality data that is then made available to the 
greater research community through contribution to shared databases. Indeed, several of the 
data obtained for this degree have been included in an analysis by the anxiety subgroup of the 
ENIGMA project (Thompson et al. 2017), in which data from multiple sites will be pooled to 
allow higher powered mega-analyses. The other key role of small experiments is exploratory: 
research involving a limited number of participants is typically more flexible than the 
protocols of large collaborative experiments allow, and permits investigators to pursue 
creative ideas, in novel directions. The results generated by such work frequently form the 
basis of hypotheses in larger directed, group efforts. In that respect, the findings reported in 
this work may already contribute to several future research directions. For example, it 
motivates for the inclusion of cerebellum in analyses that investigate regional and functional 
connectivity in the disorder; for the direct investigation of the role of the anterior cingulate 
cortex in modulating treatment response; and further studies to establish a possible link 
between graph metrics of the theory of mind network and observed biases in social 
attribution. Experiments in which investigation of social and monetary reward are included in 
the same imaging paradigm would also be beneficial in determining the specificity of reward 
processing deficits in the disorder. Additional future avenues for pilot research include work 
on novel molecular targets (serotonergic, endocannabinoid), which are particularly attractive 
given the potential therapeutic options these targets represent. Another important contribution 
that can be made by smaller studies is work directed at establishing the reliability of the 
measures utilized in psychiatric research, and quantifying the errors involved. This is 
especially true of neuroimaging methods, for which only limited data on inter- and intra-scan 
variability (whether biological or technical in origin) exists despite this being an important 
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determinant of the effect sizes detectable across groups and within the same subjects over 
time.  
 
In parallel with a trend towards mega-analyses, has come a shift in research priorities in 
psychiatric conditions. Recognizing that current diagnostic systems may artificially 
categorize related psychopathologies as distinct entities, the NIMH Research Domain Criteria 
(RDoC) project for classifying mental illnesses has promoted a trans-diagnostic approach in 
which psychiatric disorders are investigated along various functional domains and constructs 
aimed at identifying the pathophysiological underpinnings of shared features. Ultimately, the 
goal of this new research direction is to establish a diagnostic system for mental disorders 
that is based on pathophysiological processes, rather than observable behaviours and clinical 
consensus. In the case of SAD, this paradigm entails a switch to research of anxiety disorders 
as a combined group (SAD, generalized anxiety disorder, posttraumatic stress disorder, 
obsessive compulsive disorder), rather than as distinct entities, and initially prioritizes 
investigation of the pathophysiological basis of shared features (such as the acute threat 
construct of negative valence systems; or reward learning construct of positive valence 
systems) over the diagnosis-unique elements (e.g. precipitation of anxiety in social situations 
in SAD).  
 
Finally, when considering trends that are likely to shape future research efforts in SAD, it 
would be remiss not to mention technological advances that continue to refine neuroimaging 
research tools. With hybrid modalities such as PET/MR it is possible to acquire simultaneous 
data on blood flow, regional neurotransmitter concentrations, regional electrical activity 
(when acquired with simultaneous EEG recording), as well as physiological measures such as 
heart rate, which given the dynamic and variable nature of neural processes, would not be 
directly correlatable were they acquired serially. Recent advances in motion correction will 
make data acquired with PET and MRI even more reliable.  
 
To conclude, the ultimate goals of SAD research are ambitious and our current knowledge is 
in many respects still rudimentary, but recent alignments of research objectives, coupled with 
technological and analytical advances, mean that there is continuous progress towards a more 
comprehensive understanding of the disorder. As a non-invasive means of dynamically 
visualizing the anatomy and function of the brain, neuroimaging is expected to continue to 
play an essential role in eventually achieving these aims. 
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Appendix – Psychometric Measures 
 
Properties of the various psychological instrument used in this thesis are briefly described 
below. 
 
Structured Clinical Interview for DSM-IV (SCID-I + selected parts of SCID-II) (60 – 120 
min) 
A diagnostic exam used to determine DSM-IV Axis I disorders (major mental disorders) and 
Axis II disorders (personality disorders) (First et al. 2002). 
 
The Edinburgh Handedness Inventory (5 minutes) 
The Edinburgh Handedness Inventory is a 10- item list of items, which provides one with a 
measure of hand laterality (Oldfield 1971). Participants are required to indicate their 
preference in the use of hands in a number of activities. A laterality quotient is then 
calculated from the participant’s response to the inventory, with scores ranging from 0 
(extreme left handedness) to 48 (extreme right handedness). 
 
Liebowitz Social Anxiety Scale (LSAS) (20-30 min) 
A 24-item measure designed to assess both fear and avoidance of social (e.g., going to a 
party, meeting strangers) and performance situations (e.g., taking a test, giving a report to a 
group) occurring in the last week (Liebowitz 1987). Each of the items is rated from 0-3, with 
high scores representing more fear and/or avoidance. 
 
Clinical Global Impressions Improvement scale (CGI-I) (1 min) 
A 7 point scale that requires the clinician to assess how much the patient's illness has 
improved or worsened relative to a baseline state at the beginning of the intervention (Guy 
1976). Rated as: 1, very much improved; 2, much improved; 3, minimally improved; 4, no 
change; 5, minimally worse; 6, much worse; or 7, very much worse. 
 
The Sheehan Disability Scale (1-2 min) 
Developed to assess functional impairment in three inter-related domains; work/school, social 
and family life (Sheehan 1983). Ratings are made on a 10 point visual analogue scale. 
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State Trait Anxiety Inventory State versions (STAI-S) (5 min) 
Consists of a 20-item self-report measure that assesses state level of anxiety (Spielberger 
1983). Form Y (an altered version of the original Form X) which has stronger psychometric 
properties in younger, less educated, or low-SES groups, was used. Respondents indicate how 
much each statement reﬂects how they feel right now (at this moment) on four-point Likert-
type scales. Sample items from the state version include “I feel frightened” and “I feel 
pleasant.”  
 
Beck Depression Inventory II (BDI-II) (10 minutes) 
One of the most widely used instruments for measuring the severity of depression (Beck et al. 
1996). A 21-question multiple-choice self-report inventory. 
 
The Internal, Personal, and Situational Attributions Questionnaire (IPSAQ) (20 min) 
This measures attributional style (Kinderman and Bentall 1996). A 32-item questionnaire 
which can be self-administered or administered by a clinician. Clients are asked to read a 
series of hypothetical scenarios in which they have to imagine themselves having an 
interaction with another person. In these scenarios, clients must first decide what caused the 
scenario and record that response. Clients must then decide who/what caused the scenario 
(i.e. “Something about you?”; “Something about the other person or other people?”; or 
“Something about the situation (circumstances or chance)?”). The resulting data provide a 
measure of the client’s causal locus of control.”  
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